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ABSTRACT
Genetic diversity generates variation at multiple phenotypic levels, ranging from
the most basic molecular to higher-order cognitive and behavioral traits. The far-reaching
impact that genes have on higher traits is apparent in several neuropsychiatric conditions
such as stress and anxiety disorders. Like most, if not all, neural phenotypes, stress,
anxiety, and other emotion-related traits are extremely complex and are defined by the
interplay of multiple genetic, environmental, experiential, and epigenetic factors.
The work presented in this dissertation is a multi-scalar, integrative analysis of the
molecular and neuroanatomic substrates that underlie emotion-related behavior. The
amygdala is a principle component of the limbic system that controls emotionality. Using
BXD recombinant inbred (RI) mice as model organisms, the anatomy and cellular
architecture of the amygdala—specifically, the basolateral amygdala (BLA)—was
examined to assess the level of structural variation in this brain region. Quantitative trait
locus (QTL) analysis was done to identify genetic loci that modulate the neuroanatomical
traits of the BLA. The BXD RI mice were also tested using a variety of behavioral
assays, and this showed a significant association between the BLA size and emotionrelated behavior. The effect of chronic stress on subsequent behavior and endocrineresponse was also examined in several genetically diverse inbred mice.
Finally, to explore the molecular mediators of stress and anxiety, microarrays
were used to assay gene expression in three key corticolimbic brain regions—the
prefrontal cortex, amygdala, and hippocampus. Several large transcriptome data sets were
also analyzed. These expression data sets brought focus on an interval on mouse distal
chromosome 1 that modulates diverse neural and behavioral traits, and also controls the
expression of a plethora of genes. This QTL rich region on mouse distal chromosome 1
(Qrr1) provides insights into how the information in the DNA sequence is conveyed by
networks of co-regulated genes that may in turn modulate networks of inter-related
phenotypes.
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CHAPTER 1. INTRODUCTION
1.1

Complex Traits

A major goal of genetics is to understand how variation in DNA sequence gives
rise to the myriad of individual characteristics that influence traits such as vulnerability to
diseases, physiological makeup, susceptibility to substance abuse and addiction, and even
personality and behavior. There are few cases in which the link between genotype and
phenotype is simple enough that a trait can be traced to a single causal mutation. For
example, sickle cell anemia, the first disease identified to have a genetic basis, is caused
by a single point mutation in the !-globin gene (Pauling et al., 1949; Ingram, 1958).
However, unlike such a monogenic trait, most traits and diseases are complex and result
from the interplay of multiple genetic, epigenetic, and environmental factors. Complex
diseases with polygenics origins include metabolic disorders like hypercholesterolemia
and diabetes, and neuropsychiatric disorders like schizophrenia, bipolar disorder, and
stress and anxiety disorders (Riley & Kendler, 2006; Hovatta & Barlow, 2007; Sklar et
al., 2008).
Even in cases in which a single gene is strongly associated with a particular trait,
the consequence on the phenotype may vary depending on the type of allelic variation.
For example, a rare functionally deleterious knockout mutation in monoamine oxidase A
(MAOA), a gene involved in neurotransmitter degradation, has been shown to cause
violent aggressive behavior in males (Brunner et al., 1993). While this starkly
demonstrates the profound influence genetic variation can have on human behavior, a
more subtle effect of MAOA is seen when the DNA sequence variation is in the promoter
region and effects variation in transcription efficiency rather than protein function (Caspi
et al., 2002). This results in either high or low mRNA levels in individuals carrying the
different alleles. The low expressing variant is associated with violent behavior but this
behavioral trait develops only in males who experienced childhood mistreatment (Caspi
et al., 2002). This underscores the fact that the path from the DNA to phenotype is rarely
straight forward, and the penetrance of a phenotype often depends on environmental
conditions.
1.2

Genetics of Neural and Behavioral Phenotypes

The brain is arguably the most complex organ in the human body. A large fraction
of the mammalian genome, possibly over 75% of all genes, is recruited in the
development and maintenance of the brain (Sutcliffe et al., 1988; Peirce & Williams,
2006). Buttressed by this complex genetics, the brain has an intricate cytoarchitectur,
composed of multiple morphologically discreet regions. It is the neurophysiology within
each brain region and the circuitries between them that ultimately mediate the manifold
functions of the brain and give rise to complex psychological traits and behavior.
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A fundamental question is—how do structural and physiological differences in
the neural structures affect function and behavior? And what are the genetic factors that
contribute to these variations? Psychological traits such as emotional temperament and
behavioral phenotypes show significant inter-individual variations. In addition to
environmental factors and life experiences, multiple genetic factors play important roles
in defining the emotionality and behavior of an individual (Gershenfeld & Paul, 1998).
The heritability of personality traits has been estimated to be as high as 30–60%
(Bouchard, 1994; Gershenfeld & Paul, 1998). It is the genetic differences that make one
individual more vulnerable than another to stressful experiences, and confer risk factors
for different neuropsychiatric conditions such as depression, anxiety disorders, and
addiction (Charney & Manji, 2004; Goldman et al., 2005; Hariri & Holmes, 2006;
Leygraf et al., 2006).
The mouse has been extensively used as a model organism to study the genetics
of behavior (Gershenfeld & Paul, 1998; Willis-Owen & Flint, 2006). Studying behavior
in mice affords several advantages that are lacking in human studies. These include the
ability to strictly control the environment of the animal, to carry out directed mating, and
the availability of several inbred strains with diverse phenotypic profiles. Different
behavioral measures have been used as indicators of cognition and emotionality in
rodents, e.g. open field activity, elevated plus maze, light/dark environment preference,
fear conditioning, forced swim test etc. These studies have uncovered complex genetics
underlying behavior with multiple loci modulating stress responsiveness, fear, and
anxiety levels in mice (Willis-Owen & Flint, 2006). Significant concordance between
human and mouse traits also exists, e.g., the gene Rgs2 was shown to modulate anxiety in
mice, and was subsequently found to be associated with anxiety in human (Yalcin et al.,
2004; Smoller et al., 2008).
1.3

Neuroanatomy of Stress and Emotion-Related Behavior

The amygdala is a neural structure central to the experience of emotions and
expression of emotional behavior. Sensory inputs with emotional components are
transmitted to the amygdala where they are processed and further relayed to other regions
to modulate autonomic and behavioral responses, and to form emotional memories
(LeDoux, 2000; Rosen, 2004). As a neural substrate of emotionality, many
neuropsychiatric disorders have been associated with structural changes in the amygdala.
Individuals with genetically predisposed susceptibility to anxiety and depression have
been shown to have higher amygdala reactivity and smaller amygdala volumes (Pezawas
et al., 2005). Structural changes in the amygdala have also been associated with traumatic
stress disorder, bipolar disorder, and aggressive behavior (Hayek et al., 2005; Pezawas et
al., 2005; Meyer-Lindenberg et al., 2006). In addition to the amygdala, abnormalities in
structures such as the prefrontal cortex, hippocampus and other components of the limbic
system have also been associated with several neuropsychiatric disorders (Drevets, 2000;
Hajek et al., 2005; Vermetten et al., 2006).
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Such associations between neuroanatomy and disease state however do not clarify
whether the structural abnormalities are the cause or effect of neuropathological
conditions. Some studies are beginning to indicate that the neuroanatomical traits may
indeed be predisposing factors for certain disorders. For example, twin studies show that
smaller hippocampal volume, rather than being a consequence of stress, may be a
genetically determined phenotype that predisposes an individual to a higher risk for
developing stress-related disorders (Gilbertson et al., 2002). Structural abnormalities in
the amygdala and prefrontal cortex may also be preexisting risk factors for bipolar
disorder (Hajek et al., 2005). These observations imply that some genetic factors may
have pleiotropic influence on both neuroanatomy and behavior. The genetic analysis of
relevant neural structures may therefore be invaluable in identifying the genes that
modulate behavior.
Studies in mice also show that neuroanatomical phenotypes such as the volume
and cellular composition of the amygdala are highly variable traits with complex
underlying genetics (Mozhui et al., 2007). And such natural variations in the anatomical
phenotypes of the amygdala serve as significant predictors of stress-reactivity and fearrelated behaviors (Yang et al., 2008). These studies highlight the inextricable link
between genetic factors and phenotypes at the structural, physiological, and behavioral
levels, and calls for an integrative approach to analyze complex traits.
1.4

Mapping Loci that Modulate Complex Traits

1.4.1 Basics of QTL Analysis
The large majority of biological traits are polygenic and show quantitative (or
continuous), rather than qualitative (or discreet) variations. For example, body weight,
brain size, levels of anxiety etc., are traits that show quantitative differences among
individuals. The genetic regions that harbor the gene variants that contribute to such
quantitative variations are referred to as quantitative trait loci or QTLs (Lynch & Walsh,
1998). Both QTLs and Mendelian mutations are, simply put, genetic polymorphisms that
lead to phenotypic variations; the main distinction between the two types of loci lies in
the effect size, i.e. the amount of phenotypic variance generated by each locus. In contrast
to Mendelian phenotypes, complex traits are shaped by the action of multiple QTLs, each
QTL contributing to only a portion of the variance. In case of behavioral traits, a single
QTL is estimated to usually contribute to less than 10% of behavioral variance (Flint,
2003).
Identifying the genetic loci that modulate a trait based on correlation between
variation in phenotype and variation in genotype is the essence of genetic mapping. This
first involves systematically genotyping a genetically diverse population using
microsatellite or SNP markers. The phenotype of interest is then measured and its
variability in the population assessed. A statistical test is then carried out to identify
chromosomal regions that segregate with the trait and show linkage with the trait, i.e.,
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identify genetic regions that have the same genotype among individuals with similar trait
values but differ between individuals with dissimilar trait values. The statistical
significant of linkage of a QTL with the trait is expressed as the logarithm of odds ratio
(LOD) or likelihood ratio statistic (LRS) scores with associate p-value.
1.4.2 Inbred and Recombinant Inbred Mice
An invaluable resource in the genetic dissection of complex traits is the
availability of inbred strains of mice that can be used to generate experimental
populations. At the initial step, two inbred strains with divergent phenotypes are selected
as parental strains. To illustrate, C57BL/6J (B6) is a relatively seizure resistant strain
while DBA/2J (D2) is seizure susceptible (Seyfried et al., 1980). Both B6 and D2 have
been densely genotyped. In order to carry out a complex trait analysis of seizure
susceptibility, the two strains can be used as parental strains to derive populations in with
the phenotype and causal gene variants segregate. Firstly, B6 and D2 are crossed to
generate heterozygous F1 hybrids. These hybrids are generally expected to show traits
intermediate between the two parents. A population of F2 intercrosses can then be
derived from the F1s (Figure 1-1). The F2s represent a genetically segregating
population and will show varying levels of seizure susceptibility depending on the
combination of alleles inherited from each parent. QTL analysis can be carried out using
such a collection of F2.
By inbreeding the F2 mice for over 20 generation, inbred mice that are
recombinants of the parental genotype can be generated (Figure 1-1). An extensively
used set of recombinant inbred (RI) strains is the BXD RI mice that were derived by
inbreeding F2 progenies of B6 and D2 parents (Taylor, 1989; Taylor et al., 1999;
Williams et al., 2001b). About a 100 different BXD RI strains, including advanced RI
strains (inbred strains derived from progenitor BXD strains) have now been created for
this mapping panel (Peirce et al., 2004). Such RI mice provide several advantages. Unlike
F2 intercrosses, which are unique and studies with them irreproducible, RI strains are
immortal colonies. The first obvious advantage is that multiple cases of the same RI
strain can be phenotyped and the values averaged to control for environmental noise and
technical error. Studies using RI strains can also be carried out many times under
different environmental conditions or using different experimental protocols. Several
different phenotypes have been measured from the BXDs over the years
(http://www.genenetwork.org) and this allows comparison and correlation across data
sets. For example, amygdala volume data that was collected in 2006 can be correlated
with behavioral data collected in the 1990s to show significant association between the
size of the amygdala and open field behavior (Jones et al., 1999; Mozhui et al., 2008).
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Figure 1-1
Genetic segregation in F2 intercrosses and RI strains
All pairs of autosomal chromosomes (chromosomes 1 to 19) in inbred mice are
homozygous and carry identical maternal and paternal alleles. This figure illustrates one
such pair of autosomal chromosome. F1 hybrid crosses are made by mating two parental
inbred strains, in this case C57BL/6J (B6) and DBA/2J (D2). All mice in the F1
generation are isogenic and inherit one allele from B6 and the other from D2. Because of
reciprocal crossover events, the F1 gametes contain chromosomes that are recombinants
of the two parental chromosomes and mating the F1 mice generates a genetically
segregating F2 generation. The F2 mice can then be inbred to homozygosity over several
generations to form strains of inbred mice that are recombinants of the parental
chromosomes, and hence termed recombinant inbred (RI) strains.
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1.5

Systems Genetics Approach to Complex Traits

1.5.1 Gene Expression as an Intermediate Phenotype
Genetic variation can cause marked differences in gene expression among
individuals. By setting the rate of transcription and mRNA degradation, and coding for
allelic variants and alternative splicing, the DNA sequence essentially directs the amount
and type of RNA and protein produced by each gene. The quantitative and qualitative
differences in mRNAs and proteins can be considered as phenotypes that are at the most
basic molecular level (Damerval et al., 1994; de Vienne et al., 1994). Since it is from this
milieu of molecules that all higher phenotypes emerge, understanding how genetic
variation modulates gene expression is fundamental to understanding the molecular
origins of complex traits.
Microarray technology has been a boon in the study of gene expression. This
technology has made it possible to efficiently profile the expression level of numerous
genes in genetically diverse populations of organisms, including human and mice. Such
transcriptomic data have been generate for a wide variety of cell types and tissues,
including several different neural tissues from experimental mouse populations
(Hitzemann et al., 2004; Chesler et al., 2005; Peirce et al., 2006; Yang et al., 2006). The
expression level of an mRNA species can be highly variable and heritable in nature
(Brem et al., 2002; Schadt et al., 2003; Chesler et al., 2005). Similar to organism-level
phenotypes (now termed as ‘classical phenotypes’ to distinguish them from molecular
phenotypes), expression traits can exhibit Mendelian or multigenic inheritance patterns
and are therefore amenable to QTL analysis.
One aspect of expression traits that differs from classical phenotypes is that each
mRNA and protein species has a corresponding genetic locus that harbors the parent
gene. Because of this, a QTL that modulates gene expression can either be located close
to the parent gene or at a distance from the parent gene. A QTL that maps close to the
parent gene indicates cis-acting regulatory mechanisms (cis-QTL), and implicates
sequence variations within or close to the gene (e.g. in regulatory elements such as
transcription factor binding sites) as being responsible for the variation in transcript level.
A QTL that maps at a distance from the parent gene indicates trans-acting regulatory
mechanisms controlling the expression of the gene (trans-QTLs).
1.5.2 Systems Genetics
The information in the DNA sequence is transmitted via networks of genes and
molecular pathways and can have influence at multiple phenotypic levels. With the
generation of transcriptome data sets, it is now possible to analyze gene expression on a
global scale and identify gene networks that may be the molecular correlates of organism
level phenotypes (Bystrykh et al., 2005; Chesler et al., 2005; Schadt et al., 2005). This
has led to the conception of systems genetics, an integrative analytical approach that
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attempts to develop a more comprehensive view of an organism by collectively studying
many phenotypes and multiple genetic and environmental factors (Williams, 2006).
Systems genetics has been defined as “the integrative study of a multitude of gene
variants and a rich admixture of phenotypes.” Each phenotype is considered within the
backdrop of many other interrelated phenotypes, and associated gene networks.
Such an integrative approach to complex traits has become feasible only with the
production of large genomics resources such as dense genotype and SNP sequences, and
transcriptome and proteome data sets. Another area that has been vital to systems
genetics has been the development of bioinformatics resources that curate large data sets,
and provide sophisticated computational tools and analytical systems (e.g. the genome
browser at http://genome.ucsc.edu, Mouse Phenome at http://www.phenome.jax.org,
GeneNetwork at http://www.genenetwork.org).
1.6

Organization of the Dissertation

The work presented in this dissertation is a systems genetics approach to study
neuroanatomical traits in relation to emotion-related behavior. The main focus is on the
basolateral amygdala (BLA), but several other brain regions, including the prefrontal
cortex, hippocampus, and striatum, have also been considered.
To begin with, Chapter 2 examines the morphology and cytoarchitecture of the
BLA in a panel of 35 BXD RI and parental strains, and F1 hybrids (Mozhui et al., 2006).
This analysis revealed significant variation in structural traits of the BLA, and identified a
significant QTL on chromosome associated with the volume of the BLA. In addition to
the QTL on chromosome 8, few other suggestive QTLs were also detected.
In Chapter 3, the natural variations in the BLA volume are associated with stress
reactivity and fear learning behavior (Yang et al., 2008). This study showed that mice
with smaller BLA exhibited more pronounced fear learning and released more
corticosterone in response to stress. This demonstrates that structural trait of a brain
region can have a significant influence on behavior.
Chapter 4 examines the effect of chronic stress on subsequent behavior and
endocrine response. To introduce more genetic diversity, seven inbred strains, including
B6 and D2, were tested using behavioral assays of anxiety- and depression-related
behavior. Gene expression in the BLA, PFC, and hippocampus of B6 and D2 mice was
also evaluated. The expression study detected different sets of stress-sensitive genes in
B6 and D2. This study especially highlighted several genes involved in controlling the
circadian rhythm (e.g. Per1, Per2, Per3). Many of the stress sensitive genes are also
known to be associated with neurological disorders in human.
In Chapter 5, the focus is shifted to a genetic region that harbors many QTLs.
This chapter examines the QTL rich on mouse distal chromosome 1 or Qrr1 (Mozhui et
al., 2008). This QTL region appears to harbor multiple loci that control both gene
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expression and several neural traits, including the volume of the hippocampus, and
several emotion-related behavioral traits. Many genes detected to be differentially
expressed between B6 and D2 are also located in this region. By apply high-resolution
mapping and by examining multiple crosses, Qrr1 was subdivided into two broad QTL
regions. Formin 2 (Fmn2) was identified as a high priority candidate gene that may be the
chief modulator of expression traits that map to Qrr1.
Finally, Chapter 6 summarises the results and gives a concluding discussion of
the work reported in this dissertation.

8

CHAPTER 2. GENETIC AND STRUCTURAL ANALYSIS OF THE
BASOLATERAL AMYGDALA COMPLEX IN BXD RECOMBINANT INBRED
MICE*
2.1

Synopsis

The amygdala integrates and coordinates emotional and autonomic responses. The
genetics that underlie variation in amygdala structure may be coupled to variation in
levels of aggression, fear, anxiety, and affiliated behaviors. We systematically quantified
the volume and cell populations of the basolateral amygdala complex (BLA) across 35
BXD recombinant inbred (RI) lines, the parental strains—C57BL/6J (B6) and DBA/2J
(D2)—and F1 hybrids (n cases = 199, bilateral analysis). Neuron number and volume
vary 1.7- to 2-fold among strains (e.g., neuron number ranged from 88,000 to170,000).
Glial and endothelial populations ranged more widely (5- to 8-fold), in part because of
higher technical error. A quantitative trait locus (QTL) for the BLA size is located on
chromosome (Chr) 8 near the Large gene. This locus may also influence volume of other
regions including hippocampus and cerebellum. Cell populations in the BLA appear to be
modulated more weakly by loci on Chrs 11 and 13. Candidate genes were selected on the
basis of correlation with BLA traits, chromosomal location, SNP density, and expression
patterns in the Allen Brain Atlas. Neurod2, a gene shown to be significant for the
formation of the BLA by knockout studies, is among the candidate genes. Other
candidates include Large, Neurocan, and Thra. Responses to drugs of abuse and
locomotor activity were the most notable behavioral correlates of the BLA traits.
2.2

Introduction

The amygdala is a composite of functionally distinct nuclear groups in the
forebrain. It is neuroanatomically intricate and comprised of as many as 13 different
nuclei connected by complex intrinsic, and afferent and efferent connections (Pitkänen et
al., 1997). It is a major constituent of the limbic system and is regarded as a crucial neural
component underlying the experience of emotions and emotion-related cognitive
functions (McIntyre et al., 2003; McGaugh, 2004). Evidence supports its role in the
mediation of aversive and rewarding emotions (Rogan & LeDoux, 1996; LeDoux, 2000;
Calder et al., 2001; Baxter & Murray, 2002; Lee et al., 2004), and the extensive
connections it shares with the dopaminergic reward systems (Friedman et al., 2002)
indicates an amygdalar contribution in the neurophysiology of reward, anxiety,
motivation, and addiction (Phillips et al., 2003; Ciano & Everitt, 2004).
A number of human psychopathological disorders are accompanied by alterations
in the size and cytoarchitecture of the amygdala. Examples include abnormal reductions
*

Adapted with permission from Springer. Mozhui K, Hamre KM, Holmes A, Lu L,
Williams RW (2007). Genetic and structural analysis of the basolateral amygdala
complex in BXD recombinant inbred mice. Behav Genet 37:223–243.
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in volume among patients with schizophrenia (Niu et al., 2004), bipolar disorder
(Blumberg et al., 2003), depression (Rosso et al., 2005), and Williams Syndrome (Reiss
et al., 2004); and abnormal increases in volume and cell density among autistic patients
(Abell et al., 1999). Interestingly, recent studies suggest that functional abnormalities in
the amygdala of certain patient groups may be partly of genetic origin. For example,
polymorphic variants in the human serotonin transporter and monoamine oxidase A
genes are associated with trait differences in amygdala volume and/or functional
responses to aversive stimuli (Hariri & Holmes, 2006; Meyer-Lindenberg et al., 2006).
Thus genetic analysis of the structural variations of the amygdala may provide insights
into the functional and behavioral significance of such variances.
Genetic heterogeneity generates significant variations in phenotypes ranging from
expression levels of mRNAs and proteins, the size and shape of neurons and neural
structures, through to innate and learned behaviors. We are just beginning to understand
relations among sequence differences, environmental factors, and diverse multiscale
phenotypes. Mice provide an excellent population model to study such genetic and
phenotypic variability. The environment of diverse sets of strains (a test population) can
be fixed or systematically varied. In particular, the set of BXD strains (Peirce et al., 2004)
has proved to be an extremely valuable reference population to study networks of
phenotypes and their modulation by gene variants (Chesler et al., 2003; Chesler et al.,
2005). The parental strains, B6 and D2, have been sequenced, and approximately 2
million single nucleotide polymorphisms (SNPs) between them have been identified.
Complex trait studies with the BXDs are also bolstered by the availability of a
broad web-based data compilation of these strains’ genotypes, numerous behavioral and
physiological phenotypes, and microarray expression profiles, and integrated analytical
tools maintained in GeneNetwork (GN, http://www.genenetwork.org). Previous studies
have used the BXD RI panel to analyze the genetic determinants of differences in size
and cell number of brain structures including the cerebellum, hippocampus, neocortex,
striatum, and olfactory bulb (Neumann et al., 1993; Rosen & Williams, 2001; Airey et al.,
2002; Seecharan et al., 2003; Airey et al., 2005; Li et al., 2005). In the present study, we
have undertaken a complex trait analysis of the BLA. Its volume and densities of three
cell types—neurons, glia, and endothelial cells—were measured from 35 BXD strains
and their parental strains and F1 hybrids. In addition to identifying QTLs that may be
significant for the development and structure of the BLA, we performed correlative
analysis with mRNA expression levels in the brain, and with behavioral phenotypes
catalogued in GN. Such an integrated study can potentially determine modulatory roles of
multiple genetic factors in establishing brain morphology, and their influence on
neurophysiology, function, and behavior (Chesler et al., 2003).
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2.3

Materials and Methods

2.3.1 Subjects
Measurements were taken from brain sections of a set of 35 BXD RI strains, the
parental B6 and D2 strains, and F1 hybrids. The serial sections used in this study are all
part of the Mouse Brain Library (MBL) collection of physical sections. Images of these
sections can also be downloaded from http://www.mbl.org (Lu et al., 2001; Rosen et al.,
2003; Seecharan et al., 2003). The BXD strains are completely inbred and have been
generated by the repeated mating between siblings starting from the F2 stage (Taylor,
1989; Taylor et al., 1999). The animals were purchased from the Jackson Laboratory (Bar
Harbor, ME) and housed in a pathogen free colony at the University of Tennessee Health
Science Center. Animals were acclimatized for at least two weeks in the University of
Tennessee animal facility before use. Number of animals housed in a single cage did not
exceed 5 and the average cage density was 3 per cage. They were maintained on a 14/10h
light-dark cycle at 20-24˚ C and fed 5% fat Agway Prolab 3000 rat and mouse chow. The
average age of mice from which data were collected was 96 days (ranging from 30 to 500
days), and a total of 96 females and 103 males were used. All procedures followed the
guidelines of institutional animal care and use committee.
2.3.2 Fixation and Sectioning
As described previously (Airey et al., 2001; Lu et al., 2001; Seecharan et al.,
2003), mice were deeply anaesthetized with Avertin, and perfused through the heart with
0.1M phosphate buffered saline. This was followed by solutions of: 1.25%
glutaraldehyde and 1.0% paraformaldehyde in phosphate buffer (0.1 M); and 2.5%
glutaraldehyde and 2.0% paraformaldehyde in phosphate buffer. Brains were dissected
out and weighed. Brain tissues were subsequently embedded in celloidin and sectioned
along the coronal or horizontal planes at 30 !m thickness with a sliding microtome, and
stained with cresyl violet. Every tenth section was mounted on a slide and coverslipped.
An interval thickness of 300 !m separates adjacent sections on each slide (Rosen &
Williams, 2001). In the MBL, the majority of the cases have two sets of serial section
slides per brain (slide A and slide B).
2.3.3 Volumetric Measurement
Volumetric measurements were taken from a total of 199 brains. An average of 5
subjects was used per strain, and with the exception of BXD37, all other strains’ means
are representatives of at least four subjects. For BXD37, measurements were taken from
only 2 individuals due to limited availability. We decided to include the BXD37 data
because its inclusion or exclusion did not have a major affect on the subsequent linkage
analysis. Of the 199 cases, 175 were coronal sections and 24 were horizontal sections.
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The limited use of horizontal sections is because the outline of the BLA is more clearly
definable in the coronal sections.
The amygdala is a complex neural structure and has been divided into distinct
nuclear complexes, and further sub-divided into nuclei and sub-nuclei regions (Pitkänen,
2000). For this study, we took measurements from the portion of the BLA complex that is
bordered laterally by the amygdalar capsule (amc) (Swanson & Petrovich, 1998), and
medially by the external capsule (ec). These clear demarcations and definability would
ensure consistent morphometric measurements. This portion of the BLA complex
includes the lateral nucleus, which is further subdivided into the dorsolateral (LaDL),
ventrolateral (LaVL) and ventromedial (LaVM) sub-nuclei, and the basolateral nucleus,
which is further subdivided into the anterior magnocellular (BLA) and posterior
parvicellular (BLP) sub-nuclei (Figure 2-1A). These divisions have been made according
to a standard atlas of the brain of B6 (Franklin & Paxinos, 2001). The basomedial nucleus
is also a part of the BLA complex but it was not included in our measurements because
its border is less clearly definable and may have added to data inaccuracy.
NIH Image (version 1.63) was used for volumetric analysis. Images from serial
sections were captured from a Zeiss light microscope to a computer. After calibrating the
instrument to a standard length of 1 mm, the border of the amygdala delineating the BLA
was manually traced and area determined. Such manual measurements were taken along
the entire rostrocaudal thickness of the BLA (approximately 6–9 sections for each brain)
at an interval thickness of 300 !m. Measurements were taken bilaterally and the final
values represent the left-right average. Because the majority of the cases have two sets of
serial sections, the average BLA complex volume for most individual cases was

Figure 2-1
Neuroanatomy of the basolateral amygdala
(A) Nissl stained coronal section from MBL (bregma: –1.8). Outlined is the portion of the
BLA complex that included the lateral nucleus (LaDL, LaVL) and the basolateral nucleus
(BLA); amc: amygdalar capsule; ec: external capsule. (B) Expression of the Large gene
in the BLA complex (in situ taken from Allen Brain Atlas; Large_277_030609127-2,
positon: 6925).
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calculated from a total of four sets of measurements, i.e. bilateral measurement from
slides A and B.
To correct for the volumetric shrinkage caused by histological processing, the
measured values were divided by the total brain volume and multiplied by the brain
volume expected for that brain weight. The brain density of the MBL tissues is taken to
be 1.05 mg per mm3 of fixed tissue. The post-processing total brain volume was
determined by point counting and the method is described in Williams (2000). After each
individual volume measurement was corrected for shrinkage, the strain averages were
determined.
2.3.4 Stereological Methods
We applied the three-dimensional direct cell counting technique that was
developed by Williams and Rakic (1988) to estimate cell density and total number. We
used the whole-section method as it gives a relatively unbiased estimate of cell number
from a tissue section and avoids the error caused by differential shrinkage along the zaxis (von Bartheld, 2001). A count box of 32 x 33 x 30 !m was superimposed over the
live image of the section, and we followed the standard counting rules defined by
Gundersen (1977), and Williams and Rakic (1988). The same counting protocol was used
as described previously by Seecharan et al. (2003). Distinction between cell populations
was based on established criteria (Ling et al., 1973; Satorre et al., 1986) and as used by
Seecharan et al. (2003). Cells were classified into three groups: neurons, glial cells, and
endothelial/other cells. No distinction was made between projection neurons and
interneuron. Cells whose identity could not be discerned with certainty were included in
the endothelial/other group.
Stereological measurements were limited only to coronal sections from which the
volumetric measurements were taken and the horizontal sections were excluded. From
each serial section slide, the section that had the most complete representation of the
BLA complex was chosen for cell counting. A total of 10 sites were sampled from each
side of the BLA complex (2 sites for each sub-nuclei) by focusing the x100 oil objective
(NA 1.25) over each sub-nuclei (LaDL, LaVL, LaVM, BLP, BLA). Counts were taken
bilaterally and for each case, the final cell number represents the left and right average.
The number of subjects used for each strain is lower for the stereological data at an
average of 4 subjects per strain. The data for BXD37 and BXD11 represent the average
of only two individuals.
To assess the validity of stereological method we compared counts obtained from
right and left sides. While there will be some genuine left-right asymmetry, most
variation is likely to be due to sampling and technical errors (Williams et al., 1996).
Paired t-test showed no significant difference between the cell counts taken from the left
and right BLA (t165 = 1.72, p = 0.08 for glia; t165 = 1.15, p = 0.25 for endothelial cells;
t166 = 1.54, p = 0.13 for neurons). However, BLA volume—which we consider to be the
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most reliable data with a low coefficient of error—has a modest but statistically
significant left-right asymmetry (t195 = 2.5, p = 0.01).
2.3.5 Statistics
Data were organized using a spreadsheet program (Excel) and most exploratory
analysis and statistical tests were performed using Data Desk (http://www.datadesk.com).
To examine effects of cofactors such as brain weight, body weight, age, and sex on the
BLA, we applied multiple linear regression. In the case of the volume data, the plane of
section was also included as a factor. In addition, the effect of each variable as a single
factor was also examined by simple regression analysis, and the percentage of variance
explained by a covariate was computed from the adjusted correlation coefficient.
Individual trait values rather than strain means were used for regression analysis.
Residual values were calculated only for those factors that were significant predictors.
The corrected data, adjusted for these effects (residual + mean), provide a more accurate
estimate of variability specific to the BLA. The adjusted data were also used for linkage
analysis.
Effect of strain on trait variance was used as an estimate of trait heritability. The
intra-class correlation coefficient was computed by performing an analysis of variance
(ANOVA) with strain as a single factor and this provides an estimate of strain effect on
trait variance.
2.3.6 Genotyping and QTL Mapping
The B6 and D2 strains differ significantly in sequence and approximately 2
million informative SNPs have been defined across the genome (see
http://www.genenetwork.org/beta/snpBrowser.py). A subset of approximately 14,000 of
these sequence variants (SNPs and microsatellites) have been used to genotype the BXD
strains (Williams et al., 2001b; Peirce et al., 2004; Shifman et al., 2006;
http://www.well.ox.ac.uk/mouse/INBREDS/). The BLA trait data were entered into GN
and QTL mapping was performed using the WebQTL mapping module.
For linkage analysis, WebQTL performs intervals mapping using 3,795 SNP and
microsatellites as markers. The non-parametric p-value (alpha of 0.05) of the linkage
ratio statistic (LRS) is computed by performing 1000 or more permutations. This
threshold is denoted by the upper horizontal line in linkage maps. A suggestive LRS
threshold is set at a genome-wide alpha of 0.63 and is denoted by the lower horizontal
line in the linkage map. Two-thousand or more bootstraps are also performed by GN to
estimate the confidence limit of the location of the QTL peak interval, and the results are
represented as a “frequency of peak LRS value” histogram. Another parameter computed
by WebQTL is the additive effect, which is an estimate of the quantitative effect of an
allele on the measured phenotype. In the case of the BXDs, a locus can have a B6 allele
(B) or a D2 allele (D) and the additive effect is half of the difference between the means
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of homozygous cases and is calculated as: (mean of BB cases)–(mean of DD cases)/2.
The red plot in the linkage graphs denotes a positive effect by the B allele and for
computational purpose, GN gives it a nominal negative value; a positive effect by D
allele is denoted by the green plot and is assigned a positive value. These values are in the
same units as the data, in this case mm3 for volume, and number/mm3 for cell density.
Using the additive effect value, the effect size of a QTL and the percentage of variance
attributed to a QTL are approximated.
Correlative analysis with behavioral phenotypes and gene transcript expression
The GN analytical tools are integrated with data sets of numerous BXD behavioral and
physiological phenotypes, and microarray data of gene expression in the brain (Chesler et
al., 2003; Chesler et al., 2005), and this facilitates correlative analyses across a wide
range of data sets. Transcript expression levels were treated as complex traits and their
covariance with the BLA neuroanatomical traits analyzed. Both Pearson’s productmoment and Spearman’s rank correlation can be computed. For this study, we calculated
the Pearson’s product-moment correlation between the BLA traits and the mRNA
expression level data “INIA Brain mRNA M430 (Jan06)”. We also referred to the in situ
gene expression data provided by Allen Brain Atlas (ABA) (http://www.brain-map.org)
to check for the expression levels of the candidate genes within the BLA. Correlation
analysis was also done with BXD neuroanatomical and behavioral traits.
2.4

Results

2.4.1 Volume of the BLA Complex
The BXD strains exhibit a wide range of variation in the volume of the BLA.
BXD19 has the largest mean volume at 1.8 ± 0.08 mm3 and BXD29 has the smallest at
1.07 ± 0.03 mm3 (Table 2-1). This amounts to a 1.7-fold difference in size. However,
there is no significant difference between the parental strains (B6 at 1.628 ± 0.1 mm3, D2
at 1.55 ± 0.06 mm3). Relatively small phenotypic difference between parental strains
while the progeny RI strains display a wider range of variation is attributed to random
assortment of multiple alleles at different loci (Neumann et al., 1993). Depending on the
combination of alleles at multiple loci inherited from the parents, a phenotype may be
either enhanced or diminished in the offspring. Approximately 35% of the variance in
BLA volume is due to strain genotype (F (37, 198) = 2.16, p = 0.0005).
F1 hybrids have the largest BLA and this is consistent with the F1s possessing
larger traits for the lateral geniculate nucleus (LGN) (Seecharan et al., 2003), olfactory
bulb (Williams et al., 2001a), body weight, and brain weight. More robust traits in the
F1s can be explained by positive heterosis and hybrid-vigor (Falconer & Mackay, 1996).
While the size of the BLA may be modulated by specific genetic factors, the BLA
may also be under the influence of genes that have more widespread effects. It is possible
that variation in its size could partially be accounted for by variations in the overall brain

15

Table 2-1

Basolateral amygdala volume and cell number

Group

N

VA
(mm3)

VB
(mm3)

VC
(mm3)

ND

Neur
(!1K)

Gli
(!1K)

Endl
(!1K)

C57BL/6J 6 1.63
1.49
1.61
5
119
17
19
DBA/2J
6 1.55
1.63
1.56
5
116
14
14
BXD1
6 1.57
1.46
1.58
5
146
25
23
BXD2
5 1.43
1.4
1.39
5
131
16
14
BXD5
6 1.60
1.36
1.6
4
129
16
18
BXD6
5 1.22
1.32
1.26
4
88
7
15
BXD8
5 1.51
1.51
1.5
5
134
10
11
BXD9
5 1.51
1.5
1.52
3
145
7
15
BXD11
5 1.48
1.47
1.5
2
158
26
7
BXD12
6 1.47
1.44
1.45
5
169
19
15
BXD13
6 1.39
1.41
1.38
6
145
20
9
BXD14
5 1.49
1.44
1.44
5
134
17
14
BXD15
5 1.42
1.35
1.35
3
152
4
13
BXD16
6 1.55
1.48
1.54
5
130
14
11
BXD18
6 1.48
1.5
1.48
5
135
9
13
BXD19
6 1.80
1.82
1.81
5
151
14
15
BXD20
4 1.52
1.59
1.53
4
141
9
19
BXD21
4 1.45
1.45
1.45
5
128
11
15
BXD22
8 1.57
1.5
1.55
5
126
15
17
BXD23
5 1.48
1.44
1.45
5
102
15
13
BXD24
5 1.52
1.55
1.49
4
140
9
13
BXD25
5 1.40
1.48
1.47
5
111
11
21
BXD27
5 1.43
1.6
1.43
4
127
11
25
BXD28
4 1.37
1.45
1.39
3
117
17
24
BXD29
5 1.07
1.19
1.09
4
115
7
25
BXD30
5 1.14
1.34
1.19
4
121
9
16
BXD31
5 1.52
1.56
1.49
3
169
14
24
BXD32
6 1.61
1.56
1.61
6
132
16
22
BXD33
5 1.32
1.34
1.35
5
140
15
23
BXD34
6 1.54
1.56
1.53
6
148
17
22
BXD35
5 1.47
1.47
1.48
5
113
16
24
BXD36
6 1.44
1.49
1.48
4
150
17
11
BXD37
2 1.40
1.42
1.34
2
117
25
5
BXD38
5 1.43
1.47
1.44
3
111
9
15
BXD39
5 1.34
1.4
1.38
5
97
12
18
BXD40
6 1.50
1.5
1.54
5
117
19
22
BXD42
5 1.44
1.37
1.45
4
106
8
23
A
B
N: number of cases per strain for volumetric data; V : raw BLA volume; V : corrected
volume after adjusting for brain weight; VC: corrected volume after adjusting for body
weight; ND: number of cases per strain for stereology; Neur: number of neurons; Gli:
number of glial cells; Endl: number of endothelial/other cells.
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weight, body weight, age, or sex. The degree of covariance of the BLA volume with
these biological factors was evaluated by regression analyses. Multiple linear regression
showed brain weight to be a significant predictor of the BLA volume (t195 = 4.96, p "
0.0001). In contrast, body weight, age, and sex of an animal, and the plane of section, are
not significant factors for the BLA volume. However, body weight, when used as a single
regression factor, correlates significantly with the BLA volume (t195 = 3.1, p = 0.002) but
is estimated to account for only ~5% of the variance. As a single factor, brain weight
accounts for ~17% of the variance (t197 = 6.27, p " 0.0001). Sex, age, and plane of section
continue to be insignificant predictors when used as single regression factors. After
adjusting the data for the effects of brain weight, and body weight, the corrected data
were used for linkage analyses (Table 2-1).
2.4.2 BLA Cell Counts
Neurons account for 80% of the cell population in the BLA. There is about a
2-fold difference in both the number and density of neurons among the BXD strains.
BXD12 has the highest population at 169,200 ± 14,300; BXD6 has the lowest at 88,100 ±
8000 (Table 2-1). As was true for volume, parental strains do not differ significantly
(118,800 ± 7,500 in B6 versus 115,600 ± 6,200 in D2). The number and density of nonneuronal cells vary greatly among BXDs with as much as an 8-fold range in the
population of glial cells (lowest for BXD15 at 3,700 ± 1,300 and highest for BXD11 at
26,400 ± 6,500) and a 5-fold range in the population of endothelial cells (lowest for
BXD37 at 5200 ± 3500 and highest for BXD27 at 25,200 ± 6400). We suspect that some
of this variation must be technical, but there is no reciprocal relation between glial cell
and endothelial cell counts expecting if cell identification were a major problem. As
expected given its large volume, F1 hybrids possess the highest group means for both
glial and endothelial cells (Table 2-1). However, the neuron population does not appear
to follow this trend and F1s possess average number of neurons and somewhat lower
neuron density. The effect of strain on variability in neuron number is over 40% (F (37,166)
= 2.88, p < 0.0001). Strain also accounts for 30–40% of the variance in glial cell number
(F (37,166) = 1.87, p = 0.005).
For the neuron population, multiple linear regression with brain weight, body
weight, age, and sex showed none of these factors to be significant predictors. However,
regression analysis with body weight as a single factor revealed it to be a statistically
significant predictor of the neuron number (t158 = 2.34, p = 0.02). Used as single
regression factors, brain weight, age, and sex do not show significant covariance with
neuron number.
From the regression analyses, we note a great deal of similarity between the BLA
volume and glial cell traits. As in the case of the volume, when multiple linear regression
is done using brain weight, body weight, age, and sex as co-factors, only the brain weight
serves as a significant predictor of the glial cell number, but body weight becomes a
significant predictor of glial cell number when it is used as a single regression factor (t158
= 3.28, p = 0.0013) and is estimated to account for 6% of the variance. The brain weight
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is estimated to account for 7% of variance (t164 = 3.52, p = 0.0006). Age and sex are
insignificant predictors of the glial cell population. The endothelial cell population
appears to be unaffected by variations in brain weight, body weight, age and sex.
We note a rather large coefficient of error (CE = standard error/group mean) in the case
of the glial cells (average CE of 0.3) and endothelial cells (average CE of 0.2). This high
CE is suggestive of high error rate in data collection, though there is also the possibility
that there may be higher within-strain variation for the glial and endothelial cell
populations than for neurons. The CE for both the BLA volume and neuronal population
averages at only 0.06.
2.4.3 QTL Analysis for BLA Volume
The genome-wide linkage map for the raw BLA volume revealed a significant
linkage interval on mid-Chr 8 (Figure 2-2A). This linkage interval is located between 65
and 75 Mb, and has a peak LRS of 14, just above the significant threshold. At this locus,
the D allele has the positive additive effect and is estimated to increase the volume by
~10%. Two suggestive linkages are also detected on proximal Chr 1 (between 50 and 60
Mb; LRS 9.0) and mid-proximal Chr 19 (between 22 and 28 Mb; LRS 9.2). At each of
these suggestive linkage intervals, the B allele increases volume by ~10%.
To assess global effects of brain weight and body weight on the linkage map, the
BLA volume was regressed against these two factors and the adjusted data were used for
interval mapping. Differences in QTLs between the adjusted and raw data would indicate
the level of specificity of a particular QTL for the BLA. Adjusting for brain weight
eliminates the suggestive linkages on Chr 1 and Chr 19 (Figure 2-2B). The linkage to
Chr 8, though weakened, persists at a suggestive LRS of 10.7. The location of the linkage
interval is unchanged (between 65–75 Mb) and the D allele continues to have the positive
additive effect. Regression against body weight also decreases the linkages to Chr 1 and
19, but augments the linkage to mid-Chr 8 to an LRS of 15 (Figure 2-2C). Thus the
linkage to mid-Chr 8 is consistently detected on all the linkage maps for the BLA
volume, and the significant strength of association (genome-wide p " 0.05) qualifies it as
a QTL for the BLA volume. We will refer to this QTL as Vol8a. However, the reduction
in its strength upon adjusting the data for the effect of brain weight indicates a pleiotropic
interaction of Vol8a with the size of the BLA and the overall brain weight. Vol8a lies
only ~10 Mb proximal to the Cerebellar size 8a (Cbs8a at 45 cM) QTL (Airey et al.,
2001).
Simple interval mapping with the stereological data yielded only suggestive QTLs
for the neuron (Figure 2-3A) and glial cell populations (Figure 2-3B). No linkage
interval was uncovered for the endothelial cells. Both the neuron and glial cell densities
share suggestive linkages to mid-proximal Chr 13. Though the overlap in not precise, the
linkage intervals for both the neuron and glial traits reside at close proximity, the
suggestive LRS peaking at 11.4 for the neuron density and at 10.2 for the glial density. It
is noted that this linkage interval is also close to the hippocampal volume QTL, HipV13a
(Peirce et al., 2003). At this locus, it is the D allele with the positive additive effect for

18

Figure 2-2
QTL analysis of BLA volume
(A) BLA volume has a significant QTL on Chr 8 (LRS 14) and suggestive peaks on Chrs
1 (LRS 9) and 19 (LRS 9.2). (B) Adjusting BLA volume for brain weight reduces QTL
on Chr 8 but linkage remains above suggestive threshold (LRS 10.7). (C) Adjusting
BLAc volume for effect of body weight increases QTL on Chr 8 (LRS 15). Blue plot:
LRS; green plot indicates positive additive effect for D allele and red plot indicates
positive additive effect for B allele; yellow histogram: frequency of peak LRS; pink
horizontal line: significant LRS threshold at genome-wide p " 0.05; grey horizontal line:
suggestive LRS threshold at genome-wide p " 0.63.
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Figure 2-3
QTL analysis of BLA cell counts
(A) BLA neuron density has a suggestive linkage on Chr 13 (LRS 11.4). (B) Glial cell
density in the BLA has suggestive linkages on Chrs 11 (LRS 11.4) and 13 (LRS 10.3).
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both neuron and glial cell densities and is estimated to increase the neuron density by
12% and the glial density by more than 35%.
Another suggestive association is observed for the density of glial cells on distal
Chr 11. The suggestive LRS peaks at ~11.4 between 90 and 105 Mb. Glial density, after
correction for the effect of brain weight, maps to this locus at a nearly significant LRS of
14.8. The LRS peaks almost precisely over the NeuroD2 gene located at ~98 Mb. The B
allele at this locus is estimated to increase the glial cell density by more than 25%. Other
then the effect of increasing the peak over NeuroD2, regression of the cell counts data
against brain weight and body weight do not cause major alterations in the linkage maps.
2.4.4 QTL Specificity
Brain weight and body weight are the two most significant predictors of the BLA
structure. A genome wide linkage analysis was performed for brain weight (Figure 2-4A)
and body weight (Figure 2-4B) to identify any genetic loci that may primarily modulate
these global traits but are also linked with the size or cell populations of a specific brain
structure such as the BLA. This is a cautionary step to avoid erroneous identification of a
more general QTL with widespread effects as being specific for the BLA.
The brain weight variation is associated with a suggestive QTL on Chr 19. For the
body weight, suggestive linkages occur on Chrs 7, 10, and 19. This indicates the linkage
interval on Chr 19 to primarily modulate gross structures, with a non-specific association
with the BLA. Both brain weight and body weight also have linkage peaks of Chr 1, and
though both are below the suggestive thresholds, these linkage peaks may account for the
suggestive LRS on Chr 1 for the BLA volume that was weakened by regression against
brain weight and body weight.
2.4.5 Correlations between BLA Volume and Cell Populations
The strongest correlation among the BLA neuroanatomical traits is between its
volume and glial number (Figure 2-5A) with a positive Pearson’s product correlation r =
0.5, p = 0.0007. Weaker but significant positive correlations exist between the volume
and glial cell density (Figure 2-5B; r = 0.4, p = 0.03), and volume and neuron number
(Figure 2-5C; r = 0.4, p = 0.02). Neuron density in the BLA has the tendency to correlate
negatively with volume, and though this does not reach statistical significance (Figure
2-5D; r = -0.3, p = 0.1), the negative association indicates that smaller BLA will have
slightly higher neuronal density. As expected, strong positive correlations relate cellular
densities with number. This is especially true for the near perfect correlation between the
density and number of glial cells (Figure 2-5E; r = 0.9). Correlation between the number
and density of neurons is also highly significant but less stringent compared to glial cells
(Figure 2-5F; r = 0.7, p = 1.2x10-6).
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Figure 2-4
QTL maps of brain and body weight
Genome-wide linkage map for (A) brain weight: suggestive linkage on Chr 19; and (B)
body weight: suggestive linkages on Chrs 7, 8, 19. The linkage on Chr 19 overlaps with
the suggestive linkage for the BLA volume on Chr 19.
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Figure 2-5
Correlations between neuroanatomical traits of the BLA
Correlations between BLA neuroanatomical traits (A) x-axis: volume, y-axis: glial number (r = 0.5, p = 7.3 x 10-4); (B) x-axis:
volume, y-axis: glial density (r = 0.4, p = 0.03); (C) x-axis: volume, y-axis: neuron number (r = 0.4, p = 0.02); (D) x-axis: volume, yaxis: neuron density (r = –0.3, p = 0.1); (E) x-axis: glial number, y-axis: glial density (r = 0.9, p = 0); (F) x-axis: neuron number, yaxis: neuron density (r= 0.7; p = 1.1 x 10-6). (G) Cluster QTL map to detect common and unique linkages. Rows 1–6: raw volume,
body weight adjusted volume, glial number, glial density, neuron number, neuron density. The demarcations along the long-axis
represent Chrs 1 to X; red-yellow and blue-green color gradations code for intensity of linkage with higher trait values for D allele,
and B allele respectively.

To provide an overview of linkage intervals that may be common for the BLA
neuroanatomical traits, a cluster map was generated for, from rows 1 to 6, the raw
volume, body weight adjusted volume, glial number, glial density, neuron number, and
neuron density (Figure 2-5G). In addition to the overlapping linkage interval of Chr
13for the neuron and glial cell populations, closely aligned linkage intervals can be
detected on Chr 1 for all traits, on Chr 3 for the neurons and glial cells, on Chr 5 for the
volume and glial cells, and on Chr 6 for the volume and neuron number. These linkages
are below the significant threshold but may indicate potential shared QTLs.
The complex trait analysis of the BLA uncovered only one significant QTL,
Vol8a, associated with its volume, and two suggestive linkage intervals on Chr 11 and
Chr 13 associated with the cellular traits.
2.4.6 Neuroanatomical Correlates of BLA and Comparative QTL Analysis
GN maintains an archive of diverse phenotypes (BXD Published Phenotypes
database) previously collected from the BXD strains by different researchers. This makes
it possible to search for traits with significant covariance with the BLA. The “Trait
Correlation” tool was use to compute correlations between the BLA structural traits and a
variety of other BXD phenotypes that range from physiology, neuroanatomy of other
brain regions, to behavior. This analysis showed that the top 15 strongest correlates are
all neuroanatomical traits. The strongest association is between the BLA volume and the
volume of the hippocampus proper (Figure 2-6A; r = 0.7, p = 4.5x10-6, N = 34) and its
sub-regions such as the dentate gyrus (r = 0.5, p = 0.001) and pyramidal cell layer (r =
0.5, p = 0.003). The volume of the BLA also correlates significantly with the sizes of the
striatum (Figure 2-6B; r = 0.6, p = 1.2x10-5, N = 36), and the lateral geniculate nucleus
(Figure 2-6C; r = 0.5, p = 4.5x10-3, N = 35).
To determine if the linkage intervals identified in this study are specific for the
BLA, or if common QTLs may be involved in modulating the sizes of different brain
structures, we retrieved the volumetric data for the cerebellum and internal granular layer
(IGL) (Airey et al., 2001), total hippocampus, hippocampus proper, dentate gyrus and
pyramidal cell layer of the hippocampus (Lu et al., 2001; Peirce et al., 2003), LGN
(Seecharan et al., 2003), striatum (Rosen et al., 2009), and olfactory bulb weight
(Williams et al., 2001a), and performed multiple QTL mapping for these traits. To
display the overlapping linkage intervals, a cluster QTL map was generated for, from
rows 1 to 10, the IGL, IGL adjusted for brain weight, striatum, hippocampus proper,
dentate gyrus, BLA, LGN, olfactory bulb weight, BLA neuron density, and BLA glial
density (Figure 2-6D). This analysis confirms Vol8a as a major neuroanatomical QTL
but makes it less specific for the BLA. Vol8a is linked to the volumes of the IGL and the
whole cerebellum, striatum, and hippocampus proper, but not with the volumes of the
dentate gyrus, and LGN. A hint of linkage is also visible between the olfactory bulb
weight and Vol8a. In all these cases, it is the D allele in Vol8a that has the positive
additive effect. The Cbs8a QTL reported previously (45 cM; Airey et al., 2001) lies only
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Figure 2-6
Correlations between BLA volume and other brain structures
Significant correlations between BLA volume (x-axis) and volumes of (A) hippocampus proper (r = 0.7, p = 4.5x10-6, number of
cases N = 34); (B) striatum (r = 0.6, p = 1.2x10-5, N = 36); and (C) LGN (r = 0.5, p = 0.004, N = 35). (D) QTL cluster map for
volume traits. Rows 1-10: raw IGL, IGL adjusted for brain weight, striatum, hippocampus proper, dentate gyrus, BLA, LGN, olfactory
bulb weight, BLA neuron density, BLA glial density. Shared linkage interval on Vol8a for IGL, straitum, hippocampus proper, and
BLA volumes.

slightly distal to Vol8a. After the cerebellum and IGL volumes are adjusted for brain
weight, their linkage interval is shifted from Vol8a to Cbs8a. It is uncertain if Vol8a and
Cbs8a are two separate QTLs with Cbs8a specific for the cerebellum, or if they represent
the same QTL but appear separate due to low mapping resolution. If the later is the case,
then there is consensus for the linkage interval to be located on Vol8a. Vol8a may be
selectively modulating the sizes of more than one brain structure but not of other brain
structures such as the LGN and the dentate gyrus.
2.4.7 Behavioral Correlates of BLA and Comparative QTL Analysis
After the neuroanatomical traits, another category of phenotypes that show
significant covariance with the BLA structure is behavioral phenotypes related to
addiction, and locomotor activity (Table 2-2; Figure 2-7A). Among these, cocaine open
field center time behavior (GN trait ID 10333), which assesses the effect of an addictive
substance on a behavioral measure of locomotor activity and emotionality, shows the
most significant correlation with the BLA volume, and the same trait also correlates
significantly with the neuron number (r = -0.5, p = 0.02, N = 23). To search for possible
common QTLs shared between the BLA and its correlated behavioral phenotypes, a
cluster QTL analysis was performed and the most striking overlap of QTLs was found
between the BLA volume and the cocaine open field behavior. Another correlated
behavior that shares a linkage interval on Vol8a is the locomotor behavioral response
measured by Palmer et al. (2002; GN trait ID 10453). A multiple QTL map was
generated for these three traits (Figure 2-7B; red: cocaine open field, green: locomotor
response, blue: BLA volume). Three overlapping linkage peaks are observed for BLA
volume and cocaine open field behavior: (1) though the LRS is only of suggestive
strength, the cocaine open field behavior has a linkage overlapping Vol8a, (2) significant
peak for the behavioral trait on mid-proximal Chr 1 overlaps the peak that was observed
for the BLA traits on Chr 1, (3) though below the suggestive threshold for both traits,
another shared peak in LRS is observed on proximal Chr 5. Another region of overlap,
but with a much weaker LRS is observed on the distal end of Chr 18. A peak on Vol8a is
also present for the trait 10453, which measures the effect of 2-hydroxypropyl-betacyclodextrin on locomotor activity (Palmer et al., 2002).
Other significant correlates of the BLA volume are: distance traveled in open field
(r = 0.6, p = 0.003, N = 17; trait ID 10843; Yang et al., 2008); conditioned place
preference (r = –0.6, p = 0.003, N = 22; GN trait ID 10093, Cunningham, 1995); baseline
locomotor activity in grid test (r = –0.5, p = 0.02, N = 26; GN trait ID 10503, Phillips et
al., 1996); saccharin preference (r = –0.5, p = 0.02, N = 22; GN trait ID 10550, Risinger
et al., 1998); pentylenetetrazol induced seizure (r = –0.5, p = 0.02, N = 24; GN trait ID
10614, Wakana et al., 2000); ethanol induced locomotor response (r = 0.4, p = 0.02, N =
28; GN trait ID 10790; Demarest et al., 2001); ethanol intake (r = 0.5, p = 0.03, N = 19;
GN trait ID 10074, Crabbe et al., 1983).
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Table 2-2

Behavioral correlates of BLA

X-Axis
BLAc Traits
Volume
10674
10674
10674
10674
Glial cells
10879
10879

Y-Axis
Behavioral Traits

r

p

N

10333: Cocaine open filed-center time
(Jones et al., 1999)
10095: Locomotor activity (Cunningham,
1995)
10490: Cocaine induced sensitization of
locomotor response (Phillips et al., 1998)
10453: Locomotor response (Palmer et al.,
2002)

-0.6

0.001

23

-0.6

0.002

22

0.5

0.01

27

0.5

0.005

26

10038: Distance traveled (Bolivar &
Flaherty, 2003)
10783: Novel food preference (Bolivar &
Flaherty, 2004

0.6

0.002

27

-0.5

0.009

26

27
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Figure 2-7
Correlations between BLA and behavioral phenotypes
(A) Significant correlations between BLA neuroanatomical phenotypes and behavioral traits (traits, from left to right, listed in (Table
2-2). (B) Multiple genome-wide linkage map for cocaine open field (red), locomotor response (green), and BLA volume (blue).
Ovelapping linkage peaks on Chrs 1, 5, and Vol8a.

2.4.8 Candidate Genes
To narrow the search for candidate genes located within a linkage interval, we
selected only those genes that have SNPs between the parental alleles and whose wholebrain expression levels correlate significantly with the BLA traits. Cis-acting genes,
which self-regulate their own expression, are considered to be stronger candidates for
complex traits as the association between trans-acting genes and complex traits tends to
be more complicated (Chesler et al., 2003; Chesler et al., 2005; Kempermann et al.,
2006). A criterion for cis-regulated genes is that the genome-wide linkage maps for the
expression levels of these genes should have a significant LRS peak within 10 Mbs of its
chromosomal location (Chesler et al., 2003; Bystrykh et al., 2005; Chesler et al., 2005).
Several cis-acting genes located in Vol8a correlate with the BLA size and cell
counts. Of these, Large (like-glycosyltransferase) shows a very high expression
specifically in the BLA (referred to Allen Brain Atlas, Figure 2-1B). It is implicated in
the glycosylation of extracellular matrix (ECM) components such and the Large mutant
mouse serves as a model for muscular dystrophy and exhibits abnormalities in neuronal
migration (Brockington et al., 2005). Other Vol8a candidates include Ssbp4, Zfp617,
Sfrs14, and Fcho1. Proteoglycan components of the neural ECM are considered to
provide the supporting microenvironment vital for proliferation, migration and
differentiation of cells in the nervous system (Oohira et al., 2000; Ida et al., 2005).
Chondroitin sulfate proteoglycan 3 (Cspg3) or Neurocan, and Spock3 or Testican3, are
two such neural proteoglycan genes located in Vol8a. Both Cspg3 and Spock3 are
expressed in the BLA (ABA), and though neither are cis-acting genes, they are also
considered as possible candidates.
The expression of NeuroD2 (neurogenic differentiation 2) correlates significantly
with all aspects of the BLA structure though it is only the glial cell population that maps,
at a suggestive LRS, to its locus on Chr 11. The whole-brain expression level of NeuroD2
correlates significantly with the density of neurons (r = 0.5, p = 0.002, N = 29; Figure
2-8A), density of glial cells (r = 0.5, p = 0.007, N = 29; Figure 2-8B), and volume of
BLA (r = 0.4, p = 0.03, N = 29; Figure 2-8C). NeuroD2 belongs to the bHLH
transcription factor family, and these transcription factors have been implicated in
guiding neuron versus glial fate choice of cortical cells (Cai et al., 2000). Specific loss of
the BLA has been shown in NeuroD2-null mice and the heterozygotes develop smaller
BLA and exhibit aggressive and lowered anxiety behaviors (Lin et al., 2005). The top
four transcripts that correlate with BLA volume all belong to GH (Growth Hormone)
located on Chr 11 at ~106 Mb (r = 0.7, p = 0.0000009). This may be significant as this is
only ~8 Mb from NeuroD2. However, NeuroD2 does not appear to be cis-regulated, and
other genes located within this interval also correlate with the BLA traits. These include
Dlgh4, Thra, Igf2bp, and Plxdc1. Based on a higher SNP density and a tendency for cisregulation, Thra (thyroid hormone receptor alpha), which lies within 1 Mb of NeuroD2,
is also a prime candidate gene. Thra is strongly expressed in the BLA (ABA) and animals
with mutant Thra have been reported to have anxiety, memory, and locomotor
impairments (Venero et al., 2005), and abnormal fear and open field behaviors (GuadañoFerraz et al., 2003).
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Figure 2-8
Correlations between NeuroD2 and BLA traits
Whole-brain expression levels of NeuroD2 (x-axis) correlates significantly with BLA (A)
neuron density (y-axis) (r = 0.5, p = 0.002, N = 29), (B) glial density (y-axis) (r = 0.5, p =
0.007, N = 29), and (C) volume (r = 0.4, p = 0.03, N = 29).
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2.5

Discussion

2.5.1 Summary
We evaluated the genetic modulation of anatomical variation of the BLA using a
diverse panel of strains. Variation for many key parameters among normal strains is often
2-fold or greater. We uncovered a significant QTL on mid-Chr 8 (Vol8a) strongly linked
to BLA volume. This region of Chr 8 also contains loci that modulate volume of the
cerebellum, striatum, and several hippocampal regions (e.g., the pyramidal cell layer), but
not the size of the hippocampal dentate gyrus or the LGN. The most parsimonious
explanation is that a single gene variant modulates the size of several regions, but given
the size of the Chr 8 QTL interval (~10 Mb) and the large number of candidate genes,
this may be a chance colocalization of a set of gene variants with independent
mechanisms of affecting the volume of diverse brain regions. A suggestive linkage
interval on Chr 13 that may modulate neuron and glial populations in the BLA also
overlaps a hippocampal volume QTL (HipV13a).
The most BLA-specific linkage interval is on Chr 11 and it associates specifically
with the glial cell population, but the linkage is only suggestive. However, this locus is
particularly interesting because it overlaps the chromosomal location of NeuroD2, a gene
that is already known to control the BLA development (Lin et al., 2005). Expression of
this gene also correlates significantly with the volume of the BLA and its glial and
neuronal cell populations.
2.5.2 Technical Issues
Estimates of glial cell and endothelial cell numbers have comparatively high
errors—CE averaging at 0.3 and 0.2 respectively. While there is the possibility that the
higher CE reflects greater intra-strain variation among isogenic mice, it may also indicate
technical limitations in accurate data collection. A possible factor may be the lower
average packing density and cell count of the glial and endothelial cell populations
relative to the neuron population. The glial and endothelial cells are also considerably
smaller in size than the neurons. Despite these differences, we used the same counting
criteria for all three cell-types. Thus the volume of tissue through which counts were
taken may provide a less adequate representation of the glial and endothelial cell
distribution in the BLA because fewer of these cells would be included, and this may
have resulted in higher sampling variance. A count box of larger dimensions would have
reduced the variance observed in these data (Rosen & Williams, 2001).
Another factor that may have contributed to the high CE is the low sample sizes
from which the cell counts were collected. Adding more subjects would have provided a
better representation of a strain’s average trait and have lowered the error rate. We used
only the coronal sections for stereological measurements as the cell counting process
required a more discrete identification of the sub-nuclear regions within the BLA and this
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proved to be a difficult task with the horizontal sections. Despite the low sample size, the
error rate is low for the neuron data with a CE of only 0.06. Nevertheless, we consider the
volumetric measurements to be the most reliable trait data we have gathered for the BLA,
and it is the linkage map and the QTL yielded by this data that we place more confidence
on. However, a concern with the volumetric data is the use of both coronal and horizontal
sections. Unlike the cell counting process, the volumetric measurements required the
identification of the gross outline of the amygdala from multiple serial sections and
summing of these areas to obtain the volume, and measurements could be taken from
both coronal and horizontal sections. More coronal sections than horizontal sections were
used because the BLA structure is more clearly distinguishable in the coronal sections,
but for the final data, strain means were calculated from both types of sections. The
regression analysis does not indicate the inclusion of horizontal sections to have a
significant effect on the volume data.
2.5.3 Interactions between QTLs
Are genetic effects on BLA volume and cell populations specific to this region or
are they merely secondary effects of variance in brain weight? Variation in volume of
specific brain regions may correlate with variation in brain weight. For example, overall
BLA volume correlates with brain weight (explained variance of 16%). At a finer grain
of analysis, we can now begin to resolve the sources of this type of covariance. The
strongest and most significant BLA volume locus, Vol8a, also modulates the volumes of
the cerebellum and hippocampus, but does not appear to modulate total forebrain volume
(Beatty & Laughlin, 2006). This suggests that the covariance between BLA volume and
brain weight can actually be decomposed into an amygdala-hippocampus-cerebellum
shared QTL.
An interesting point from this analysis is the quantitative effects of the B and D
alleles on the size of the BLA. In the case of Vol8a, the D allele has the positive additive
effect and contributes to a larger BLA. In contrast, the suggestive linkage on Chr 19 has
the B allele with a positive additive effect for both the BLA size and brain weight. This
may be reflected by the larger brain weight and the generally higher BLA trait values in
B6 compared to D2 mice (Table 2-1). However, it is worth noting that after regression
correction for brain weight, the relative volume of B6 BLA is actually smaller than that
of D2, though this difference does not reach statistical significance. This trend is
consistent with the surprising finding that despite having a much smaller brain than B6,
the area of the neocortical barrel field (rostral and dorsolateral neocortex) of D2 is
significantly larger than that of B6 (Airey et al., 2005; Li et al., 2005).
Linkage of variation in glial cell density to Chr 11 appears to be more BLA
specific. In contrast to most other traits, regression of this trait against brain weight
strengthens the LRS.
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2.5.4 Relations with Other CNS Structures
The amygdala and hippocampus are two closely associated limbic structures and
the covariance in their sizes and possible common genetic linkages is not unexpected.
However, the most intense linkage of Vol8a is with the sizes of the BLA and the raw
IGL, and Vol8a lies only slightly proximal of Cbs8a (Airey et al., 2002). Although the
cerebellum is not a limbic structure, it has been attributed with emotion-related cognitive
functions and shares connections with the limbic system (Lee et al., 2004). In addition,
both the amygdala and cerebellum have been implicated in the etiology of autism (Abell
et al., 1999). Interestingly, in a study on the coordinated evolution of functionally and
neuroanatomically related brain regions, the amygdala and cerebellum were the two
structures that were unexpectedly indicated to have undergone correlated evolutionary
changes in size across animal species (Barton & Harvey, 2000). These observations point
to a more intimate relation between the amygdala and cerebellum.
2.5.5 Implications for Behavioral Phenotypes
A large literature implicates the amygdala in a range of behavioral processes
(McIntyre et al., 2003; McGaugh, 2004), and mediation of behavioral responses to drugs
of abuse (Ryabinin et al., 1999; Floyd et al., 2003; Sharpe et al., 2005). Of particular
salience to the present findings, Lin et al. (2005) recently found that mutant mice lacking
NeuroD2 have reduced cell number and volume of the BLA, but not other amygdala
nuclei. These mice also exhibit low levels of anxiety and impaired emotional learning.
This provides an example of how genetically-driven abnormalities in BLA volume may
translate to disturbances in complex behavioral phenotypes (Rosvold et al., 1954; Prather
et al., 2001). In this context, a correlative analysis of BLA traits with a range of
behavioral phenotypes catalogued in GN highlights significant associations between BLA
and responses to drugs of abuse, and emotionality. The association is especially
significant between the BLA volume and cocaine induced behavioral responses as
measured by the open field behavior (Jones et al., 1999; GN trait 10333). The shared
linkage intervals between the brain structure and behavioral phenotype signify multiple
genetic loci that may modulate the formation and structure of a neural substrate, which, in
turn, underlies a complex behavior. Several studies have underscored the role of the BLA
in chronic addiction to drugs of abuse and cocaine seeking behavior (See et al., 2003;
Fuchs et al., 2006), and psychostimulants which alter locomotor activity levels in animals
have been shown to have specific effects on the basolateral complex (Trinh et al., 2003).
A genetic dissection of the amygdala may provide further insights into genetics of these
behaviors.
2.5.6 Conclusion
In this study we combined three complimentary methods to study the BLA: (1) a
classic quantitative dissection of the BLA; (2) an analysis of gene expression across the
same BXD strains, as well as high resolution spatial data on gene expression using in situ
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gene expression data provided by ABA; and (3) a correlative analysis using 30 years of
studies on the BXD strains. On the basis of transcript expression covariance with the
BLA size and cell populations, and the presence of SNPs, the following three genes are
prime candidates: Large, NeuroD2, and Thra.
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CHAPTER 3. VARIATION IN MOUSE BASOLATERAL AMYGDALA
VOLUME IS ASSOCIATED WITH DIFFERENCES IN STRESS REACTIVITY
AND FEAR LEARNING*
3.1

Synopsis

A wealth of research identifies the amygdala as a key brain region mediating
negative affect, and implicates amygdala dysfunction in the pathophysiology of anxiety
disorders. Although there is a strong genetic component to anxiety disorders such as
posttraumatic stress disorder (PTSD) there remains debate about whether abnormalities in
amygdala function predispose to these disorders. In the present study, groups of C57BL/6
x DBA/2 (B x D) recombinant inbred strains of mice were selected for differences in
volume of the basolateral amygdala complex (BLA). Strains with relatively small,
medium, or large BLA volumes were compared for Pavlovian fear learning and memory,
anxiety-related behaviors, depression-related behavior, and glucocorticoid responses to
stress. Strains with relatively small BLA exhibited stronger conditioned fear responses to
both auditory tone and contextual stimuli, as compared to groups with larger BLA. The
small BLA group also showed significantly greater corticosterone responses to stress than
the larger BLA groups. BLA volume did not predict clear differences in measures of
anxiety-like behavior or depression-related behavior, other than greater locomotor
inhibition to novelty in mice with smaller BLA. Neither striatal, hippocampal nor
cerebellar volumes correlated significantly with any behavioral measure. The present data
demonstrate a phenotype of enhanced fear conditioning and exaggerated glucocorticoid
responses to stress associated with small BLA volume. This profile is reminiscent of the
increased fear processing and fear reactivity that is associated with amygdala excitability
and reduced amygdala volume in humans carrying loss of function polumorphism in the
serotonin transporter and monoamine oxidase A genes. Our study provides a unique
example of how natural variation in amygdala volume associates with specific fear- and
stress-related phenotypes in rodents, and further supports the role of amygdala
dysfunction in anxiety disorders such as PTSD.
3.2

Introduction

The past decade has seen great advances in understanding how genetically driven
individual differences in the anatomy and function of specific brain regions confer risk
for a variety of neuropsychiatric diseases (Caspi & Moffitt, 2006; Hariri et al., 2006).
This literature is based upon the assumption that associations between genes, neural
function, and clinical end points are causative in nature. However, associations between
clinical symptoms and measures of neural activation are invariably made a posteriori:
*

Adapted with permission from Nature Publishing Group. Yang RJ, Mozhui K, Karlsson
RM, Cameron HA, Williams RW, Holmes A (2008). Variation in mouse basolateral
amygdala volume is associated with differences in stress reactivity and fear learning.
Neurophychopharmacology 22:2595–2604.
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that is, after the phenotype is observed. By contrast, there has been little demonstration
that variation in a brain region of interest can successfully predict, a priori, the likely
prevalence of a clinical or behavioral trait.
A pertinent case in point is posttraumatic stress disorder (PTSD). There is a
significant genetic component to risk for PTSD (Kendler, 2001), as well as neurological
abnormalities in unaffected probands that are suggestive of antecedent genetic or familial
risk factors (Gurvits et al., 2006). Functional neuroimaging studies have identified
hyperactivityof the amygdala as a neural correlate for the clinical symptoms seen in
PTSD (Rauch et al., 2006; Shin et al., 2006). In addition, some but not all structural
imaging and postmortem studies have found a trend for smaller left amygdala volume in
patients with the disorder (Bremner et al., 1997; Bonne et al., 2001; De Bellis et al., 2001,
2002; Fennema-Notestine et al., 2002; Lindauer et al., 2004; Wignall et al., 2004; Karl et
al., 2006). Taken together, these findings suggest that amygdala dysfunction may
predispose individuals to PTSD and other stress-related disorders. However, while there
are data showing that smaller hippocampal volume can precede the development of
PTSD (Gilbertsob et al., 2002), the hypthesis that variation in amygdala anatomy can lead
to PTSD has not been directly tested.
A major role for the amygdala in PTSD is consistent with a large corpus of data
from animal models demonstrating amygdala mediation of a spectrum of behavioral and
mnemonic functions that include, but are not limited to, the regulation of emotion and
negative affect (Davis & Whalen, 2001; Robbins & Everitt, 2002; Fanselow & Poulos,
2005; Phelps & LeDoux, 2005). Ablation of specific subnuclei of the rat amygdala
produces alterations in certain fear-, anxiety-, and stress-related behaviors. Specifically,
the basolateral amygdala complex (BLA) appears necessary for the formation and/or
expression of associative fear memories. This has led to a model in which the lateral
nucleus within BLA serves as a convergence site for sensory and aversive information
that is relayed eitherdirectly or via the basal nucleus to the major output center of the
amygdala, the central nucleus (CeA), to drive fear-related behaviors (Fanselow &
LeDoux, 1999; Maren & Quirk, 2004). Thus, rodents receiving pre-training lesions of the
lateral, but not basal, nucleus fail to form fear memories (Goosens & Maren, 2001; Nader
et al., 2001; Koo et al., 2004), while post-training lesions of the basal nucleus prevent the
expression of fear memory but not the ability to acquire new memories (AngladaFigueroa & Quirk, 2005). These findings provide clear evidence that the BLA is
necessary for certain forms of learned fear behavior. They do not, however, address the
issue of whether natural variation in amygdala anatomy and function is sufficient to
predict differences in these behaviors.
In the present study, we sought to address this issue by utilizing a genetically
defined panel of C57BL/6 x DBA/2 (BXD) recombinant inbred strains that we have
recently shown to exhibit up to 2-fold variation in BLA volume in large sample of 37 RI
lines (Mozhui et al., 2007). BXD RI mice are inbred strains derived from C57BL/6 and
DBA/2 (Taylor, 1989; Chesler et al., 2003) that have been used to identify chromosomal
loci underlying fear- and anxiety-related phenotypes (Caldarone et al., 1997; Owen et al.,
1997; Wehneret et al., 1997; Valentinuzzi et al., 1998), as well as volume and cell
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number variation in various brain regions (Neumannet et al., 1993; Airey et al., 2001,
2002; Lu et al., 2001; Rosen &Williams, 2001; Williams et al., 2001a; Seecharan et al.,
2003). We selected 17 BXD RI lines and assigned them to subgroups with relatively
small, medium, and large BLA volume. Our objective was to test whether a priori
categorization of mice according to BLA volume differences within a natural range was
sufficient to predict differences in fear-, anxiety-, and stress-related phenotypes. The
results obtained provide some of the strongest evidence to date that genetically driven
variation in amygdala volume is sufficient to predict the magnitude of fear- and stressrelated phenotypes.
3.3

Materials and Methods

3.3.1 Histology
Histological analysis of the BXD RI lines was performed previously at the
Department of Anatomy and Neurobiology, University of Tennessee Health Science
Center, and is described in detail by Mozhui et al. (2007). Briefly, the BLA complex was
defined as the portion between the external capsule and the amygdalar capsule, as
described by Swanson and Petrovich (1998). This includes the lateral and basolateral, but
not basomedial, nuclei (Figure 3-1A). Images from bilateral 30 mm thick serial sections
were captured from a Zeiss light microscope to a computer and the BLA was manually
traced to determine cross-sectional area (mm2) along the entire rostrocaudal thickness of
the BLA (B6–9 sections for each brain). Volume was calculated by multiplying the
interval thickness between serial sections (which was 300 mm) and correcting for
volumetric shrinkage caused by the histological process ((measured values/total brain
volume) x expected brain volume for given brain weight). Post-processing total brain
volume was determined by the point-counting method described by Williams (2000).
These data can be viewed at an anatomical database at http://www.genenetwork.org.
3.3.2 Selection of BXD RI Lines and Assignment to BLA Volume Groups
In an earlier study, we conducted a comprehensive analysis of 35 BXD RI lines
(plus the C57BL/6J and DBA/2J parental lines) for BLA volume (Mozhui et al., 2007).
This revealed up to 2-fold variation in BLA volume across this panel of RI lines. In the
current study we obtained a subset of this larger panel. We selected lines on the basis of a
desire to obtain a range of relatively small, medium, and large BLA volumes; but this
was limited by the availability of lines from a single commercial vendor (The Jackson
Laboratory, Bar Harbor, ME), which was necessary to avoid a potentially confounding
source of variability (ie supplier). Of the 15 BXD RI lines (plus the C57BL/6J and
DBA/2J parental lines) obtained, we cross-referenced with the dataset (Mozhui et al.,
2007) to assign an approximately equal number of lines to ‘small,’ ‘medium,’ and ‘large’
groups. This resulted in five lines in the small group (BXD13, BXD21, BXD28, BXD38,
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Figure 3-1
Basolateral amygdala volume differences in BXD RI lines
(A) Neuroantomical definitions of the BLA complex. (B) BLA volume differences in
mice selected for relatively small (S), medium (M), and large (L) BLA. (C) Dorsal
striatal, total hippocampal, and total cerebellar volume differences in mice selected for
BLA volume differences (n = 24–34 per volume group). **p < 0.01 vs L, ## p < vs M.

38

and BXD39), seven lines in the medium group (BXD8, BXD11, BXD12, BXD23,
BXD31, BXD34, and DBA/2J), and five lines in the large group (BXD16, BXD19,
BXD22, BXD32, and C57BL/6J). Next, we took the BLA volume data for each line (an
average of n = 4–8 mice per line) from the dataset (Mozhui et al., 2007) and calculated
the mean average and within-group variance of BLA volume within each of our three
volume groupings. Volume differences between the subgroups were then analyzed using
one-way analysis of variance (ANOVA) followed by Newman–Keuls post hoc analysis.
This showed that the subgroups differed significantly from one another (main effect of
volume group: F2, 14 = 18.58, post hoc comparisons: all p < 0.01). For depiction of mean
differences and within-group variance as measured by standard error, see Figure 3-1B.
To determine whether BLA volume differences in our groups generalized to other
brain regions, we obtained the volume values for dorsal striatum (caudate putamen), total
hippocampus, and total cerebellum in each of the RI lines we tested from
http://www.genenetwork.org. These data were originally described in the following
sources: for dorsal striatum, Rosen and Williams (2001) and Lu et al. (2001); for
hippocampus, including dentate gyrus, excluding subiculum, Peirce et al. (2003); and for
cerebellum, Airey et al. (2001). One-way ANOVA and post hoc tests showed that the
subset of RI lines we designated as the large BLA groups also had significantly greater
striatal volume than the group designated as the small BLA group (main effect of group:
F2, 14 = 3.78, p < 0.05, post hoc comparison: p < 0.05; Figure 3-1C). ANOVA showed
that the BLA subgroups did not significantly differ in either total hippocampal or
cerebellar volume (Figure 3-1C).
3.3.3 Animal Husbandry and Behavioral Phenotyping
Mice were bred at The Jackson Laboratory and transported to the NIH at ~8
weeks of age and housed 1–4 per cage in same-strain groupings in a temperature- and
humidity-controlled vivarium under a 12 h light–dark cycle (lights on 0600 hours). There
were a total of 190 male mice at the start of the study, with at least n = 8–12/RI line
except for BXD28 (n = 5). This resulted in a total of 47 mice in the small BLA group, 82
in the medium BLA group, and 61 in the large BLA group. Behavioral testing was
conducted during the light phase between 0900 and 1700 hours. Given evidence of
qualitative differences between rodent tests for anxiety-like behavior (Holmes et al.,
2003), three separate tests were employed. Mice were tested on a battery of tests in the
following order with the putatively more stressful assays at the end of the sequence and at
least 1 week between tests: exploratory and anxiety-like behavior (novel open-field,
elevated plus-maze, light–dark exploration tests), Pavlovian fear conditioning,
depression-related behavior (forced swim test, FST), hot plate (as a control for pain
perception in fear conditioning), and glucocorticoid responses to stress (corticosterone
levels following swim stress). All experimental procedures were performed in accordance
with the National Institutes of Health Guide for Care and Use of Laboratory Animals and
were approved by the local Animal Care and Use Committee.
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3.3.4 Pavlovian Fear Conditioning
Pavlovian fear conditioning (Kim & Fanselow, 1992) was conducted in a chamber
with transparent walls and a metal rod floor based on methods described previously
(Wellman et al., 2007). To provide a distinctive olfactory environment, the chamber was
cleaned between subjects with a 79.5% water/19.5% ethanol/1% vanilla extract solution.
After an initial 120 s acclimation period, the mouse received three pairings (60–120 s
interval after each pairing) between the conditioned stimulus (CS; 30 s, 80 dB, 3 kHz
tone) and the unconditioned stimulus (US; 2 s, 0.6mA scrambled footshock), in which the
US was presented during the last 2 s of the CS. The presentation of stimuli was controlled
by a San Diego Instruments (San Diego Instruments, San Diego, CA) or Med Associates
fear conditioning system (Med Associates, Burlington, VT).
After 24 h, expression of the fear memory for the CS was tested in a novel
context, in a different room from training. The novel context had black/white checkered
walls and a solid Plexiglas, opaque floor. This chamber was cleaned between subjects
with a 50% ethanol/50% water solution. After an initial 180 s acclimation period, the CS
was continuously presented for 180 s. After 24 h, expression of the fear memory for the
conditioned context was tested in the same room as conditioning by placing the mouse in
the training chamber for 5 min. Freezing was defined as absence of any visible movement
except that required for respiration, and was scored at 5 s intervals by an observer who
was blind to BXD line. The number of observations scored as freezing was converted to a
percentage ((number of freezing observations/total number of observations) x 100) for
analysis.
The hot plate test was conducted as a control for group differences in pain
perception (Boyce-Rustay & Holmes, 2006). The apparatus was a flat plate (Columbus
Instruments, Columbus, OH) heated to 551C on which the mouse was placed. The
latency to show a hind paw shake or lick was timed by an observer, with a maximum
response latency of 30 s.
3.3.5 Depression-Related Behavior and Glucocorticoid Responses to Stress
The FST was conducted as previously described (Porsolt et al., 1978; Hefner &
Holmes, 2007). The apparatus was a transparent Plexiglas cylinder (25 cm high, 20 cm
diameter) filled halfway with water (24 ± 1° C) into which the mouse was gently lowered
for a 10 min trial. The presence/absence of immobility (cessation of limb movements
except minor involuntary movements of the hind limbs) was manually observed using an
instantaneous sampling technique every 5 s during the last 8 min and expressed as a
percentage of total observations. The result was converted to a percentage ((number of
immobility observations/total number of observations) x 100) for analysis.
Glucocorticoid responses to stress were measured after a 4-week rest period
following the FST described above. The mouse was subjected to a 10 min forced swim
stress trial and then returned to the home cage. After 30 min, mice were killed via rapid
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cervical dislocation and decapitation to collect trunk blood. Nonstressed controls were
killed within 30 s of removal from the home cage. To minimize disturbance of
nonstressed controls, all mice were individually housed 24 h prior to killing. Blood
samples were centrifuged at 13 000 r.p.m. for 30 s. Serum was extracted and assayed for
total corticosterone (bound and free) using the Coat-a-Count RIA TKRC1 kit (limit of
detection 5.7 ng/ml; Diagnostic Products Corp, Los Angeles) as previously described
(Boyce-Rustay et al., 2007).
3.3.6 Anxiety-Related Behavior
The novel open-field test was conducted as previously described (Wiedholz et al.,
2007). The apparatus was a square arena (39 cm x 39 cm x 35 cm) with opaque white
Plexiglas walls and floor that was evenly illuminated to B20 lux. The mouse was placed
in a corner and allowed to freely explore for 30min. Distance traveled, time spent
moving, time spent in the (20 cm x 20 cm) center, and entries into the center were
measured using the Ethovision videotracking system (Noldus Information Technology
Inc., Leesburg, VA). The apparatus was cleaned with 70% EtOH (v/v) and dried between
subjects.
The elevated plus-maze test was conducted as previously described (Handley &
Mithani, 1984; Boyce-Rustay & Holmes, 2006). The apparatus consisted of two open
arms (30 cm x 5 cm; 55 lux) and two closed arms (30 cm x 5 cm x 15 cm; 5 lux)
extending from a 5 cm x 5 cm central area and elevated 20 cm from the ground (San
Diego Instruments). The walls were made from black ABS plastic and the floor from
white ABS plastic. A 0.5 cm raised lip around the perimeter of the open arms prevented
mice from falling off the maze. The mouse was placed in the center facing an open arm
and allowed to explore the apparatus for 5 min. Time spent in the open arms, and entries
into the open and closed arms were measured by the Ethovision videotracking system
(Noldus Information Technology Inc.). The apparatus was cleaned with 70% EtOH (v/v)
and dried between subjects.
The light–dark exploration test was conducted as previously described (Crawley,
1981; Boyce-Rustay & Holmes, 2006). The apparatus consisted of two compartments
(each 17 cm x 13 cm x 13 cm), one with white Plexiglas walls and clear Plexiglas floor
(40 lux) (‘light’ compartment) and the other with black Plexiglas walls and clear
Plexiglas floor (0 lux) (‘dark’ compartment), which were connected by a partition at floor
level with a small opening (5 cm) (Med Associates, Georgia, VT, Model ENV-3013).
The mouse was placed into the dark compartment facing away from the aperture and
allowed to explore the apparatus for 10 min. Time spent and full-body transitions into the
light compartment, and total full-body transitions between the light and dark
compartments were measured by photocells connected to Med Associates software. The
apparatus was cleaned with 70% EtOH (v/v) and dried between subjects.
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3.3.7 Statistics
BLA group effects were analyzed using ANOVA and Newman–Keuls post hoc
tests where appropriate. One mouse was an extreme outlier (45 standard deviation from
the mean) for preconditioning freezing and was excluded from the study. Genetic
correlations were performed (treating each of the 17 strains as an individual data point)
between BLA, dorsal striatal, total hippocampal, and cerebellar volume, and behavioral
and neuroendocrine measures using Spearman’s test. The threshold for statistical
significance was set at p < 0.05.
3.4

Results

3.4.1 Pavlovian Fear Conditioning
There was no significant difference between BLA groups for percent freezing
during the (2-min) preconditioning or (2-min) postconditioning periods (Figure 3-2A).
BLA groups significantly differed in percent freezing to the CS (F2, 158 = 7.74, p < 0.01)
and context (F2, 159 = 5.37, p < 0.01). The small BLA group froze more in response to the
CS (Figure 3-2B) and to the context (Figure 3-2C) than the medium or large groups.
There was a significant genetic correlation between freezing to CS and volume of BLA,
but not striatum, hippocampus, or cerebellum (Table 3-1).
There were no group differences in the hot plate test for nociception (mean ±
SEM latency to respond: small = 6.42 ± 0.47 s, medium = 7.39 ± 0.48 s and large = 6.14
± 0.37 s).
3.4.2 Depression-Related Behavior and Glucocorticoid Responses to Stress
There was no effect of BLA group on percent immobility in the FST (Figure
3-3A). Corticosterone levels were affected by stress in a BLA group-dependent manner
(stress x group interaction: F2, 41 = 3.41, p < 0.05). While there were no group differences
in corticosterone in nonstressed mice, corticosterone levels following stress were
significantly greater in the small BLA group than the medium or large groups (Figure
3-3B). There was a significant baseline correlation between nonstressed corticosterone
and striatal, but not BLA, hippocampus, or cerebellar, volume (Table 3-1).
3.4.3 Tests for Anxiety-Related Behavior
There was a significant effect of BLA group on distance traveled (F2, 186 = 8.21, p
< 0.01), but not percent time in the center in the novel open-field test. The small BLA
volume group traveled less than the medium or large BLA volume groups (Figure 3-4A),
while percent time in the center was no different between groups (Figure 3-4B). There

42

Figure 3-2
Pavlovian fear conditioning in mice differing in BLA volume
(A) There were no differences in freezing during the preconditioning and immediate
postconditioning periods between mice with relativel small (S), medium (M), or large (L)
BLA volume. The small BLA group froze more than medium or large BLA groups
during exposure to the conditioned stimulus (CS) (B) and conditioned context (C) (n =
35–75 per volume group). **p < 0.01, *p < 0.05 vs L, ##p < 0.01 vs. M.
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Table 3-1
Genetic correlations between BLA, striatum, hippocampus,
cerebellum and behavior.
Behavior
Pavlovian fear conditioning
Preconditioning freezing
Postconditioning freezing
Freezing to conditioned cue
Freezing to conditioned
context

BLA

Striatum Hippocampus Cerebellum

–0.23
–0.03
–0.50*
–0.29

–0.04
–0.05
–0.21
0.06

–0.33
–0.17
–0.42
–0.06

0.52
0.20
–0.03
0.21

Forced swim test
Immobility

–0.13

–0.30

0.02

–0.25

Corticosterone
Baseline
Poststress

–0.10
–0.49

–0.42*
0.18

–0.24
0.18

–
0.37

Novel open field
Distance traveled
Center time

0.50*
0.34

0.04
0.18

0.30
0.39

–0.41
–0.12

Elevated plus maze
Time in open arms
Time in center square
Total arm entries
Open arm entries
Closed arm entries

0.04
0.65*
0.38
0.02
0.43

–0.47
0.43
0.21
–0.35
0.42

–0.31
0.16
–0.02
–0.06
0.06

–0.12
–0.05
–0.07
–0.23
0.22

Dark-light exploration
Time in light
0.37
–0.12
Light-dark transitions
0.34
–0.20
BLA, basolateral amygdala complex, *p < 0.05

0.27
0.11

–0.24
–0.24
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Figure 3-3
Depression-related behavior and glucocorticoid responses to stress in
mice differing in BLA volume
(A) BLA volume was not associated with differences in percent immobility in the forced
swim test (n = 25–49 per volume group). (B) Mice with relatively small (S) BLA showed
normal baseline corticosterone, but higher corticosterone responses to swim stress than
medium (M) or large (L) BLA groups (n = 5–ß11 per volume group per stress
condition). **p < 0.01, *p < 0.05 vs. L.
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Figure 3-4
Exploratory- and anxiety-like behaviors in mice differing in BLA
volume
Mice with relatively small (S) BLA traveled less distance than mice with medium (M) or
large (L) BLA (A) while groups showed equivalent percent center time (B). Small and
medium BLA groups spent less time in the center square but not open arms (C) and made
fewer total and closed but not open arm entries (D) in the elevated plus-maze than the
large BLA group. Small and medium BLA groups spent less time in the light
compartment (E) and made fewer light–dark transitions (F) in the light–dark exploration
test than the large BLA group (n = 35–84 per volume group). **p < 0.01, *p < 0.05 vs. L,
##
p < 0.01, #p < 0.05 vs. M.
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was a significant genetic correlation between distance traveled and volume of BLA, but
not striatum, hippocampus or cerebellum (Table 3-1).
There was a significant effect of BLA group on total (F2, 183 = 4.24, p < 0.05) and
closed arm entries (F2, 183 = 6.93, p < 0.01) and percent time in the center square (F2, 183 =
8.28, p < 0.01), but not percent open arm time or open arm entries in the elevated plusmaze. The medium and small BLA groups spent less time in the center square (Figure
3-4C) and made fewer total and closed arm entries (Figure 3-4D) than the large BLA
volume group. There was a significant genetic correlation between percent center time
and volume of BLA, but not striatum, hippocampus, or cerebellum (Table 3-1).
There was a significant effect of BLA group on percent time in the light
compartment (F2, 175 = 4.14, p < 0.05) and light–dark transitions (F2, 175 = 13.16, p < 0.01)
in the light–dark exploration test. The medium and small BLA groups spent less time in
the light compartment (Figure 3-4E) and made fewer light–dark transitions (Figure
3-4F) than the large BLA volume group, while the medium group made fewer transitions
than the large group. Neither measure significantly correlated with volume of BLA,
striatum, hippocampus, or cerebellum (Table 3-1).
3.5

Discussion

The major finding of the present study was that variation in volume of the BLA
complex in a panel of BXD RI inbred strains was associated with differences in specific
measures of mouse fear-, anxiety-, depression-, and stress-related phenotypes.
There is compelling evidence that the BLA is necessary for the formation and
expression of associative fear memories, as typically evidenced by the effects of lesions
on the type of Pavlovian fear conditioning task employed in our study (Davis & Whalen,
2001; Fanselow & Poulos, 2005; Phelps & LeDoux, 2005). The present findings
reinforce and extend this literature by showing that mice with naturally occurring
variation in BLA volume exhibit significant differences in fear conditioning. BXD RI
strains selected for BLA volumes that were relatively small showed significantly greater
levels of conditioned freezing than strains with a larger BLA. There were no differences
in levels of freezing immediately prior to or immediately after conditioning,
demonstrating that differences between BLA groups in the recall/expression of fear
memory were not due to differences in unconditioned freezing or in capacity to express
short-term fear memory. Moreover, pain perception measured in the hot plate test did not
differ between the groups, excluding variation in pain perception as a confounding
influence.
Differences in fear expression between BLA volume groups were found both for
conditioned fear to discrete (auditory cue) and compound (context) stimuli, which is
consistent with the ability of BLA lesions (Goosens & Maren, 2001) and gene knockoutinduced gross disruption of BLA (Lin et al., 2005) to impair both forms of associative
fear memory. Interestingly however, there was a significant genetic correlation between
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BLA volume-varying BXD lines and cued, but not contextual, conditioned fear. A
relatively greater correlation for cued conditioning is in agreement with evidence from
lesion studies demonstrating the importance of the BLA for cued relative to contextual
fear conditioning, the latter involving greater recruitment of additional structures, notably
the hippocampus (Maren & Quirk, 2004). These data also concur with gene-mapping
studies in BXD RIs indicating that cued and contextual conditioning are under partly
dissociable genetic control (Owen et al., 1997; Wehner et al., 1997). Finally, the fact that
we were able to detect two correlating phenotypic traits (BLA volume and fear memory)
across two laboratories (University of Tennessee, NIH) speaks both to the strength and
replicability of the underlying genetic component (Wahlsten et al., 2006).
BLA volume-related variation in fear conditioning was dissociated from
differences in anxiety-like behavior. The small BLA volume group showed less
locomotor exploration in the novel open-field and elevated plus-maze than the larger
BLA groups, but there were no differences in the principal measures of anxiety-like
behavior (open-field center time, elevated plus-maze open arm exploration). In a third
test of anxiety-like behavior, the light–dark exploration test, the small and medium BLA
groups spent less time in the light compartment and made fewer light–dark
intercompartment transitions than the large BLA group. Different mouse tests for anxiety
likely measure different forms of behavior controlled by distinct genetic factors (Turri et
al., 1999; Holmes et al., 2003; Kliethermes & Crabbe, 2006) and it is possible that the
profile of the small and medium BLA groups in the light–dark exploration test reflects a
high anxiety-like phenotype that is not seen in the other tests. Taken together however,
the differences between BLA volume groups on the anxiety-related assays (particularly
the open-field and light–dark exploration tests) were marginal and are most
parsimoniously interpreted as modest locomotor inhibition in response to novelty rather
than a clear high anxiety-like phenotype in mice with smaller BLA volumes. Indeed, the
absence of anxiety-related differences would be consistent with the lack of effects of
BLA lesions or temporary inactivation on anxiety-like behaviors in rats tested under the
standard task conditions used in the current study (Decker et al., 1995; Moller et al.,
1997; Herry et al., 2007; Moreira et al., 2007).
To our knowledge, there has been little investigation of the role of BLA in rodent
depression-related behaviors; with one study finding no effect of BLA lesions in the rat
FST for depression-related behavior (Shimazoe et al., 1988). The present data found no
link between variation in BLA volume and immobility in the mouse FST. By contrast,
BLA groups differed markedly in their glucocorticoid responses to swim stress. Thus,
while baseline levels of corticosterone were no different between the groups,
corticosterone levels following swim stress were significantly greater in small BLA mice
than in the larger BLA groups.
A pathway from the main output nucleus of the amygdala, the CeA, to the
paraventricular nucleus of the hypothalamus (Swanson & Petrovich, 1998) is thought to
modulate hypothalamic–pituitary–adrenal (HPA) axis responses to stress (reviewed in
Herman et al., 2005). Lesions encompassing the CeA can inhibit HPA-axis responses to
at least some forms of stress (Beaulieu et al., 1986; Van de Kar et al., 1991), whereas
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amygdala stimulation can increase glucocorticoid release (Redgate & Fahringer, 1973;
Dunn & Whitener, 1986). As such, the relatively greater HPA-axis response in small
BLA mice could be another manifestation of abnormal amygdala function.
Corticosterone also exerts effects within the amygdala via glucocorticoid
receptors (Aronsson et al., 1988). Of particular interest in this context, BLA has been
identified as a critical site of action through which glucocorticoids modulate associative
fear memory, (for example) glucocorticoid receptor agonists administered systemically or
directly into the BLA enhance fear conditioning in rats (Zorawski & Killcross, 2002; Hui
et al., 2004; Roozendaal et al., 2006). This raises the possibility that increased
glucocorticoid receptor activity in smaller BLA mice may be a factor driving enhanced
fear conditioning, although this remains to be tested. A related issue is whether BLA
variation is a consequence rather than cause of differences in stress reactivity. While we
do not discount this possibility it seems unlikely given evidence that chronic stress
increases rather than decreases spine density and dendritic arborization in rats and mice
(Vyas et al., 2002; Mitra et al., 2005; Govindarajan et al., 2006). On the other hand,
because stress causes dendritic shrinkage in rodent ventromedial prefrontal cortex
(vmPFC) (Wellman, 2001; Izquierdo et al., 2006; Radley et al., 2006), it would be of
interest to examine vmPFC and fear-related behaviors mediated by vmPFC such as fear
extinction (Quirk & Mueller, 2007) in mice with different BLA volumes.
BLA groups were selected for differences in BLA volume; and the fact that
groups comprised multiple RI strains, each with a unique genotype, reduces the
likelihood that differences in fear conditioning and stress reactivity were due to spurious
idiosyncrasies (for example poor vision, hearing, nociception) of specific strains.
However, this approach cannot exclude the potential contribution of other phenotypic
traits that covary with BLA volume. We have recently shown that a common genetic
locus may underlie the structures of multiple forebrain regions including amygdala,
cerebellum, dorsal striatum, and portions of the hippocampus (Mozhui et al., 2007).
Analysis of the volume of these three structures in our three BLA volume groups
indicated volume differences in dorsal striatal but not hippocampal or cerebellar volume,
raising the possibility that striatal volume variation contributed to behavioral differences
between BLA groups, (for example via affects on motor function). Arguing against this
possibility, however, there were no significant correlations between striatal volume and
any behavioral measure (c.f. baseline corticosterone), while BLA volume significantly
correlated with novel open-field locomotion. Moreover, BLA volume predicted
corticosterone responses to stress, unlikely to be influenced by locomotion, while other
measures predicted to be affected by locomotor differences, such as FST immobility,
were unrelated to BLA volume. Nonetheless, although present data suggest a specific
influence of amygdala function on fear conditioning and stress reactivity, we cannot rule
out the possible contribution of differences in other brain regions or other, as yet
undetermined, traits genetically correlated with BLA volume. In fact, given the highly
integrated nature of the neural circuitry subserving stress, fear, and anxiety behaviors
(Amat et al., 2005; Hariri & Holmes, 2006; Quirk & Mueller, 2007; Ressler & Mayberg,
2007; Wellman et al., 2007), it is unlikely that the amygdala would act in isolation to
mediate these complex functions.
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The finding that relatively smaller BLA is associated with increased fear and
stress reactivity may at first appear counterintuitive given the effects of amygdala lesions,
but this is in fact entirely consonant with recent findings from genetic studies in humans.
For example, functional neuroimaging studies of two gene variants implicated in stressrelated disorders, the low-expressing forms of the serotonin transporter and monoamine
oxidase A, demonstrate that these variants produce exaggerated amygdala reactivity
during fear processing and that this is coupled with lesser amygdala volume (Pezawas et
al., 2005; Meyer-Lindenberg et al., 2006). The volume differences underlying these fearrelated phenotypes were modest, as they were in our mouse sample. Thus, it appears that
relatively modest variation in BLA volume is sufficient to determine fear- and stressrelated phenotypes.
Elucidating the molecular and physiological factors associated with volume
differences is likely to be key to understanding this relationship between BLA volume
and behavior. A pertinent observation in this regard is that the total number of neurons
(and non-neuronal cells) in BLA was equivalent across BLA volume groups (Mozhui et
al., 2007), indicating that rather than having a relative loss of neurons, the smaller BLA
mice had a slightly denser packing of neurons (Mozhui et al., 2007). An important
question for future studies will be how variation in this and other intrinsic properties of
BLA, such as neuronal morphology and the ratio of excitatory over inhibitory cells,
might contribute to the behavioral differences between BLA volume groups. Another
interesting question is whether phenotypic differences between BLA groups are localized
to specific subnuclei within the BLA complex. For example, akin to the small BLA
phenotype observed in our study, lesions of the lateral nucleus prior to fear conditioning
block acquisition (Goosens & Maren, 2001; Nader et al., 2001; Koo et al., 2004),
postconditioning lesions of the basal nucleus (corresponding to basolateral nucleus in
Figure 3-1A) impair the expression, but not acquisition, of fear memory (AngladaFigueroa & Quirk, 2005).
In summary, the present study has shown that variation in BLA volume is
associated with differences in fear memory, glucocorticoid responses to stress, and
locomotor inhibition in response to novelty. The present findings also provide parallels
with clinical data, to the extent that PTSD patients also exhibit enhanced fear memory
(American Psychiatric Association, 1994; Peri et al., 2000) and exaggerated
glucocorticoid responses to stress (Yehuda, 2002; de Kloet et al., 2006), as well as
amygdala hyperactivity and possibly smaller amygdala volume (Bremner et al., 1997;
Wignall et al., 2004; Karl et al., 2006; Rauch et al., 2006; Shin et al., 2006), relative to
controls. Thus, the present study not only provides a novel extension to the literature
linking the amygdala with fear- and stress-related processing with possible implications
for understanding amygdala dysfunction in PTSD, but also provides one of the first
examples of how structural variation in a specific brain region can successfully predict
differences in specific phenotypic traits in the rodent.

50

CHAPTER 4. GENETIC VARIATION IN STRESS SUSCEPTIBILITY IS
ASSOCIATED WITH DIVERGENT CORTICOLIMBIC GENE EXPRESSION
4.1

Synopsis

Genetic factors have significant influence in determining an individual’s
susceptibility to the adverse effects of stress. In this study, we used diverse inbred mouse
strains as models to examine the genotype dependent effect of stress. Seven different
inbred strains—129/SvImJ, A/J, BALB/cJ, BALB/cByJ, C57BL/6J (B6), DBA2/J (D2),
and FVBN/J—were subjected to repeated restraint stress. Their relative vulnerability to
stress was then assessed using different behavioral and physiological indices. We found
significant strain differences in anxiety- and depression-like phenotypes, and differences
in blood corticosterone level in response to stress. Of particular interest was the
behavioral divergence between B6 and D2. D2 showed a much higher basal anxiety-like
behavior than B6, and anxiety level was heightened by restraint stress. In contrast, B6
appeared more resilient to stress and did not show a significant difference in anxiety-like
behavior before and after the restraint treatment. We further assayed global gene
expression in the prefrontal cortex, amygdala, and hippocampus of B6 and D2 mice. Our
analysis detected substantial expression difference between B6 and D2 in all three
regions. We also identified a large set of genes that showed expression change in
response to restraint stress, including several genes that have been associated with
psychiatric illnesses in human (e.g., Homer1, Nr4a2, Gal). In addition, several clock
genes involved in regulating the circadian rhythm (Per1, Per2, Per3, Dbp) showed an
upregulation following restraint, suggesting possible links between the molecular
mediators of stress and the sleep cycle.
4.2

Introduction

Stress is a known major risk factor for neuropsychiatric diseases ranging from
mood and anxiety disorders to schizophrenia and drug addiction. Susceptibility to stress
varies considerably between individuals and is under the influence of genetic factors
(Caspi & Moffitt, 2006; Hariri & Holmes, 2006; Yehuda & LeDoux, 2007; Uher &
McGuffin, 2008). However, despite being the subject of enormous research efforts, the
specific genes underlying vulnerability and resilience to stress have not yet been well
established. This is in part due to the complexity that arises from multiple genetic,
lifestyle and environmental factors in human populations.
Rodents provide important model systems for identifying genetic factors that
influence vulnerability to stress (Ramos & Mormede, 1998; Cryan & Holmes, 2005). Of
considerable value are inbred mouse strains. A panel of inbred strains can represent a
restricted degree of environmental variance, within which each individual strain provides
a stable genetic pool. Previous studies have shown that inbred strains differ in their
responses to stress on various neural, neuroendocrine and behavioral measures. For
example, acute exposure to stress produces heightened anxiety-like behavior and
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hypothalamic-pituitary-adrenal (HPA)-axis activation in some strains, such as BALB/cJ
and D2, but less so or not at all in others, such as B6 (Belzung & Griebel, 2001; Anisman
& Matheson, 2005; Jacobson & Cryan, 2007; Millstein & Holmes, 2007). Inbred mouse
strains have also been shown to differ in their responses to repeated stress exposure
(Tannenbaum & Anisman, 2003; Anisman & Matheson, 2005; Mineur et al., 2006),
although there have been surprisingly few studies of this kind to date. This differential
sensitivity to repeated stress is particularly pertinent to attempts at modeling human
neuropsychiatric diseases because risk for these disorders is often associated with history
of repeated trauma (Caspi et al., 2002; Berton & Nestler, 2006; Yehuda & LeDoux, 2007;
Holmes & Wellman, 2009).
In the present study, we surveyed anxiety-, depression- and HPA-axis responses
following repeated stress in genetically diverse inbred mice. This multiple strain
comparison was done using a panel of seven inbred mice. The aim was to identify strains
that differ in anxiety-related traits and sensitivity to repeated stress. To this end, we
employed a repeated restraint stress protocol that has been shown to cause significant
alterations in the morphology of principal neurons in three key corticolimbic regions
known to mediate the effects of stress: medial prefrontal cortex (mPFC), amygdala and
hippocampus (e.g., Vyas et al., 2002; Vyas et al., 2003; Govindarajan et al., 2006;
Bennur et al., 2007; Shansky et al., 2009). Based on the results obtained, our second
major aim was to examine gene expression in mPFC, amygdala and hippocampus in two
strains (B6 and D2) that differed in anxiety-like behavior before and after restraint.
4.3

Materials and Methods

4.3.1 Subjects
Subjects were male mice of the 129/SvImJ (129S1), A/J, BALB/cJ, BALB/cByJ,
C57BL/6J (B6), DBA2/J (D2), and FVBN/J inbred strains. These strains were selected on
the basis of 1) their frequent use in behavioral neuroscience and as genetic backgrounds
for mouse mutant lines, 2) inclusion as "group A" priority strains in the Mouse Phenome
Project, an international effort to provide the biomedical research community with
phenotypic data on the most commonly used mouse strains
(http://www.jax.org/phenome), and 3) prior studies demonstrating differential trait
anxiety- and depression-related and stress-sensitivity phenotypes (Anisman & Matheson,
2005; Millstein & Holmes, 2007). Mice were obtained from The Jackson Laboratory (Bar
Harbor, ME) to reduce a potential source (i.e., supplier) of genetic and behavioral
variation. Mice were aged 8-9 wks at the start of the study, housed 2/cage (by strain and
stress condition), with cages placed side-by-side in a temperature- (72 ± 5° C) and
humidity- (45 ± 15%) controlled vivarium under a 12 hour light/dark cycle (lights on
0600 hour). Testing was conducted in a manner counterbalanced for strain and stress
condition. The number of mice used is given in the figure legends. All experimental
procedures were approved by the National Institute on Alcohol Abuse and Alcoholism
Animal Care and Use Committee and followed the National Institute of Health guidelines
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outlined in ‘Using Animals in Intramural Research’ and the local Animal Care and Use
Committees.
4.3.2 Repeated Restraint Stress
Previous studies have shown that 10 days of immobilization in ‘immobilization
bags’ produces significant changes in neuronal morphology in the mPFC, basolateral
amygdala and CA3 region of the hippocampus in rats and mice (Vyas et al., 2003;
Govindarajan et al., 2006; Shansky et al., 2009). We adopted a modified version of this
protocol in which mice were placed in ventilated 50 mL Falcon tubes for 2 hour/day
(1000 – 1200 hr) for 10 consecutive days. To be consistent with earlier studies using this
stressor in rats and mice (Vyas et al., 2002; Govindarajan et al., 2006; Shansky et al.,
2009), non-stressed controls remained in the home cage. We reasoned that restraint in
tubes would be a less severe stressor than restraint in immobilization bags and would
therefore allow us to better detect differential sensitivity to stress across strains than a
severe stressor that might cause profound changes across all strains.
4.3.3 Effect of Repeated Restraint on Body Weight
To obtain a systemic measure of the effects of restraint, we measured reductions
in body weight (Willner et al., 1996; Pothion et al., 2004; Krishnan et al., 2007; Shansky
et al., 2009). Changes in body weight over the 10-day restraint period were compared
between restrained and non-restrained groups. Statistical significance for this and all
other analyses was set at p ! 0.05.
4.3.4 Effect of Repeated Restraint on Anxiety-Related Behavior
Twenty-four hours after the final restraint, mice were tested for anxiety-like
behavior using the dark-light emergence test, modified from a procedure previously
described (Holmes et al., 2003). We employed this task rather than more commonly used
tests for anxiety-like behavior, such as the elevated plus-maze (Cryan & Holmes, 2005),
because under baseline conditions in our laboratory, B6 mice typically display lesser
anxiety-like behavior in the emergence test (~25% time out of shelter (e.g., this study)
than in the elevated plus-maze (~10% open arm time (e.g., Norcross et al., 2008). Thus,
we predicted that emergence test would facilitate the detection of increases in anxietylike behavior caused by stress by avoiding a ‘floor effect.’
The mouse was placed in an opaque black Plexiglas shelter (39 x 13 x 16 cm)
with a 13 x 8 cm aperture at floor level that opened onto a large white Plexiglas square
arena (39 x 39 x 35 cm) illuminated to ~90 lux. Latency to first exit the shelter, the
number of shelter exits (defined as all 4 paws out of the shelter) and time spent out of the
shelter in the open field over a 15 min session was recorded by an observer using
Hindsight (Hindsight, Services, Wokingham, UK). To dissociate the anxiety-related and
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general exploratory phases of the test session, data were separately analyzed during the
first 5 min and last 5 min, respectively. The effects of strain and stress were analyzed
using 2-factor analysis of variance (ANOVA) followed by Newman Keuls post hoc tests.
Given the high number of strains tested and the resultant reduction of power in
our analysis, we conducted planned post hoc comparisons of strain and/or stress effects in
the presence of significant ANOVA main effects regardless of whether a significant
strain x stress interaction effect was also found.
4.3.5 Effect of Repeated Restraint on Depression-Related Behavior
Twenty-four hours after the emergence test, mice were assessed for depressionrelated behavior in the forced swim test (Porsolt et al., 1977; Cryan & Holmes, 2005).
Mice were gently lowered into a transparent Plexiglas cylinder (20 cm diameter) filled
halfway with water (24 ± 1ºC) for a 6 min session, as previously described (BoyceRustay & Holmes, 2006). The presence/absence of immobility (cessation of limb
movements except minor involuntary movements of the hind limbs) was manually
observed using an instantaneous sampling technique every 5 sec during min 2-6 and
expressed as a percentage of total observations. The effects of strain and stress were
analyzed using 2-factor ANOVA followed by Newman Keuls post hoc tests.
4.3.6 Effect of Repeated Restraint on Swim Stress Activation of HPA-Axis
Mice exposed to repeated social defeat stress exhibit an augmented HPA-axis
response to swim stress (Krishnan et al., 2007). We tested whether repeated restraint
stress similarly sensitized the HPA-axis response to swim stress. Restraint stressed mice
and non-restrained controls were returned to the home cage after the forced swim stress
session described above. Thirty min later, mice were sacrificed via rapid cervical
dislocation and decapitation to collect trunk blood. An additional set of experimentallynaïve mice were sacrificed at the same time to provide non-swim-stressed baseline
corticosterone data. Blood samples were centrifuged at 13,000 rpm for 30 sec. Serum was
extracted and assayed for total corticosterone (bound and free) using the Coat-a-Count
RIA TKRC1 kit (limit of detection: 5.7 ng/ml; Diagnostic Products Corp, Los Angeles)
as previously described (Boyce-Rustay et al., 2007). The effects of strain and stress were
analyzed using 2-factor ANOVA followed by Newman Keuls post hoc tests.
4.3.7 Sample Preparation for Expression Analysis
We next performed genome-wide gene expression analysis of B6 and D2 mice in
order to compare changes in gene expression following restraint stress in the two strai.
Mice were exposed to repeated restraint (as above), and then sacrificed via cervical
dislocation and rapid decapitation 4 hour after the final restraint stress. A set of naïve D2
and B6 mice was also sacrificed at the same time. Brains were quickly removed and
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stored in RNAlater (Ambion, Austin, TX). Three corticolimbic brain regions mediating
stress- emotion-related behaviors, the medial prefrontal cortex (mPFC), amygdala
(principally the basolateral nucleus) and hippocampus, were microdissected within 48
hour of brain collection. The brain was placed in a coronal matrix and sectioned 1.4-2.4
mm from Bregma to obtain the mPFC (tissue medial to the forceps minor, mainly
comprising the infralimbic and prelimbic cortices), and 1.0-2.0 mm from Bregma to
obtain the amygdala and hippocampus. The amygdala was visualized under dark-field
microscope and dissected using the external and internal capsules as a guide to obtain the
basolateral nucleus (although we cannot exclude some inclusion of tissue from the central
nucleus and striatum). The whole hippocampus was then dissected.
Tissue was immediately frozen and stored at -80° C. Samples from each mouse
were stored and analyzed separately (i.e., no pooling). Total RNA was isolated using
RNAqueous Micro kit (Ambion, Austin, TX). RNA purity and concentration was
evaluated with a spectrophotometer using a 260/280 nm absorbance ratio, and RNA
quality was checked using Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara,
CA). Samples were processed according to the manufacturer’s instructions and
hybridized onto a total of 36 Illumina Mouse–6.1 arrays (Illumina, Inc, San Diego, CA).
Samples that differed by strain, region, and treatment were interleaved on arrays on the
same slide (6 arrays per slide) to avoid batch confounds. Raw microarray data were
normalized using the rank invariant and background subtraction protocols provided by
Illumina as part of its BeadStation software suite. We log-transformed the expression
values and stabilized the variance of each array. The Illumina Mouse–6.1 array consists
of > 46,000 probes. We extensively re-annotated these probes and the improved
annotations were incorporated into the data analysis for the current study.
4.3.8 Microarray Data Analysis
Probes were initially filtered by expression: i.e., expression signals below
background in half or more of the samples were excluded resulting in 25,908 probes for
analyses. This set of expressed genes was analyzed by hierarchical clustering, using the
TM4 MeV software (Saeed et al., 2003), to sort the samples based on global expression
patterns. Baseline strain effects were defined as gene expression values in non-restrained
B6 mice that showed both a fold-difference " 1.3 and a significant difference as
determined by Student’s t-test relative to values in non-restrained D2 mice. Restraint
effects were defined as gene expression values in restrained vs. non-restrained mice of
the same strain that showed both a fold-difference " 1.3 and a significant difference as
determined by Student’s t-test.
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4.4

Results

4.4.1 Effect of Repeated Restraint on Body Weight
We measured loss of body weight as a systemic measure of the stress caused by
repeated restraint. ANOVA revealed a significant strain x restraint interaction for change
in body weight over the 10-day stress period (F6,84 = 3.57, p < 0.01). Post hoc tests
showed that all strains except 129S1 and D2 showed a significant difference in body
weight change between the restrained and non-restrained groups (Figure 4-1). The lack
of a statistically significant difference in D2 was likely due to high variability in the
restrained D2 group in this experiment.
4.4.2 Effect of Repeated Restraint on Anxiety-Related Behavior
We measured behavior during the first 5 minutes of the dark-light emergence test
as an assay for the effects of repeated restraint and strain differences in anxiety-like
behavior. ANOVA found a significant stress x strain interaction (F6,98 = 2.71, p < 0.05)
for the number of shelter exits. Post hoc analysis showed that all strains except FVBN/J
made significantly fewer shelter exits than the reference B6 strain, while restrained D2
and FVBN/J mice made significantly fewer exits than their non-restrained D2 and

Figure 4-1
Differences in repeated restraint-induced changes in body weight
Restraint stress reduced body weight in a strain-dependent manner, with significantly
greater net reductions in BALB/cByJ and FVBN/J than the reference C57BL/6J strain
(N = 5-9 per strain and condition). *p < 0.05 vs. non-restraint mice of the same strain, #p
< 0.05 vs. C57BL/6J. Data are Means ± SEM.
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FVBN/J counterparts (Figure 4-2A). There was also significant effect of strain (F6,98
=29.64, p < 0.01), but no main effect of stress and or strain x stress interaction, for
percent time spent out of the shelter during the first 5 min. Post hoc comparison between
restraint and non restraint groups found that only restrained D2 spent significantly lesser
time out of the shelter than non-restrained counterpart. Under baseline conditions, 129S1,
A/J, BALB/cByJ, and BALB/cJ spent significantly less time, and FVB/NJ spent more
time, out of the shelter than B6 (Figure 4-2B). Lastly, there was a significant effect of
strain (F6,98 = 18.45, p < 0.01) but not stress, and no strain x stress interaction, for latency
to first exit the shelter. At baseline, 129S1, A/J, BALB/cByJ, and BALB/cJ were
significantly slower to exit the shelter than B6 (Figure 4-2C). Latency did not differ
between restrained and non-restrained mice of any strain.
We reasoned that the final 5 minutes of the 15 minutes test session would be less
sensitive than the first 5 minutes to true-positive strain- or restraint-related effects on
anxiety-like behavior. During this period, there was a significant effect of strain for
shelter exits (F6,98 = 36.15, p < 0.01) and for percent time out of the shelter (F6,98 = 47.02,
p < 0.01), but no significant main effect of stress and no strain x stress interaction for
either measure. Post hoc comparisons showed that all strains except D2 and FVBN/J
made significantly fewer less shelter exits and spent less time out of the shelter, as
compared to B6. Repeated restraint had no effect on either measure in any strain during
this period.
4.4.3 Effect of Repeated Restraint on Depression-Related Behavior
We next examined depression-related behavior using the forced swim test. There
was a significant effect of strain (F6,98 = 58.24, p < 0.01) and stress (F1,98 = 5.61, p < 0.05)
but no strain x stress interaction for percent immobility. Post hoc analysis showed that
D2 and FVB/NJ showed significantly less immobility than the B6 reference strain, and
that restrained BALB/cByJ showed significantly less immobility than non-restrained
BALB/cByJ counterparts (Figure 4-3).
4.4.4 Effect of Repeated Restraint on the HPA-Axis
Serum corticosterone levels were measured 30 minutes after forced swim stress.
There was a significant stress x strain interaction (F6,152 = 4.82, p < 0.01), as well as main
effects of stress (F2,12 = 228.74, p < 0.01) and strain (F6,12 = 7.00, p < 0.01), for
corticosterone levels. Post hoc analysis showed that swim stress significantly increased
corticosterone in all strains as compared to non-swim baseline, regardless of prior
repeated restraint stress (Figure 4-4). In addition, swim stress-induced corticosterone
levels were significantly higher in BALB/cJ, B6 and D2 following repeated restraint
relative to their non-restrained counterparts. Conversely, repeatedly restrained 129S1
showed a significantly lesser corticosterone response to swim stress than non-restrained
129S1.
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Figure 4-2
Differences in anxiety-like behavior in emergence test
(A) All strains except FVBN/J made significantly fewer shelter exits than the reference
C57BL/6J strain, irrespective of stress. DBA/2J and FVBN/J mice, but no other strain,
showed significantly fewer shelter exits following repeated restraint, as compared to nonrestrained mice. (B) DBA/2J mice, but no other strain, spent significantly less time out of
the shelter following repeated restraint, as compared to non-restrained DBA/2J mice. (C)
There was no difference between restraint and non-restraint groups in latency to first exit
shelter. 129S1, A/J, BALB/cByJ, and BALB/cJ were significantly slower to exit the
shelter than B6. N = 7–9 per strain and condition. *p < 0.05 vs. non-stressed controls of
same strain; #p < 0.05 vs. C57BL/6J. Data are Means ± SEM.
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Figure 4-3
Differences in depression-related behavior
DBA/2J and FVBN/J mice were significantly less immobile than the reference C57BL/6J
strain, regardless of stress. BALB/cByJ mice, but no other strain, showed significantly
less immobility as compared to non-restrained BALB/cByJ mice. N = 7-9 per strain and
condition. *p < 0.05; #p < 0.05 vs. C57BL/6J.
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Figure 4-4
Differences in corticosterone responses to swim stress
Exposure to swim stress significantly increased serum corticosterone levels, relative to
non-swim/non-restraint baseline, in all strains regardless of repeated restraint stress
history. Swim stress-induced corticosterone levels were significantly lower in 129S1 and
significantly higher in BALB/cJ, C57BL/6J and DBA/2J mice following repeated
restraint, as compared to non-restrained counterparts. N = 5–15 per strain and condition.
*p < 0.05 vs. non-restrained of same strain; †p < 0.05 vs. non-restrained and swim
stressed of same strain.
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4.4.5 Corticolimbic Gene Expression in B6 and D2
Our behavioral analyses showed that B6 and D2 exhibited differences in anxietylike behavior, consistent with previous studies (Millstein & Holmes, 2007). These
differences further diverged following exposure to repeated restraint. On the basis of
these observations, we conducted a genome-wide analysis of baseline gene expression
differences between B6 and D2 in the amygdala, mPFC and hippocampus, as well as
gene expression changes in each strain following repeated restraint.
Hierarchical cluster of all probes with gene expression signal above background
showed that gene expression data segregated as a function of brain region, with relatively
greater similarity in the amygdala and mPFC than the hippocampus (Figure 4-5). Within
each brain region, samples segregated by strain and, to a lesser extent, restraint,
demonstrating a stronger effect of strain than restraint on gene expression.
Basal gene expression differed markedly between B6 and D2 in all 3 regions,
albeit with a greater number of differences in the hippocampus (2540 probes representing
2154 known genes) followed by the amygdala (1786 probes/1524 known genes) and then
the mPFC (1712/1491 known genes) (Figure 4-6A). There was also considerable overlap
across regions in the genes differentially expressed by the 2 strains, with 560 probes
detecting differences common to all 3 regions.
We then assessed the extent of overlap in restraint-induced expression changes in
the three brain regions. We considered all probes that detected expression changes
following repeated restraint and compared them across tissues (Figure 4-6B). In contrast
to the effect of strain, only a small subset of expression changes associated with restraint
overlapped across 2 brain regions (36 between amygdala and hippocampus, 22 between
amygdala and mPFC, 13 between hippocampus and mPFC) and only 5 probes detected
expression changes in all 3 regions. Of these 5, 3 target known genes: Period 2 (Per2), D

Figure 4-5
Hierarchical cluster analysis of expression data
Hierarchical clustering was done using 25,908 probes that detected expression signals
above background in at least 18 out of 36 samples. The cluster analysis was able to group
the samples by brain region and strain. Based on global gene expression patterns, the
samples segregated into 3 main region-specific branches—medial prefrontal cortex
(mPFC), amygdala (Amy), and hippocampus (Hip). These further bifurcated into
C57BL/6J (B6) and DBA/2J (D2) branches. Samples from the same treatment conditions,
restraint-stressed (R) or non-restraint (NR), also tended to group together.
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Figure 4-6
Differences in corticolimbic gene expression
(A) Basal gene expression differed markedly between C57BL/6J and DBA/2J. Relatively
more strain difference in expression traits was evident in the hippocampus than the
amygdala and mPFC. There was significant overlap in C57BL/6J and DBA/2J
differentially expressed genes across the 3 region in the genes. (B) Overall, in both
C57BL/2J and DBA/2J, repeated restraint was associated with significant more gene
expression changes in the amygdala, with significant but relatively fewer, changes in the
hippocampus and medial prefrontal cortex (mPFC). A limited subset of expression
changes overlapped across any 2 brain regions, and only 5 changes overlapped across all
3 regions. (C) C57BL/6J and DBA/2J mice showed approximately equal number of
restraint-stress induced expression changes following repeated restraint in the amygdala
and mPFC, while C57BL/6J showed more changes in the hippocampus than DBA/2J.
Gene expression changes associated with restraint were highly divergent between
C57BL/6J and DBA/2J, with very few genes showing alterations in both these strains in
any region. N = 3 per strain per condition.
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site of albumin promoter binding protein (Dbp), and Claudin 5 (Cldn5). Notably, both
Per2 and Dbp are circadian rhythm regulator genes and have been associated with bipolar
disorder (Shi et al., 2008). Cldn5 codes for a component of tight junctions and this gene
has been implicated in susceptibility to schizophrenia (Sun et al., 2004). Both Per2 and
Dbp are consistently upregulated by stress and Cldn5 is downregulated by stress in all
three regions (Table 4-1).
We then examined gene expression changes following restraint in B6 and D2.
This revealed significant divergence between the two strains (Figure 4-6C). In both
strains the amygdala showed the greatest number of restraint-induced gene expression
changes (488/447 known genes in B6, and 439 probes/408 known genes in D2) but only
9 probes were common to both strains. In the hippocampus, B6 showed noticeably more
expression changes after restraint than D2 (445 probes/401 known genes in B6, 205
probes/187 known genes in D2), and only 10 of these were common to both strains. For
both the amygdala and hippocampus in B6 and D2, there were an approximately equal
number of upregulation and downregulation following repeated restraint. In the mPFC,
B6 and D2 showed similar number of expression changes (221 probes/202 known genes
in B6, 229 probes/211 known genes in D2); only 2 of these changes were in both the
strains. In this region, there were more downregulation than upregulation for B6, but
more upregulation than downregulation for D2.
4.4.6 RT-PCR Analysis
We used RT-PCR to confirm 16 gene expression differences associated with
strain and/or restraint. Eight of these genes were selected on the basis of prior evidence
linking the gene to stress-related behaviors, as in the case of Gal (Karlsson & Holmes,
2006), Atp1a2 (Ikeda et al., 2003), Bdnf (Nestler et al., 2002), Nr4a2 (Rojas et al., 2007),
Chrna4 (Labarca et al., 2001), Comt (Zubieta et al., 2003; Papaleo et al., 2008) Drd1a
(Hains & Arnsten, 2008), and Rgs2 (Yalcin et al., 2004). Four genes (Grik1, Grin1,
Gria1, and Homer1) are key components of glutamate-mediated neurotransmission and
neural plasticity (Malenka & Bear, 2004; Szumlinski et al., 2004; Szumlinski et al.,
2005). A third set are circadian genes (Per1, Per2, Per3, and Dbp) are increasingly
implicated in neuropsychiatric diseases, notably mania (McClung, 2007).
Table 4-1

Restraint-stress induced upregulation of clock genes
mPFC

BLA

Hippocampus
B6
D2

Gene

B6

D2

B6

D2

Per2

#2.2**

#1.9*

#1.8**

#1.5*

ns

#1.6**

Dbp

#2.0**

#1.8*

#1.8**

ns

#2.5**

#1.8**

Cldn5

$1.8**

ns

$1.5**

ns

$1.7**

$2.2**

*p < 0.05, **p < 0.01
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In the amygdala, we found that basal expression of Grin1 was lower in B6
relative to D2 (Table 4-2). In addition, basal hippocampal expression of Gria1 was
lower, and Bdnf higher, in B6 relative to D2. As compared to D2, microarray analysis
found that B6 hippocampal expression of Atp1a2 was lower, while RT-PCR analysis
found that opposite pattern. As the microarray probes and RT-PCR primers do not
perfectly target the same sequence, this inconsistency may be due to spliced variants
(Korostynski et al., 2006). Finally, basal mPFC expression of Comt was higher, and
expression of Chrna4 and Rgs2 lower, in B6 relative to D2.
Regarding expression differences between restrained and non-restrained B6, we
found Grik1 and Gal were downregulated, while Grin1 was upregulated in the amygdala
following restraint (Table 4-2). In the hippocampus, expression of Nr2a2 was
downregulated in B6 following restraint. Chrna4, Drd1a and Per2 were all upregulated
in the mPFC after restraint in B6. Atp1a2 was upregulated according to the microarray
analysis but downregulated according to RT-PCR, again suggesting the possibility of
spliced variants.
We confirmed 4 expression differences between restrained and non-restrained D2
mice. In the amygdala, the expression of Per1 was upregulated in restrained relative to
non-restrained (Table 4-1) while in the hippocampus, Dbp was upregulated and Homer1
was downregulated following restraint. Lastly, in the mPFC of D2, Per2 was upregulated
in after restraint.
4.4.7 Candidate Genes in BLA Volume QTL
We previously identified a significant QTL for BLA volume on mid-chromosome
8, Vol8a (Mozhui et al., 2007). Using the BLA expression data, we searched for genes
located in Vol8a that show significant basal expression difference between B6 and D2.
Among the candidates that were previously identified in Mozhui et al. (2007), only
Neurocan (Ncan or Cspg3) showed significant differential expression between B6 and
D2 with 2.4-fold higher expression in B6 BLA than in D2 BLA (p < 0.001). Two other
genes with substantial expression difference are sterol-C4-methyl oxidase-like (Sc4mol)
and occluding/ELL domain containing 1 (Ocel1). While Sc4mol showed 4.3-fold higher
expression in B6 than in D2 (p < 0.0001), Ocel1 showed 4-fold higher expression in D2
than in B6 (p = 0.0001). These genes that have strong strain difference in expression in
the BLA are high priority candidates for differences in BLA volume.
4.5

Discussion

In this study, we analyzed anxiety-like behavior prior to, and following repeated
restraint in seven inbred strains of mice. The major finding of the current study was that
different strains of mice exhibit varying levels of vulnerability to restraint stress, and such
differences may be associated with divergent corticolimbic expression of genes
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Table 4-2

Fold-difference scores for microarray and quantitative PCR

Gene
Amygdala
Grik 1 (glutamate
receptor, ionotropic,
kainate 1)
Grin1 (glutamate
receptor, ionotropic,
NMDA1)
Gal (galanin)
Per1 (period
homolog 1)
Prefrontal cortex
Chrna4 (cholinergic
receptor, nicotinic,
alpha polypeptide 4)
Comt (catechol-Omethyltransferase)
Drd1a (dopamine
receptor D1A)
Per2 (period
homolog 2)
Rgs2 (regulator of Gprotein signaling 2)
Hippocampus
Atp1a2 (ATPase,
Na+/K+ transporting,
alpha 2 polypeptide)
Bdnf (brain-derived
neurotrophic factor)
Dbp (D site albumin
promoter binding
protein)
Gria1 (glutamate
receptor, ionotropic,
AMPA1 (alpha 1)
Homer1 (homer
homolog 1)

B6 vs. D2
Array
qPCR

B6, NR vs. R
Array
qPCR

D2, NR vs. R
Array
qPCR

–

–

$2.2**

$1.3*

–

–

$1.7*

$2.2*

#1.9**

#2.2*

–

–

#4.9**
–

ns

$2.8**
–

$6.6*

–
#1.3**

–
#2.4**

$1.7**

$1.6*

#1.3**

#1.7*

–

–

#1.6**

#1.4*

#1.3**

ns

–

–

–

–

#1.4*

#1.4*

–

–

–

–

#2.2**

#1.7**

#1.9*

#1.9**

$1.5**

$1.2*

–

$1.3*

ns

$2.0**

#1.5**

#2.2**

$1.4*

–

–

#1.9**

#1.4**

$1.6*

ns

–

–

#2.5**

ns

#1.8**

#2.8**

#1.4**

ns

–

–

$2.9**

ns

$1.6**

$1.3*

–
$1.4*

$1.2**

–
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Table 4-2 (continued)
Gene
Nr4a2 (nuclear
receptor subfamily 4,
group A, member 2)
Rora (RAR-related
orphan receptor
alpha)
Per3 (period
homolog 3)
*p < 0.05, **p < 0.01

B6 vs. D2
Array
qPCR
#1.5*
ns

B6, NR vs. R
Array
qPCR
$1.4*
$1.4**

D2, NR vs. R
Array
qPCR
–
1.6**

–

–

$1.3**

ns

–

1.6**

–

–

#1.2*

#1.4*

#1.5*

1.6**
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previously implicated in stress-related behavior as well as neural plasticity and circadian
regulation.
Our initial strain survey of the effects of repeated restraint stress resulted in a
number of important observations. As in previous studies from other laboratories using
various repeated stressor, including ten-day restraint, in both rats and mice (e.g., Willner
et al., 1996; Pothion et al., 2004; Krishnan et al., 2007; Shansky et al., 2009), we
examined relative loss of body weight as an indicator of the efficacy of our stress
regimen. As expected, restraint produced a net loss of body weight relative to nonrestrained controls and this was clearly strain-dependent. While, 129S1 mice showed
minimal loss, BALB/cByJ and FVBN/J showed the most marked net reduction in body
weight, as compared to B6 (which we considered our reference strain).
The 129S1, A/J, BALB/cJ, and BALB/cByJ strains displayed a heightened trait
anxiety-like phenotype in the dark/light emergence test under non-restraint
basalconditions, as compared to the reference B6 strain, a finding largely consistent with
a number of previous studies (for reviews, see Belzung & Griebel, 2001; Anisman &
Matheson, 2005; Jacobson & Cryan, 2007; Millstein & Holmes, 2007). The strong basal
phenotype in these strain did, however, prevented the detection of further increases in this
behavior as a result of chronic restraint. By contrast, basal anxiety-like behavior in the
FVBN/J strain was no different from B6, but unlike B6, FVBN/J mice displayed an
anxiogenic-like profile (albeit only on one measure only—shelter exits) following
repeated restraint, as compared to non-restrained FVBN/J mice. Of even greater interest,
the D2 strain showed both a higher basal level of anxiety-like behavior, as compared to
B6, and a further increase in anxiety-like behavior following repeated restraint. Thus, D2
and B6 showed divergent trait and restraint-induced anxiety-like behavior, suggestive of
a susceptible and resilient phenotype, respectively. That the B6 strain displayed a
relatively stress resilient phenotype concurs with previous reports (for reviews see,
Anisman & Matheson, 2005; Holmes et al., 2005).
In contrast to the marked trait and restraint-induced differences in emergence test
anxiety-like behavior between strains, there were fewer clear strain- or restraint-related
differences in depression-related behavior as measured via the forced swim test. Perhaps
the most notable observation was a decrease in immobility in the BALB/cByJ strain
following restraint. A decrease in immobility is similar to that seen with antidepressant
treatment (Cryan & Holmes, 2005) and was therefore an unexpected consequence of
restraint, especially in this characteristically high-anxiety and stress-reactive strain
(Anisman et al., 2001; Belzung & Griebel, 2001; Dulawa et al., 2004; Norcross et al.,
2008), and additional studies will be needed to clarify the precise nature of this effect.
All strains, including BALB/cByJ, showed robust HPA-axis activation, as
measured by serum corticosterone levels, to forced swim stress. Moreover, following
repeated restraint, both B6 and D2 showed an augmented HPA-axis response to swim
stress, as compared to non-restrained counterparts. This is consistent with a restraintinduced sensitization of the HPA-axis response to a novel stressor in these strains. A
similar sensitization was recently found in B6 mice exposed to ten days of social defeat
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(Krishnan et al., 2007). Although none of the other inbred strains we tested showed this
effect this may simply have been due to a ‘ceiling’ level of swim-induced corticosterone
obscuring the detection of further increases in the restrained mice. Interestingly however,
restrained 129S1 mice actually showed a significantly decreased corticosterone response
to swim stress relative to non-restrained counterparts. This finding is intriguing because
there is evidence of augmented HPA-axis inhibition in patients with post-traumatic stress
disorder (PTSD) (Yehuda, 2002), and we have recently found that the 129S1 strain has an
impairment in fear extinction (Hefner et al., 2008); a major symptomatic characteristic of
PTSD.
Notwithstanding, the main conclusion from these analyses was that the divergent
anxiety-related phenotypes between B6 and D2 did not generalize to measures of
depression-related behavior or HPA-axis activation, on which the two strains did not
diverge following repeated restraint. Krishnan and colleagues made a similar observation
in a study of the effects of repeated social defeat (Krishnan et al., 2007). These authors
found that a subgroup of B6 mice that showed decreased body weight and increased
social avoidance after repeated defeat did not show abnormalities in forced swim
immobility or swim stress-induced corticosterone. Along similar lines, Stekalova et al.
(2004) found that C57BL/6N mice exposed to four weeks of a combination of stressors
(rat exposure, restraint, tail suspension) had reduced body weight and increased anxietylike behavior (tested in the elevated plus-maze) but normal forced swim performance
(Strekalova et al., 2004). Taken together with the current data, these findings indicate
that depression-related behavior measured by the forced swim test is insensitive to the
effects of repeated stress in most mouse strains.
Genome-wide analysis of gene expression in subpopulations of B6 mice classified
as susceptible or resilient to repeated social defeat was recently used as a strategy to
identify molecular candidates underlying these differences (Krishnan et al., 2007). We
applied a similar strategy to explore the molecular basis of the differences in trait and
restraint-induced anxiety-like behavior between B6 and D2 by examining patterns of
gene expression in three key regional loci of the corticolimbic circuit mediating stress
responses and stress-induced changes in behavior—the mPFC, amygdala, and
hippocampus. Consistent with previous studies (Kerns et al., 2005; Grice et al., 2007),
our analysis detected substantial expression difference between B6 and D2 with several
genes differentially expressed in all three regions.
Amongst the differentially expressed genes confirmed with RT-PCR, B6 had
lower amygdala levels of Grin1 (encoding the ionotropic N-methyl-D-aspartate
(NMDAR) 1 subtype). Interestingly, reduced NMDAR function hs anxiolytic-like effects
in rodents (Boyce-Rustay & Holmes, 2006; Cryan & Dev, 2007). In addition, B6 had
higher hippocampal levels of Bdnf (encoding brain-derived neurotrophic factor) and
lower levels of Gria1 (GluR1 AMPA glutamate receptor) than D2. GluR1 is a principal
mediator of glutamatergic excitatory neurotransmission (Malenka & Bear, 2004) and
gene knockout of GluR1 produces altered reward and schizophrenia-related disturbances
(Bannerman et al., 2006; Wiedholz et al., 2008). A number of interesting strain
differences were also found in the mPFC. These included relatively higher mRNA
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expression of Comt (catechol-O-methyltransferase) and lower expression of Chrna4 (%4
nicotinic receptor) in B6 mice. Both a high COMT activity gene variant (val158met) in
humans (Zubieta et al., 2003) and transgenic overexpression of Comt in mice (Papaleo et
al., 2008) are associated with reduced stress reactivity. On the other hand, a point
mutation causing Chrna4 hypersensitivity increases anxiety-like behavior in mice
(Labarca et al., 2001). Of further note, B6 had lower levels of Rgs2 (regulator of Gprotein signaling 2) in the mPFC. Rgs2 was recently identified a candidate gene
underlying variation in anxiety-like behavior in both mice (Yalcin et al., 2004) and
humans (Smoller et al., 2008). Taken together, these basal gene expression differences
between B6 and D2 are highly convergent with previous data implicating the same genes
in anxiety- and stress-related behaviors, and identify a number of possible candidates
underlying the trait differences in anxiety between the two strains.
Repeated restraint produced a pattern of corticolimbic gene expression differences
that was very different from that associated with the trait anxiety-related differences
between B6 and D2 mice. The amygdala was by far the most stress-sensitive region in
terms of number of expression changes produced by restraint, with a lesser although still
significant, number of changes in the hippocampus and mPFC. Moreover, in contrast to
the considerable regional overlap in expression difference associated with strain, there
was a very limited set of genes differentially expressed after restraint in any two regions
(< four percent of the total number of probes). This indicates that restraint drove the
expression of quite unique sets of genes in the three regions we examined. An important
additional finding was that these restraint-sensitive gene sets were (with some notable
exceptions, see below) by and large highly divergent between the B6 and D2 strains; i.e.,
few of the same expression changes seen in B6 were also seen in D2.
B6 mice showed a significant upregulation of amygdala Grin1 (encoding the
NMDAR1 glutamate receptor subtype) and a parallel downregulation of Grik1 (kainate 1
glutamate receptor subtype) and Gal (galanin). Numerous studies have pointed to a role
for galanin in stress-mediation (Karlsson & Holmes, 2006), including recent work
showing that galanin is upregulated in the ventral tegmental area by repeated social
defeat in a ‘stress-susceptible’ subgroup of C57BL/6J mice (Krishnan et al., 2007).
A striking cluster of gene expression changes associated with repeated restraint
involved the circadian genes encoding the period homologs Per1, Per2 and Per3 and a
modulator of their expression, Dbp (D site albumin promoter binding protein) (Ueda et
al., 2005). The diurnal dynamics of these clock genes are modulated by intricate
transcriptional and post-translational regulatory loops and are tightly synchronized with
glucocorticoid levels (Maywood et al., 2007; Son et al., 2008). Several circadian genes,
including Per1, are known to have glucocorticoid response elements in their regulatory
regions (Reddy et al., 2007). It is plausible that in the CNS, the persistent stress-induced
perturbations in glucocorticoid levels may be mediating the expression changes in the
circadian genes. These circadian genes may in turn have downstream effect on the
expression of genes such as Homer1 and the glutamate receptors (Maret et al., 2007).
Interesting, Nr4a2, a nuclear receptor that interacts directly with the glucocorticoid
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receptor to co-regulate gene expression (Carpentier et al., 2008), was decreased in
expression following restraint stress in C57BL/6J.
Unlike the expression changes discussed above, both strains showed significant
upregulation in the clock genes. These changes were particularly interesting in the
context of growing evidence linking circadian genes alcoholism and mood disorders
(McClung, 2007; Takahashi et al., 2008). For example, mice with knockout of Dbp
exhibit locomotor hyperactivity after chronic heterogeneous stress (Le-Niculescu et al.,
2008), while Per2 inactivation increases extracellular levels of glutamate and promotes
alcohol drinking (Spanagel et al., 2005), and Per1 and Per2 inactivation alters sensitivity
to cocaine (Abarca et al., 2002). These data raise the intriguing possibility that repeated
restraint might alter the behavioral effects of psychostimulant drugs of abuse and alcohol
in mice, as has been found with other forms of repeated stress (Boyce-Rustay et al.,
2007).
In summary, the results of the current study provide further evidence of marked
strain differences in anxiety-like behavior and identify divergent behavioral effects of
repeated stress between two strains, B6 and D2. These differential effects were specific to
a measure of anxiety-like behavior and did not generalize to a measure of depressionrelated behavior or sensitization of the HPA-axis to stress. Restraint-induced strain
variation in behavior was associated with marked differences in gene expression in
corticolimbic brain regions mediating stress-related behaviors. The hippocampus showed
that largest number of gene expression differences between B6 and D2 at baseline, while
the amygdala was the most sensitive region to repeated restraint. We identified a number
of candidate genes underlying differences in anxiety-like behavior between B6 and D2
(e.g., Rgs2, Comt, Grin1) and the differential response to repeated restraint between the
strains (e.g., Grin1, Grik1, Gal). Significant upregulation of circadian clock genes (Per1,
Per2, Per3, Dbp) were seen in both strains.
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CHAPTER 5. DISSECTING A QTL HOTSPOT ON MOUSE DISTAL
CHROMOSOME 1 THAT MODULATES NEUROBEHAVIORAL PHENOTYPES
AND GENE EXPRESSION*
5.1

Synopsis

A remarkably diverse set of traits maps to a region on mouse distal chromosome 1
(Chr 1) that corresponds to human Chr 1q21–q23. This region is highly enriched in
quantitative trait loci (QTLs) that control neural and behavioral phenotypes, including
motor behavior, escape latency, emotionality, seizure susceptibility (Szs1), and responses
to ethanol, caffeine, pentobarbital, and haloperidol. This region also controls the
expression of a remarkably large number of genes, including genes that are associated
with some of the classical traits that map to distal Chr 1 (e.g., seizure susceptibility). Here
we ask whether this QTL-rich region on Chr 1 (Qrr1) consists of a single master locus or
a mixture of linked, but functionally unrelated QTLs. To answer this question and to
evaluate candidate genes, we generated and analyzed several gene expression, haplotype,
and sequence data sets. We exploited six complementary mouse crosses, and combed
through 18 expression data sets to determine class membership of genes modulated by
Qrr1. Qrr1 can be broadly divided into a proximal part (Qrr1p) and a distal part (Qrr1d),
each associated with the expression of distinct subsets of genes. Qrr1d controls RNA
metabolism and protein synthesis, including the expression of ~20 aminoacyl-tRNA
synthetases. Qrr1d contains a tRNA cluster, and this is a functionally pertinent candidate
for the tRNA synthetases. Rgs7 and Fmn2 are other strong candidates in Qrr1d. FMN2
protein has pronounced expression in neurons, including in the dendrites, and deletion of
Fmn2 had a strong effect on the expression of a subset of genes modulated by Qrr1d. Our
analysis revealed a highly complex gene expression regulatory interval in Qrr1,
composed of multiple loci modulating the expression of functionally cognate sets of
genes.

5.2

Introduction

The distal part of mouse Chr 1 harbors a large number of QTLs that generate
differences in behavior. Open field activity (DeFries et al., 1978), fear conditioning
(Caldarone et al., 1997), rearing behavior (Gershenfeld et al., 1997), and several other
measures of emotionality (Flint et al., 1995) have been repeatedly mapped to distal Chr 1.
This region is also notable because it appears to influence responses to a wide range of
drugs including ethanol (Crabbe, 1996), caffeine (Casley et al., 1999), pentobarbital
(Buck et al., 1999), and haloperidol (Patel et al., 1999). In addition to the behavioral
traits, a number of metabolic, physiological and immunological phenotypes have been
mapped to this region (e.g., Beamer et al., 2001; Wang et al., 2004). This QTL rich
*

Adapted with permission. Mozhui K, Ciobanu DC, Schikorski T, Wang X, Lu L,
Williams RW (2008). Dissection of a QTL hotspot on mouse distal chromosome 1 that
modulates neurobehavioral phenotypes and gene expression. PLoS Genet 4:e1000260.
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region on mouse distal Chr 1 exhibits reasonably compelling functional and genetic
concordance with the orthologous region on human Chr 1q21–q23. Prime examples of
genes in this region that have been associated with similar traits in mouse and human are
Rgs2 (anxiety in both species), Apoa2 (atherosclerosis), and Kcnj10 (seizure
susceptibility) (Ferraro et al., 2004; Wang et al., 2004; Yalcin et al., 2004; Smoller et al.,
2008; Takada et al., 2008).
Studies of gene expression in the central nervous system (CNS) of mice have
revealed major strain differences in the expression level of numerous genes located on
distal Chr 1, e.g., Copa, Atp1a2, and Kcnj9 (Sandberg et al., 2000; Hitzemann et al.,
2003; Kerns et al., 2006). These differentially expressed genes are strong candidates for
the behavioral and neuropharmacological traits that map to this region. We have recently
shown that sequence variants near each of these candidate genes are often responsible for
the prominent differences in expression (Hitzemann et al., 2003; Chesler et al., 2005;
Peirce et al., 2006). In other words, sequence differences near genes such as Kcnj9 cause
expression to differ, and variation in transcript level maps back to the location of the
source gene itself. Transcripts of this type are associated with cis-QTLs.
These expression genetic studies have also uncovered another unusual
characteristic of mouse distal Chr 1. In addition to the extensive cis-effects, a large
number of transcripts of genes located on other chromosomes map into this same short
interval on distal Chr 1 (Matthews et al., 2005; Peirce et al., 2006). These types of QTLs
are often referred to as trans-QTLs. The clustering of trans-QTLs to distal Chr 1 has been
replicated in multiple crosses and CNS microarray data sets (Peirce et al., 2006). We
refer to this region of Chr 1, extending from Fcgr3 (172.5 Mb) to Rgs7 (177.5 Mb) as the
QTL-rich region on Chr 1, or Qrr1. It is possible that these modulatory effects on
expression are the first steps in a cascade of events that are ultimately responsible for
many of the prominent differences in behavior and neuropharmacology. For example,
Qrr1 modulates the expression of several genes that have been implicated in seizure (e.g.,
Scn1b, Pnpo, Cacna1g), and this may be a basis for the strong influence Qrr1 has on
seizure susceptibility (Ferraro et al., 2004).
In this study, we exploited 18 diverse array data sets derived from different mouse
crosses to systematically dissect the expression QTLs in Qrr1. The strong trans effects
are consistently detected in CNS tissues of C57BL/6J (B6) x DBA/2J (D2) and B6 x
C3H/HeJ (C3H) crosses, but are largely absent in ILS/Ibg (ILS) x ISS/Ibg (ISS) and
C57BL/6By (B6y) x BALB/cBy (BALB), and in all non-neural tissues we have
examined. We applied high-resolution mapping and haplotype analysis of Qrr1 using a
large panel of BXD recombinant inbred (RI) strains that included highly recombinant
advanced intercross RI lines. Our analyses revealed multiple distinct loci in Qrr1 that
regulate gene expression specifically in the CNS. The distal part of Qrr1 (Qrr1d) has a
strong effect on the expression of numerous genes involved in RNA metabolism and
protein synthesis, including more than half of all aminoacyl-tRNA synthetases. Fmn2 and
Rgs7, and a cluster of tRNAs are the strongest candidates in Qrr1d.
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5.3

Materials and Methods

5.3.1 Microarray Datasets
The microarray data sets used in this study (Table 5-1) were generated by
collaborative efforts (Hitzemann et al., 2004; Chesler et al., 2005; Bystrykh et al., 2006;
Peirce et al., 2006; Yang et al., 2006; Gatti et al., 2007). All data sets can be accessed
from http://www.genenetwork.org. They provide estimates of global mRNA abundance
in neural and non-neural tissues in the BXD, LXS, and CXB RI strains, B6D2F2
intercrosses, and B6C3HF2 intercrosses. Detailed description of each set, tissue
acquisition, RNA extraction and array hybridization methods, and data processing and
normalization methods are provided in the “Info” page linked to each data set. In brief,
the data sets are:
1) BXD CNS transcriptomes: The BXD CNS data sets measure gene expression in
the forebrain and midbrain (INIA Forebrain), striatum (HBP/Rosen Striatum and
HQF Striatum), hippocampus (Hippocampus Consortium and UMUTAffy
Hippocampus), cerebellum (SJUT Cerebellum mRNA), and eye (Hamilton Eye)
of BXD RI strains. The INIA Brain and HBP/Rosen Striatum data sets have been
described in Peirce et al. (2006). The Hippocampus Consortium data set measures
gene expression in the adult hippocampus of 69 BXD RI strains, the parental B6
and D2 strains, and F1 hybrids. The SJUT Cerebellum data set measures gene
expression in the adult cerebellum of 45 BXD RI strains, parental strains, and F1
hybrids. The Eye dataset measures gene expression in the eyes of 64 BXD RI
strains, parental strains, and F1 hybrids. The HQF BXD Striatum is one of the
newest data sets and was generated on Illumina Sentrix Mouse–6.1 arrays. It is
similar to the HBP/Rosen Striatum and measures gene expression in the striatum
of 54 BXD RI strains, parental strains, and F1 hybrids.
2) BXD non-neural transcriptomes: The non-neural BXD array sets measure gene
expression in the liver (UNC Liver) of 40 BXD strains, kidney (Kidney
Consortium) of 53 BXD strains, and hematopoietic stem cells (GNF
Hematopoietic Cells) of 30 BXD strains (Bystrykh et al., 2006; Gatti et al., 2007).
3) LXS hippocampus transcriptome: The LXS Hippocampus data set measures gene
expression in the adult hippocampus of 75 LXS RI strains and the parental ILS
and ISS strains.
4) B6D2F2 CNS transcriptomes: The B6D2F2 data sets measure gene expression in
the whole brain (OHSU/VA Brain), and striatum (OHSU/VA Striatum) of B6xD2
F2 intercrosses (Hitzemann et al., 2004; Peirce et al., 2006). The whole brain data
set comprises of samples from 56 F2 animals, and the striatum data set comprises
of samples from 58 F2 animals.
5) B6C3HF2 transcriptomes: These data sets were generated from large numbers of
B6xC3H F2 intercross progeny and assayed using Agilent arrays (Yang et al.,
2006). These data sets have been described in Yang et al. (2006).
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Table 5-1

Expression QTLs in Qrr1 in different crosses and tissues

Cross

NA

B6D2F2

58

B6D2F2

56

BXD

45

BXD

69

BXD

39

BXD

64

BXD

54

BXD

29

BXD

63

BXD

40

BXD

53

Dataset
Normalization
OHSU/VA
(Sep05)
PDNN
OHSU/VA
(Aug05)
PDNN
SJUT
(Mar05)
PDNN
Hippocampus
Consortium
(Dec05)
PDNN
INIA
(Jan06)
PDNN
Hamilton
Eye
Institute
(Sep06)
RMA
HQF
(Nov 07)
RankInv
HBP/Rosen
(Apr05)
PDNN
UMUTAffy
(Mar08)
RMA
UNC
(Jan06)
LOWESS
Kidney
Consortium
(Aug06)
PDNN

LOD ! 3
TB

CB

Striatum

Affymetrix 197
M430v2

56

8

5

Whole
brain

Affymetrix
M430

79

30

1

2

Cerebellum

Affymetrix 439
M430

44

9

2

Hippocam- Affymetrix 345
pus
M430v2

54

7

1

Forebrain

Affymetrix 279
M430

39

5

1

Eye

Affymetrix 156
M430v2

43

2

1

Striatum

Illumina
M6.1

97

31

1

1

Striatum

Affymetrix
M430v2

94

25

2

1

Hippocam- Affymetrix 700 302
pus
Exon 1.0
ST
Liver
Agilent
9
20
G4121A

0.4

1

0.3

1

Kidney

0.2

1

Tissue

Array

Affymetrix
M430v2

74

8

33

%TC %CD

Table 5-1 (continued)
Dataset
LOD ! 3
NormaliCross
NA
zation
Tissue
Array
TB CB %TC %CD
BXD
30 GNF
HematoAffymetrix 0
6
0
3
(Mar03)
poietic
U74Av2
MAS5
Cells
LXS
75 NIAAA
Hippocam- Illumina
10 28
0.4
1
INIA
pus
M6.1
(May07)
RankInv
B6C3F2
238 UCLA
Brain
Agilent
516 51
14
3
(2005)
mlratio
B6C3F2
306 UCLA
Muscle
Agilent
15 33
0.3
2
(2005)
mlratio
B6C3F2
298 UCLA
Liver
Agilent
63 46
0.7
3
(2005)
mlratio
B6C3F2
282 UCLA
Adipose
Agilent
56 34
0.5
3
(2005)
mlratio
CXB
13 Hippocampus Hippocam- Affymetrix 7
12 0.08
2
Consortium
pus
M430v2
(Dec05)
PDNN
A
Number of RI strains or F2 mice; BNumber of trans-QTLs (T) and cis-QTLs (C);
C
Percent of trans-QTLs in Qrr1 = [(number of trans-QTLs in Qrr1)/(total number of
trans-QTLs in the whole genome) x 100]; DPercent of cis-QTLs in Qrr1 = [(number of
cis-QTLs in Qrr1)/(total number of cis-QTLs in the whole genome) x 100].

75

5.3.2 Mouse Strains and Genotype Data
The conventional BXD RI strains were derived from the B6 and D2 inbred mice
(Taylor, 1989; Taylor et al., 1999). The newer sets of advanced RI strains were derived
by inbreeding intercrosses of the RI strains (Peirce et al., 2004). The parental B6 and D2
strains differ significantly in sequence and have approximately 2 million informative
SNP. A subset of 14,000 SNPs and microsatellite markers have been used to genotype the
BXD strains (Williams et al., 2001b; Shifman et al., 2006). We used 3,795 informative
markers for QTL mapping. Thirty such informative markers are in Qrr1 and we queried
these markers to identify strains with recombinations in Qrr1; genes with strong cisQTLs (Sdhc, Atp1a2, Dfy, and Fmn2) were used as additional markers. Smaller sub-sets
of markers were used to genotype the two F2 panels (total of 306 markers for the whole
brain, and 75 markers for the striatum F2 datasets).
The LXS RI strains were derived from the ILS and ISS inbred strains. They have
been genotyped using 13,377 SNPs, and some microsatellite markers (Williams et al.,
2004). 2,659 informative SNPs and microsatellite markers were used for QTL mapping.
The CXB panel consists of 13 RI strains derived from C57BL/6By and BALB/cBy
inbred strains. A total of 1384 informative markers were used for QTL mapping.
The B6 x C3H/HeJ F2 intercrosses have been genotyped using 13,377 SNPs and
microsatellite markers, and 8,311 informative markers were used for QTL mapping.
5.3.3 Animals and Tissue Acquisition
Majority of the BXD and LXS tissues (cerebellum, eye, forebrain, hippocampus,
kidney, liver, and striatum for the HQF Illumina data set) were dissected at the University
of Tennessee Health Science Center (UTHSC). Mice were housed at the UTHSC in
pathogen-free colonies, at an average of three mice per cage. All animal procedures were
approved by the Animal Care and Use Committee. Mice were killed by cervical
dislocation, and tissues were rapidly dissected and placed in RNAlater (Ambion,
http://www.ambion.com) and kept overnight at 4° C, and subsequently stored at –80° C.
Tissue were then processed at UTHSC or shipped to other locations for processing.
5.3.4 RNA Isolation and Sample Preparation
For the tissues that were processed at UTHSC (all BXD and LXS CNS tissues
except HBP Affymetrix striatum), RNA was isolated using RNA STAT-60 (Tel-Test
Inc., http://www.tel-test.com) as per manufacturer’s instructions. Samples were then
purified using standard sodium acetate methods prior to microarray hybridization. The
eye samples required additional purification steps to remove eye pigment; this was done
using the RNeasy MinElute Cleanup Kit (Qiagen, http://www.qiagen.com). RNA purity
and concentration was evaluated with a spectrophotometer using 260/280 nm absorbance
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ratio, and RNA quality was checked using Agilent Bioanalyzer 2100 prior to
hybridization. Array hybridizations were then done according to standard protocols.
5.3.5 Microarray Probe Set Annotation
We have re-annotated a majority of Affymetrix probe sets to ensure more accurate
description of probe targets. Each probe set represents a concatenations of eleven 25-mer
probes, and these have been aligned to the NCBI built 36 version of the mouse genome
(mm8 in UCSC Genome Browser) by BLAT analysis. We have also re-annotated the
Illumina probes and incorporated these annotations into GeneNetwork. Each probe in the
Illumina Mouse–6 and Mouse–6.1 arrays is 50 nucleotides in length, and these have been
aligned to NCBI built 36.
5.3.6 QTL Mapping
We used the strain average expression signal detected by a probe or probe set.
QTL mapping was done for all transcripts using QTL Reaper (Peirce et al., 2006). QTL
Reaper performs up to a million permutations of an expression trait to calculate the
genome-wide empirical p and the LOD score associated with a marker. We selected only
those transcripts that have highest LOD scores, i.e., genome-wide adjusted best p-values,
on markers located on Chr 1 from 172 to 178 Mb. This selected transcripts that are
primarily modulated by Qrr1 but excluded transcripts that have QTLs in Qrr1 but have
higher LOD scores on markers located on other chromosomal regions. Cis- and transQTLs were distinguished based on criteria described by Peirce et al. (2006). To identify
trans-QTLs common to multiple data sets, we selected probes/probe sets that target the
same genes and have peak LOD scores within 10 Mb in the different data sets.
5.3.7 Screening Local QTLs
We screened all Affymetrix probe sets with cis-QTLs in Qrr1 for SNPs in target
sequences. This step was taken to identity false cis-QTLs caused by differences in
hybridization. As probe design is based on the B6 sequence, such spurious cis-QTLs
show high expression for the B allele, and low expression for the D allele. Our screening
identified only two probe sets in which SNPs result in spurious local QTLs—1429382_at
(Tomm40l) , and 1452308_a_at (Atp1a2). The majority of cis-QTLs in Qrr1 are likely to
be due to actual differences in mRNA abundance. We did not detect a bias in favor of the
B allele on cis-regulated expression and the ratio of transcripts with B- and D- positive
additive effects is close to 1:1.
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5.3.8 Analysis of Allele Specific Expression Difference
To measure expression difference between the B and D alleles, we exploited
transcribed SNPs to capture allelic expression difference in F1 hybrids (Cowles et al.,
2006) using a combination of RT-PCR and a single base extension technology
(SNaPshot, Applied Biosystems, http://www.appliedbiosystems.com). For each transcript
we analyzed, Primer 3 (Rozen et al., 2000) was used to design a pair of PCR primers that
target sequences on the same exon and flanking an informative SNP.
We prepared four pools of RNA from the hippocampus, and four pools of
genomic DNA from the spleen of F1 hybrids (male and female B6xD2 and D2xB6 F1
hybrids). To avoid contamination by genomic DNA, the four RNA pools were treated
with Turbo DNase (Ambion, http://www.ambion.com), and then first strand cDNA was
synthesized (GE Healthcare, http://www.gehealthcare.com). The genomic DNA samples
were used as controls, and both cDNA and genomic DNA samples were tested
concurrently using the same assay to compare expression levels of B and D transcripts.
We amplified the cDNA and genomic DNA samples using GoTaq Flexi DNA
polymerase (Promega Corporation, http://www.promega.com). PCR products were
purified using ExoSap-IT (USB Corporation, http://www.usbweb.com) followed by
SNaPshot to extend primer by a single fluorescently labeled ddNTPs. Fluorescently
labeled products were purified using calf intestinal phosphatase (CIP, New England
BioLabs, http://www.neb.com) and separated by capillary electrophoresis on ABI3130
(Applied Biosystems). Quantification was done using GeneMapper v4.0 software
(Applied Biosystems), and transcript abundance was measured by peak intensities
associated with each allele. Ratio of B and D allele in both cDNA and gDNA pools was
computed, and t-test (one tail, unequal variance) was done to validate expression
difference and polarity of parental alleles.
5.3.9 SNP Analysis in Multiple Crosses
GeneNetwork has compiled SNP data from different sources—Celera
(http://www.celera.com), Perlegen/NIEHS
(http://mouse.perlegen.com/mouse/download.html), BROAD institute
(http://www.broad.mit.edu/snp/mouse), Wellcome–CTC (Shifman et al., 2006), dbSNP,
and Mouse Phenome Database (http://www.jax.org/phenome/SNP). SNP counts were
done on the GeneNetwork SNP browser.
5.3.10 Partial Correlation Analysis
A partial correlation is the correlation between X and Y conditioned on one or
more control variables. In this study, first order partial correlation was used to detect the
interaction between trans-regulated transcripts and cis-regulated candidate genes
conditioned on the genotype (marker rs8242481 at 175.058 Mb). If x, y and z are trans-
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regulated transcripts, cis-regulated transcript, and genotype in the QTL, respectively, then
the first order partial correlation coefficient is calculated as—

rxy.z =

rxy " rxz ryz

(1" r )(1" r )
2
xz

2
yz

where rxy can be either Pearson correlation or Spearman’s rank correlation between x and
y. We employed the Spearman’s rank correlation because the expression levels of many
transcripts do not follow!a normal distribution. The significance of a partial correlation
with n data points was assessed with a two-tailed t test—

t=r

n!2!k
~ tn ! 2 ! k
1! r2

where r is the first order correlation coefficient, and k is the number of variables on
which we are conditioning.
5.3.11 Immunocytochemistry
Cultured hippocampal neurons from male B6 mice, prepared as described in
Schikorski et al. (2007) and cultured for 23 days, were fixed with 4% paraformaldehyde
and 0.1% glutaraldehyde in HEPES buffered saline (pH7.2) for 15 min. Cell membranes
were permeabilized with 0.1% triton X-100 and unspecific binding sites were quenched
with 10% BSA for 20 min at room temperature (RT). Neurons were incubated with a
polyclonal anti-FMN2 antibody (Protein Tech Group, http://www.ptglab.com) diluted to
0.3 &g/ml at RT overnight. An anti-rabbit antibody raised in donkey (1:500,
http://www.invitrogen.com) conjugated with the fluorescent dye Alexa488 was used for
the detection of the first antibody. All regions of interest were photographed with
identical illumination and camera settings to allow for a direct comparison of the staining
in labeled and control neurons.
5.3.12 Microarray Analysis of Fmn2-Knockout Mice
The Fmn2-/- mice were generated using 129/SvEv (now strain 129S6/SvEvTac)
derived TC-1 embryonic stem cells. Chimeric mice were backcrossed to 129/SvEv
(Leader et al., 2000). The Fmn2-null and littermate controls are therefore coisogenic. To
validate the isogenicity of regions surrounding the targeted locus (Gerlai, 1996), we
genotyped the Fmn2+/+, Fmn2+/-, and Fmn2-/- mice using ten microsatellite markers
located on, and flanking Fmn2 (markers distributed from 172 Mb to 182 Mb). These
markers are D1Mit455, D1Mit113, D1Mit456, D1Mit356, D1Mit206, D1Mit355,
D1Mit150, D1Mit403, D1Mit315, and D1Mit426. With the exception of a marker at
Fmn2 (D1Mit150), all alleles in null, heterozygote, and wildtype animals were identical.
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RNA was isolated from whole brain samples of Fmn2+/+ and Fmn2-/- mice, and assayed
on Illumina Mouse-6 array slides (six samples per slide). We compared five samples
from Fmn2-/- nulls, and five samples from Fmn2+/+ wildtype. Equal numbers of each
genotypes were placed on each slide to avoid batch confounds. Microarray data were
processed using both raw and rank invariant protocols provided by Illumina as part of the
BeadStation software suite (http://www.illumina.com). We subsequently log-transformed
expression values and stabilized the variance of each array. To identify genes with
significant expression difference between the Fmn2-/- and Fmn2+/+ cases, we carried out
two-tailed t-tests and applied a Bonferroni correction for multiple testing, and selected
probes with a minimum adjusted p < 0.05.
5.3.13 Bioinformatics Tools
The April 2008 version of Mouse Genome Informatics was used to survey
classical QTLs in Qrr1 (MGI: http://www.informatics.jax.org) (Eppig et al., 2005).
Search for tRNAs was done using tRNAscan-SE 1.21
(http://lowelab.ucsc.edu/tRNAscan-SE/) (Lowe et al., 1997). GO analysis was done using
the analytical tool DAVID 2007 (http://david.abcc.ncifcrf.gov/) (Dennis et al., 2003).
Overrepresented GO terms were identified and statistical significance of enrichment was
calculated using a modified Fisher’s Exact Test or EASE score (Hosack et al., 2003). We
used the Allen Brain Atlas to analyze expression pattern in the brain of young C57BL/6J
male mice (http://www.brain-map.org) (Lein et al., 2007; Lau et al., 2008).
5.3.14 Control for Non-Syntenic Association and Paralogous Regions
In RI strains, non-syntenic associations can lead to LD between distant loci
(Petkov et al., 2006; Williams et al., 2001b). In the BXDs, we detected such non-syntenic
associations between markers in Qrr1 and markers on distal Chr 2 and proximal Chr 15.
As a result of these associations, some transcripts that have strong cis- or trans-QTLs in
Qrr1 tend to have weak LOD peaks, usually below the suggestive threshold, on distal Chr
2 and proximal Ch15. However, there is no bias for genes located in these intervals in LD
with Qrr1 to have trans-QTLs in Qrr1.
The Qrr1 segment has been reported to have paralogues on mouse Chrs 1
(proximal region), 2, 3, 6, 7, 9, and 17 (Katsanis et al., 1996; Stanier et al., 1998). We
examined if the trans-QTLs in Qrr1 are of genes located in these paralogous regions.
However, genes located in the paralogous regions are not overrepresented among the
trans-QTL.
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5.4

Results

5.4.1 Enrichment in Expression QTLs in Neural Tissues
In this section, we summarize the number of expression phenotypes that map to
Qrr1 in different tissues and mouse crosses. The results are based on the analysis of 18
array data sets that provide estimates of global mRNA abundance in neural and nonneural tissues from six different crosses. These crosses are—(i) BXD RI and advanced
intercross RI strains derived from B6 and D2, (ii) CXB RI strains derived from B6y x
BALB, (iii) LXS RI strains derived from ILS and ISS, (iv) B6xC3H F2 intercrosses, and
(v & vi) two separate B6xD2 F2 intercrosses. These data sets were generated by
collaborative efforts over the last few years (Hitzemann et al., 2004; Bystrykh et al.,
2005; Chesler et al., 2005; Peirce et al., 2006; Yang et al., 2006; Gatti et al., 2007) and
some were generated more recently (e.g., the Illumina data sets for BXD striatum and
LXS hippocampus, and BXD Hippocampus UMUTAffy Exon Array data set). All data
sets can be accessed from GeneNetwork (http://www.genenetwork.org).
We mapped loci that modulate transcript levels and selected only those transcripts
that have peak QTLs in Qrr1 with a minimum LOD score of 3. This corresponds to a
generally lenient threshold with genome-wide p of 0.1 to 0.05, but corresponds to a
highly significant pointwise p. Because we are mainly interested in testing a short
segment on Chr 1, a pointwise (region-wise) threshold is more appropriate to select those
transcripts that are likely to be modulated by Qrr1. Qrr1 covers approximately 0.2% of
the genome and extends from Fcgr3 (more precisely, SNP rs8242852 at 172.887364 Mb
using Mouse Genome Assembly NCBI m36, UCSC Genome Browser mm8) through to
Rgs7 (SNP rs4136041 at 177.273526 Mb). We defined this region on the basis of the
large number of transcripts that have maximal LOD scores associated with markers
between these SNPs.
Hundreds of transcripts map to Qrr1 with LOD scores ! 3 in neural tissue data
sets of BXD RI strains, B6D2F2 intercrosses, and B6C3HF2 intercrosses (Table 5-1).
The QTL counts in Qrr1 are far higher than the average of 15 to 35 expression QTLs in a
typical 6 Mb interval. The fraction of QTLs in Qrr1 is as high as 14% of all trans-QTLs,
and 5% of all cis-QTLs in the whole genome. The enrichment in trans-QTLs in Qrr1 is
even more pronounced when the QTL selection stringency is increased to a LOD
threshold of 4 (genome-wide p of approximately 0.01). For example, 27% of all highly
significant trans-QTLs in the BXD cerebellum data set are in Qrr1. The BXD
hippocampus data set that was assayed on the Affymetrix Exon ST array is an
exception—there are over a million probe sets in this array, and the percent enrichment of
QTLs in Qrr1 appears to be relatively low. Nevertheless, about 1000 transcripts map to
Qrr1 in this exon data set.
In contrast to the CNS data sets, relatively few transcripts map to Qrr1 in nonneural tissues of the BXD strains and B6C3HF2 intercrosses. While the number of cis-
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QTLs is still relatively high (1–3%), Qrr1 has limited or no trans-effect in these data sets
(Table 5-1).
Qrr1 does not have a strong trans-effect in the LXS and CXB hippocampus data
sets (Table 5-1). This indicates that the sequence variants underlying the trans-QTLs do
not segregate to nearly the same extent in the LXS and CXB RI panels as they do in
B6xD2 and B6xC3H crosses. This contrast among crosses can be exploited to parse Qrr1
into sub-regions and identify stronger candidate genes.
5.4.2 Replication of Trans-QTLs in Multiple Data Sets
The trans-QTLs in Qrr1 are highly replicable. A large fraction of the transcripts,
in some cases represented by multiple probes or probe sets, map to Qrr1 in multiple CNS
data sets. For example, there are 747 unique trans-QTLs with LOD scores greater than 4
(genome-wide p ! 0.01) in the BXD hippocampus data set (assayed on Affymetrix
M430v2 arrays). Out of these highly significant trans-QTLs, 155 are in Qrr1 and the
remaining 592 are distributed across the rest of the genome (Figure 5-1). We compared
the trans-QTLs in the hippocampus data set with a similar collection of trans-QTLs
(LOD " 4) in the cerebellum data set (assayed on Affymetrix M430 arrays). Only 101
trans-QTLs in the hippocampus are replicated in the cerebellum (for trans-QTLs that
were declared as common, the average distance between peak QTL markers in the two
data sets is 1.6 Mb). But it is remarkable that of the subset of common trans-QTLs, 64
are in Qrr1 (Figure 5-1). The replication rate of trans-QTLs in Qrr1 is therefore about 6fold higher relative to the rest of the genome. When we compared the BXD hippocampus
data set with the B6C3HF2 brain dataset (assayed on Agilent arrays), we found 54 transQTLs common to both data sets (for the common trans-QTLs, the average distance
between peak markers in the two data sets is 2.7 Mb). Strikingly, out of the 54 transQTLs common to both crosses, 52 are in Qrr1 (Figure 5-1).
Among the transcripts with the most consistent trans-QTLs are glycyl-tRNA
synthetase (Gars), cysteinyl-tRNA synthetase (Cars), asparaginyl-tRNA synthetase
(Nars), isoleucyl tRNA synthetase (Iars), asparagine synthetase (Asns), and activating
transcription factor 4 (Atf4). These transcripts map to Qrr1 in almost all data sets in
which the strong trans-effect is detected. Gars, Cars, and Nars are aminoacyl-tRNA
synthetases (ARS) that charge tRNAs with amino acids during translation. Asns and Atf 4
are also involved in amino acid metabolism—Asns is required for asparagines synthesis
and is under the regulation of Atf4, which in turn is sensitive to cellular amino acid levels
(Sui et al., 2002). Other transcripts that consistently map as trans-QTLs to Qrr1 include
brain expressed X-linked 2 (Bex2), splicing factor Sfrs3, ribonucleoproteins Snrpc and
Snrpd1, ring finger protein 6 (Rnf6), and RAS oncogene family member Rab2.
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Figure 5-1
Highly replicable trans-QTLs in Qrr1
The charts illustrate the total number of trans-QTLs (LOD " 4) in Qrr1 (shaded) and in
other regions of the genome (non-shaded) in three data sets—BXD cerebellum, BXD
hippocampus, and B6C3H F2 brain. The smaller charts represent the trans-QTLs in BXD
hippocampus that are also detected in BXD cerebellum, and B6C3HF2 brain data sets.
Out of the 101 trans-QTLs common to both BXD hippocampus and cerebellum, 64 are in
Qrr1 and the remaining 37 are located in other regions of the genome. The BXD
hippocampus and B6C3HF2 brain data sets have 54 common trans-QTLs, and almost all
(52 out of 54) are in Qrr1.
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5.4.3 Candidates in Qrr1
Qrr1 contains 164 known genes. The proximal part of Qrr1 is gene-rich and has
several genes with high expression in the CNS (e.g. Pea15, Kcnj9, Kcnj10, Atp1a2). The
middle to distal part of Qrr1 is relatively gene sparse and consists mostly of clusters of
olfactory receptors and members of the interferon activated Ifi200 gene family. Though
comparatively gene sparse, the middle to distal part of Qrr1 contains a small number of
genes that have high expression in the CNS—Igsf4b, Dfy, Fmn2, and Rgs7.
A subset of 35 genes were initially selected as high priority candidates based on
the number of known and inferred sequence differences between the B6 allele (B) and D2
allele (D) and based on expression levels in multiple CNS data sets (Table 5-2). Eleven
of these candidates contain missense SNPs segregating in B6xD2 crosses. We also
scanned Qrr1 for variation in copy number (Li et al., 2004; Graubert et al., 2007).
Graubert et al. (2007) reported segmental duplication in Qrr1 with a copy number gain in
D2 compared to B6 near the intelectin 1 (Itlna) gene at 173.352 Mb. We failed to detect
any expression signatures of a copy number variation around Itlna in any of the
GeneNetwork data sets. However, we did identify an apparent 150 kb deletion across the
Ifi200 gene cluster (175.584–175.733 Mb). Affymetrix probe sets 1426906_at,
1452231_x_at, and 1452349_x_at detect Ifi204 and Mnda transcripts in B6 but not in D2.
The expression difference is robust enough to generate cis-QTLs with very high LOD
scores (> 40). This gene cluster has low expression in the CNS (Affymetrix declares this
probe sets to be “not present”), but high expression in tissues such as hematopoietic stem
cells and kidney, in which the trans-effect of Qrr1 is not detected. The Ifi200 gene cluster
was therefore excluded as a high priority candidate.
5.4.4 Cis-QTLs in Qrr1
Transcripts of 26 of the 35 selected candidate genes map as cis-QTLs (LOD " 3)
in the BXD CNS data sets (Table 5-2). These putatively cis-regulated genes are among
the strongest candidates in the QTL interval. The D allele in Qrr1 has the positive effect
on the expression of Sdhc, Ndufs2, Adamts4, Dedd, Pfdn2, Ltap, Pea15, Atp1a2, Kcnj9,
Kcnj10, Igsf4b, and Grem2. Increase in expression caused by the D allele ranges from
about 10% for Adamts4 to over 2-fold for Atp1a2. In contrast, the B allele has the positive
effect on the expression of Pcp4l1, Fcer1g, B4galt3, Ppox, Ufc1, Nit1, Usf1, Copa,
Pex19, Wdr42a, Igsf8, Dfy, Fmn2, and Rgs7. Increase in expression caused by the B
allele ranges from about 7% for Usf1 to 40% for Pex19.
Individual probes were screened to assess if the strong cis-effects are due to
hybridization artifacts caused by SNPs in probe targets. Thirteen candidate genes with
cis-QTLs were then selected for further analysis and validation of cis-regulation by
measuring allele specific expression (ASE) difference (Cowles et al., 2002). This method
exploits transcribed SNPs, and uses single base extension to assess expression difference
in F1 hybrids. By means of ASE, we validated the cis-regulation of 10 candidate genes—
Ndufs2, Nit1, Pfdn2, Usf1, Copa, Atp1a2, Kcnj9, Kcnj10, Dfy, and Fmn2 (Table 5-3).
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Table 5-2

Candidate genes in Qrr1
Gene

SNPA

ExpB

BXDC

B6C3H CXBC LXSC
F2C

Fcgr3
2
8.2
cis
Sdhc
2
12.3
cis
cis
Pcp4l1
8.7
cis
cis
Tomm40l
9.67
cis
cis
Apoa2
7.2
cis
cis
cis
Fcer1g
8.5
cis
cis
Ndufs2
2
13.6
cis
Adamts4
1
8.1
cis
cis
cis
cis
B4galt3
9.5
cis
Ppox
7.8
cis
cis
cis
Usp21
9.0
cis
Ufc1
10.8
cis
cis
cis
cis
Dedd
9.7
cis
Nit1
1
9.8
cis
cis
cis
cis
Pfdn2
12.8
cis
cis
cis
Arhgap30 4
7.6
Usf1
7.5
cis
cis
cis
Refbp2
2
9.7
cis
cis
Vangl2
7.6
cis
cis
cis
cis
Ncstn
8.5
cis
cis
Copa
1
12.7
cis
cis
cis
Pex19
1
9.9
cis
cis
cis
Wdr42a
10.3
cis
cis
Pea15
14.1
cis
Atp1a2
15.4
cis
cis
cis
cis
Igsf8
12.1
cis
Kcnj9
9.1
cis
cis
cis
cis
Kcnj10
1
11.2
cis
cis
cis
Tagln2
8.8
Dusp23
7.4
cis
Dfy
10.3
cis
cis
cis
Igsf4b
10.6
cis
Fmn2
3
10.4
cis
cis
cis
Grem2
8.2
cis
Rgs7
11.5
cis
cis
A
B
Number of missense SNPs between B and D, Mean expression signal of probe sets in
BXD Hippocampus PDNN dataset; below 7 is considered below background; CCis-QTLs
in BXD, B6C3HF2, CXB, and LXS crosses.
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Table 5-3

Gene

Validation of cis-QTLs

ProbeSet ID

Add.
Cis- Effect
LOD (QTL)A

SNP ID

High
Allele
(ASE)

P

Ndufs2
1451096_at
rs8245216
12
0.172
D
2.4x10-5
Adamts4 1455965_at
rs31537832 25
-0.376
0.2
Ufc1
1416327_at
rs13470410 21
-0.262
D
0.02
Nit1
1417468_at
rs31552469 15
-0.154
B
0.01
Pfdn2
1421950_at
rs31549998
5
0.174
D
4.1x10-7
Usf1
1426164_a_at rs31542370
5
-0.166
B
0.004
Copa
1415706_at
rs13461812
9
-0.148
B
3.9x10-5
Atp1a2
1455136_at
rs31570902 49
1.186
D
0.02
Kcnj9
1450712_at
rs31569118 19
0.511
D
0.01
Kcnj10
1419601_at
rs30789204 28
0.349
D
0.003
Dfy
1432273_a_at rs31616337 24
-0.337
B
0.006
Igsf4b
1418921_at
rs31613626
7
0.171
0.3
Fmn2
1450063_at
rs33800912 17
-0.286
B
5.5x10-6
A
Additive effect is computed as [(mean expression in DD homozygote) – (mean
expression in BB homozygote)]/2 on a log2 scale. Positive value means D high
expression, and negative value means B high expression.
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Adamts4 and Igsf4b failed to show significant allelic expression difference. In the case of
Ufc1, the polarity of the allele effect failed to agree with the ASE result (D positive at p =
0.02).
5.4.5 High-Resolution Cis-QTL Mapping
The BXD CNS data sets were generated from a combined panel of conventional
RI strains and advanced RI strains that were derived by inbreeding advanced intercross
progeny. The advanced RIs have approximately twice as many recombinations compared
to standard RIs and the merged panel offers over a 3-fold increase in mapping resolution
(Peirce et al., 2004). This expanded RI set combined with the relatively high intrinsic
recombination rate within Qrr1 (Paigen et al., 2008) provides comparatively high
mapping resolution. Mapping precision can be empirically determined by analyzing cisQTLs in multiple large data sets, particularly the BXD Hippocampus Consortium,
UMUTAffy Hippocampus, and Hamilton Eye data sets. These three data sets were
selected because they have expression measurements from six BXD strains with
recombinations in Qrr1. These strains—BXD8, BXD29, BXD62, BXD64, BXD68, and
BXD84—collectively provide six sets of informative markers and divide Qrr1 into six
non-recombinant segments, labeled as segments 1–6 (haplotype structures shown in
Figure 5-2).
As cis-acting regulatory elements are usually located within a few kilobases of a
gene’s coding sequence (Cowles et al., 2002), we used the cis-QTLs as an internal metric
of mapping precision by measuring the offset distance between a cis-QTL (position of
peak QTL marker) and the parent gene (Figure 5-3). For cis-QTLs with LOD scores
between 3–4 (genome-wide p of 0.1–0.01) the mean gene-to-QTL peak distance is 900
kb. The offset decreases to a mean of 640 kb for cis-QTLs with LOD scores greater than
4 (p < 0.001). Very strong cis-QTLs with LOD scores greater than 11 (p < 10-6) have a
mean gene-to-QTL peak distance of only 450 kb. In all, 60% of cis-QTLs we examined
have peak linkage on markers located precisely in the same non-recombinant segment as
the parent gene, and 30% have peak linkage on markers in a segment adjacent to the
parent gene (dataset S1). These cis-QTLs provide an empirical metric of mapping
precision within Qrr1.
Parsing trans-QTLs by high-resolution mapping and gene functions
Mapping precision of cis-QTLs is comparatively higher in the BXD hippocampus data
set (average offset of only 410 kb), and we used this set to examine the trans-QTLs
(LOD " 3) at higher resolution. The trans-QTLs in Qrr1 were parsed into subgroups
based on the location of peak LOD score markers. This method of resolving trans-QTLs
effectively grouped subsets of transcripts into functionally related cohorts. For instance,
all the QTLs for the aminoacyl-tRNA synthetases (ARS) have peak LOD scores only
within the distal three segments of Qrr1 (Figure 5-4). This consistency in QTL peaks for
transcripts of the same gene family is itself a good indicator of mapping precision. In
addition to the ARS, numerous other genes involved in amino acid metabolism and
translation map to the distal part of Qrr1 (e.g., Atf4, Asns, Eif4g2, and Pum2).
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Figure 5-2
Haplotype maps of Qrr1 recombinant BXD strains
BXD8, BXD29, BXD62, BXD64, BXD68, and BXD84 have recombinations in Qrr1. B
haplotype is assigned blue (–), D haplotype is assigned pink (+), and recombination
regions are shown in grey. The Qrr1 interval (in Mb scale) is shown above and
approximate positions of recombination are highlighted (red). The recombinant strains
collectively divide Qrr1 into six segments (labeled 1–6), and provide six sets of
informative markers. Markers are shown below and approximate positions of candidate
genes (yellow bars) and tRNA clusters (orange triangles) are indicated.
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Figure 5-3
QTL mapping precision in Qrr1
Mapping precision was empirically determined by measuring the distance between a cisQTL peak and location of parent gene. Cis-QTLs in BXD Hippocampus Consortium,
UMUTAffy Hippocampus, and Hamilton Eye data sets were used for this purpose. Mean
gene-to-QTL peak distance (y-axis) was plotted as a function of LOD score (LOD score
range on x-axis). Number of probe sets in each LOD range is shown. Mapping precision
increases with increase in LOD score. The mean offset for cis-QTLs with LOD scores 3–
4 (genome-wide adjusted p-value of 0.1–0.01) is 900 kb, and the offset decreases to 650
kb at 4–5 LOD scores (p-value of 0.01–0.001). Cis-QTLs with LOD scores greater than
11 (p-value < 10-6) have mean offset of only 450 kb.
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Figure 5-4
QTL for aminoacyl-tRNA synthetase in distal Qrr1
Transcripts of Gars, Cars, Nars, Mars, and Yars map as trans-QTLs to Qrr1 at LOD > 4
(genome-wide p < 0.01) in the BXD hippocampus data set. The trans-QTLs have peak
LOD precisely on markers in distal part of Qrr1, ~175–177.5 Mb (shaded regions).
Yellow seismograph on Chr 1 (x-axis) tracks SNP density between B and D alleles.
Affymetrix probe set ID for each transcript is shown.
We divided the trans-QTLs into two broad subgroups—those with peak QTLs on
markers in the proximal part of Qrr1 (Qrr1p; 172-174.5 Mb or segments 1, 2, 3 in Figure
5-2), and those with peak QTLs on markers in the distal part of Qrr1 (Qrr1d; 174.5-177.5
Mb or segments 4, 5, and 6 in Figure 5-2). While Qrr1p is relatively gene-rich, only 35%
of the trans-QTLs (129 out of 365 probe sets) have peak LOD scores in this region. The
majority of trans-QTLs—about 65% (236 out of 365 probe sets)—have peak QTLs in the
relatively gene-sparse Qrr1d.
The two subsets of transcripts—those with trans-QTLs in Qrr1p and those with
trans-QTLs in Qrr1d—were analyzed for overrepresented gene functions using the
DAVID functional annotation tool (http://david.abcc.ncifcrf.gov/). This revealed distinct
gene ontology (GO) categories enriched in the two subsets. Enriched GOs among the
transcripts modulated by Qrr1p include GTPase-mediate signal transduction (modified
Fisher’s exact test p = 0.001), and structural constituents of ribosomes (p = 0.003).
Transcripts modulated by Qrr1d are highly enriched in genes involved in RNA
metabolism (p = 4 x 10-7), tRNA aminoacylation (p = 1 x 10-5) and translation (p = 2 x
10-5), RNA transport (p = 0.003), cell cycle (p = 0.004), and ubiquitin mediated protein
catabolism (p = 0.006). Other GO categories show enrichment in both Qrr1p and Qrr1d.
For example, genes involved in RNA metabolism and ubiquitin-mediated protein
catabolism are also overrepresented among the transcripts modulated by Qrr1p (p =
0.002 for RNA metabolism and p = 0.005 for ubiquitin-protein ligases). This may either
be due to limitations in QTL resolution, or due to multiple loci in Qrr1p and Qrr1d
controlling these subsets of transcripts.
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5.4.6 An Aminoacyl-tRNA Synthetase Trans-QTL in Distal Qrr1
A remarkable number of transcripts of the ARS gene family map to Qrr1. A total
of 16 ARS transcripts have trans-QTLs at a minimum LOD score of 3 in one or multiple
BXD, B6D2F2, and B6C3H CNS data sets (Table 5-4). In almost all cases, QTLs peak
on markers on the distal part of Qrr1. Except for Hars, the B allele in Qrr1 consistently
increases expression by 10% to 30%. In the case of Hars, the D allele has the positive
additive effect and increases expression by about 10%.
We examined all probes or probe sets that target ARS and ARS-like genes in the
B6xD2 CNS data sets. The Affymetrix platform measures the expression of 34 ARS and
ARS-like genes; 24 of these map to Qrr1 at LOD scores ranging from a low of 2 to a
high of 12. Even in the case of the suggestive trans-QTLs (i.e., LOD values between 2
and 3), the B allele in Qrr1 has the positive effect on expression. The ARS family is also
highly represented among trans-QTLs in the B6C3HF2 brain data set. Thirty-seven
probes in this data set target the tRNA synthetases, eleven of these have trans-QTLs in
Qrr1d (LOD scores ranging from 2 to 20), and almost all have a B positive additive effect
(exceptions are Hars and Qars). The co-localization of trans-QTLs to Qrr1d, the general
consensus in parental allele effect, and their common biological function indicate that
there is a single QTL in the distal part of Qrr1 modulating the expression of the ARS. It
is crucial to note that this genetic modulation is only detected in CNS tissues.
In the LXS hippocampus data set, Qrr1 has only a limited trans-effect on gene
expression. Despite the weak effect, expression of Dars2 (probe ID ILM580427) maps to
the distal part of Qrr1 at a LOD of 3. Although this is only a weak detection of the ARS
QTL in the LXS data set, it nonetheless demonstrates the strong regulatory effect of Qrr1
on the expression of this gene family. In the case of the CXB hippocampus data set, not a
single trans-QTL for the ARS is detected in Qrr1.
5.4.7 Trans-QTLs for Transcripts Localized in Neuronal Processes
In addition to the high overrepresentation of transcripts involved in translation
and RNA metabolism, several transcripts known to be transported to neuronal processes
or involved in RNA transport also map to Qrr1d, including Camk2a, Bdnf, Cdc42, Eif4e,
Eif4g2, Hnrpab, Ppp1cc, Pabpc1, Eif5, Kpnb1, Rhoip3, Stau2, and Pum2 (Duchaîne et
al., 2002; Eberwine et al., 2002; Poon et al., 2006; Vessey et al., 2006). An interesting
example is provided by the brain derived neurotrophic factor (Bdnf). Two alternative
forms of Bdnf mRNA are known—one isoform has a long 3’ UTR and is specifically
transported into the dendrites; the other isoform has a short 3’ UTR and remains
primarily in the somatic cytosol (An et al., 2008) The Affymetrix M430 arrays contain
two different probe sets that target these Bdnf isoforms. Probe set 1422169_a_at targets
the distal 3’ UTR and is essentially specific for the dendritic isoform, and probe set
1422168_a_at targets a coding sequence common to both isoforms. Although both probe
sets detect high expression signal in the hippocampus, only the dendritic isoform maps as
a trans-QTL to Qrr1d. This enrichment in transcripts that are transported to neuronal
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Table 5-4

Aminoacyl-tRNA synthetases that have trans-QTLs in Qrr1

Gene

Name

Nars

asparaginyltRS
glycyl-tRS

ProbeIDA

ChrB

Data setC

LODD

B/DC

1452866_at Chr 18 BXD
12.0
B
_A
cerebellum
Gars
1423784_at Chr 6 BXD
10.6
B
hippocampus
Rars
arginyl-tRS
1416312_at Chr 11 BXD
8.9
B
_A
forebrain
Cars
cysteinyl-tRS
100244060 Chr 7 B6C3HF2
8.9
B
01
brain
Yars
tyrosyl-tRS
100243998 Chr 4 B6C3HF2
8.0
B
42
brain
Iars
isoleucine-tRS 1426705_s Chr 13 BXD
7.8
B
_at
cerebellum
Sars
seryl-tRS
1426257_a Chr 3 BXD
6.9
B
_at
cerebellum
Mars methionine1455951_at Chr 10 BXD
6.5
B
tRS
hippocampus
Hars histidyl-tRS
1438510_a Chr 18 BXD
5.2
D
_at
hippocampus
Iars2 isoleucine-tRS 1426735_at Chr 1 BXD
4.3
B
hippocampus
Tars
threonyl-tRS
100243956 Chr 15 B6C3HF2
4.0
B
55
brain
Aars
alanyl-tRS
1451083_s Chr 8 BXD
3.9
B
_at
eye
Lars
leucyl-tRS
1448403_at Chr 18 BXD
3.7
B
_A
cerebellum
Ears2 glutmyl-tRS
ILM52904 Chr 7 BXD ILM
3.7
B
46
striatum
Aarsd alanyl-tRS
1424006_at Chr 11 B6D2F2
3.5
B
1
domain 1
brain
Dars aspartyl-tRS
1423800_at Chr 1 BXD
3.2
B
_A
cerebellum
A
Probe/Probe set ID; BPhysical location of gene; Iars2 is located on Chr 1 at 186.9 Mb,
and Dars on Chr 1 at 130 Mb; CData set in which transcript has highest trans-QTL in
Qrr1; DHighest LOD score in Qrr1; EAllele that increases expression.
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processes raises the possibility that this CNS specific trans-effect may be related to local
protein synthesis.
5.4.8 tRNAs in Qrr1
Prompted by the many ARS transcripts that consistently map to Qrr1d, we
searched the genomic tRNA database (Lowe et al., 1997) for tRNAs in this region.
Interestingly, distal Chr 1 is one of many tRNA hotspots in the mouse genome and
several predicted tRNAs are clustered in the non-coding regions of Qrr1 (Figure 5-2).
The majority of these tRNA sequences are in the proximal end of Qrr1, over 2 Mb away
from Qrr1d. We scanned the intergenic non-coding regions in Qrr1d for tRNAs using the
tRNAscan-SE software (Lowe et al., 1997) and uncovered tRNAs for arginine and serine,
and three pseudo-tRNA sequences between genes Igsf4b and Aim2 (175.204–175.257
Mb) in Qrr1d (dataset S3). Transfer RNAs are involved in regulating transcription of the
ARS in response to cellular amino acid levels (Rychelynck et al., 2005) and are
functionally highly relevant candidates in Qrr1d. Polymorphism in the tRNA clusters
(e.g., possible copy number variants, differences in tRNA species) may have significant
impact on the expression of the ARS.
5.4.9 Sequence Analysis of Multiple Crosses
Trans-regulation of large number of transcripts by Qrr1 is a strong feature of
crosses between B6 and D2 —both the BXD RI set and B6D2F2 intercrosses—and in the
B6 and C3H intercrosses. The feature is much weaker in the large LXS RI set and in the
small CXB panel. The effect specificity demonstrates that a major source of the Qrr1
signal is generated by variations between B and D, and B and C3H alleles (H) but not by
variations between the ILS and ISS alleles (L and S, respectively), and B and BALB
alleles (C). This contrast can be exploited to identify sub-regions that underlie the transQTLs (Hitzemann et al., 2002).
SNPs were counted for all four pairs of parental haplotypes—B vs D, B vs H, B vs
C, and L vs S—and SNP profiles for the four crosses were compared (Figure 5-5). Qrr1
is a highly polymorphic interval in the B6xD2 crosses. The flanking regions, however,
have few SNPs (170–172.25 Mb proximally, and 177.5–179.5 Mb distally) and are
almost identical-by-descent between B6 and D2. The B6xBALB crosses, despite being
negative for the trans-effect, have moderate to high SNP counts in Qrr1 and share a SNP
profile somewhat similar to B6xD2 crosses. The B6xC3H crosses also have moderate to
high SNP counts in Qrr1, with a relatively higher SNP count in Qrr1d compared to
Qrr1p. In contrast, in the LXS, Qrr1p is more SNP-rich than Qrr1d. Most notably, the
segments that harbor the tRNAs and candidates Fmn2, Grem2, and Rgs7 are almost
identical by descent between ILS and ISS. This SNP comparison indicates that the
strongest trans-effect is from Qrr1d. A possible reason why the trans-effect is not
detected in the CXB RI strains, despite being SNP rich in Qrr1, is that the crucial SNPs
underlying the trans-QTLs may not be segregating in this cross or that undetected copy
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Figure 5-5
SNP comparison of multiple crosses
SNPs in Qrr1 were counted for (A) C57BL/6J (B6) x DBA/2J (D2), (B) B6 x BALB/cBy
(BALB), (C) B6 x C3H/HeJ (C3H), and (D) ILS x ISS. Vertical red lines mark the
approximate positions of recombination. Region covered by Qrr1p (horizontal line),
candidate genes in Qrr1d (yellow bars), and position of tRNA clusters (triangles) are
shown above the graphs. The B6xD2, B6xBALB, and B6xC3H crosses have moderate to
high SNP counts throughout Qrr1. In the ILSxISS cross, Qrr1p is relatively SNP-rich but
Qrr1d is SNP-sparse.
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number variants make important contributions to the Qrr1 effects. A final explanation
may be that the small CXB data set (13 strains) is simply underpowered.
5.4.10 High-Ranking Candidates Based on Cross-Specificity of Cis-QTLs
We used the specificity of cis-QTLs in the multiple crosses to identify higher
priority candidates in Qrr1. The assumption is that candidate genes whose transcripts
have cis-QTLs (LOD score above 3) in the B6xD2 and B6xC3H crosses but not in the
LXS and CXB RI strains are stronger candidates for trans-QTLs that are detected in the
former two crosses but not in the latter two crosses. In contrast, cis-QTLs with the
inverse cross specificity are less likely to underlie these trans-QTLs. Based on this
criterion, there are four high-ranking candidates in Qrr1p—Purkinje cell protein 4-like 1
(Pcp4l1), prefoldin (Pfdn2), WD repeat domain 42 a (Wdr42a), and Kcnj10 (Table 5-2).
There are only two high-ranking candidates in Qrr1d—formin 2 (Fmn2), an actin binding
protein involved in cytoskeletal organization, and regulator of G-protein signaling 7
(Rgs7) (Table 5-2).
Both Fmn2 and Rgs7 are almost exclusively expressed in the CNS and are high
priority candidates for the CNS specific trans-QTLs. A point of distinction between the
two candidates is that while expression of Rgs7 maps as a cis-QTL only in the B6xD2
and B6xC3H crosses, expression of Fmn2 maps as a cis-QTL in B6xD2 and B6xC3H
crosses, and in the CXB RI strains in which the trans-effect is not detected (Table 5-2).
Based on the pattern of specificity of cis-QTLs in multiple crosses, Rgs7 is a more
appealing candidate. However, Fmn2 has known missense SNPs that segregate in the
B6xD2 (Glu610Asp, Pro1077Leu, Asp1431Glu) and B6xC3H crosses (Val372Ala).
There are no known missense mutations in Fmn2 in the CXB and LXS RI strains, and no
known missense mutation in Rgs7 in any of the four crosses.
5.4.11 Partial Correlation Analysis
Linkage disequilibrium (LD) is a major confounding factor that limits fine-scale
discrimination among physically linked candidates in a QTL. To further evaluate the two
high-priority candidates in Qrr1d—Fmn2 and Rgs7—we implemented a partial
correlation analysis (de La Fuente et al., 2004) in which the effect of genotype at Qrr1d
was controlled. For this analysis, we computed the partial correlation coefficient between
cis-regulated transcripts and each trans-regulated transcript after regression against the
Qrr1d genotype. This partial correlation reveals residual variance that links cis candidates
with trans targets, independent of genetic variance at Qrr1d. We computed the partial
correlation between Rgs7 and Fmn2, and 14 transcripts representative of the different
GOs that map to Qrr1d. The highest partial correlations are between Fmn2 and Rnf6 (r =
0.68, p < 10-13), Atf4 (r = 0.6, p < 10-9), Asns (r = 0.55, p < 10-7), Ube2d3 (r = 0.5, p <
10-6), Hnrpk (r = 0.5, p = 10-5), Rab2 (r = –0.5, p = 10-5), and Gars (r = 0.5, p = 10-5).
The strongest correlate of Fmn2 is Rnf6, a gene involved in regulating actin dynamics in

95

axonal growth cones (Tursun et al., 2005) Although not unequivocal, this analysis
provides stronger support for Fmn2 than for Rgs7.
5.4.12 Effect of Fmn2-Deletion on Gene Expression
Fmn2 is almost exclusively expressed in the nervous system (Leader et al., 2000)
and is a strong candidate for a trans-effect specific to neural tissues. However, its precise
function in the brain has not been established. Fmn2-null mice do not have notable CNS
abnormalities (Leader et al., 2002), but to evaluate a possible role of Fmn2 on expression
of genes that map to Qrr1d, we generated array data from brains of Fmn2-null (Fmn2-/-)
and coisogenic (Fmn2+/+) 129/SvEv controls. At a stringent statistical threshold
(Bonferroni corrected p < 0.05), only eight genes have significant expression differences
between Fmn2-/- and Fmn2+/+ genotypes (Table 5-5). Five out of the eight genes,
including Pou6f1, Usp53, and Slc11a, have trans-QTLs in Qrr1d. Deletion of Fmn2 had
the most drastic effect on the expression of the transcription factor gene Pou6f1, a gene
implicated in CNS development and regulation of brain-specific gene expression (Cui et
al., 1998; Drews et al., 2007). Expression of Pou6f1 maps as a trans-QTL (at LOD score
of 3) to Qrr1d in the hippocampus data set, and its expression was down-regulated more
than 44-fold in the Fmn2-/- line. While the expression analysis of Fmn2-null mice does
not definitively link all the trans-QTLs to Fmn2, variation in this gene is likely to
underlie some of the trans-QTLs in Qrr1d. The possible compensatory mechanism in the
Fmn2-null CNS, and the different genetic background of the mice (129/SvEv) are factors
that may have contributed to the weak detection of trans-effects in the knockout line.
5.4.13 Sub-Cellular Localization of FMN2 in Hippocampal Neurons
We examined the intracellular distribution of FMN2 protein in neurons using
immunocytochemical techniques. All hippocampal pyramidal neurons on a culture dish
exhibited distinct and fine granular immunoreactivity for FMN2. The cell body itself had
the strongest signal (Figure 5-6). This fine punctate labeling extended into proximal
dendrites and could be followed into distal dendrites. In some instances very thin
processes, possibly the axons, were also labeled.
5.4.14 Linking Expression and Classical QTLs: Szs1
The strong trans-effect that Qrr1 has on gene expression is a likely basis for the
classical QTLs that map to this region. For example, the major seizure susceptibility QTL
(Szs1) has been precisely narrowed to Qrr1p (Ferraro et al., 2007). We found that 10
genes already known to be associated with seizure or epilepsy have trans-QTLs with
peak LOD scores near Szs1and in Qrr1p. These include Scn1b, Cacna1g, Pnpo, and
Dapk1 (Table 5-6). In every case, the D allele has the positive additive effect on the
expression of these seizure related transcripts, increasing expression 5% to 20%. The two
potassium channel genes, Kcnj9 and Kcnj10, are the primary candidates (Ferraro et al.,
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Table 5-5

Genes differentially expressed between Fmn2+/+ and Fmn2-/Chr

Fmn
2+/+B

Pou6f1

15

11.96 6.48

45

3X10 3.0

Zfp420

7

10.12 7.70

5

0.002

Txnl1

18

10.72 6.70

16

0.002 3.0

Usp53

3

7.17

4

0.009 3.3

LOC33113
9
Slc11a2

4

14.45 10.59 15

0.01

15

9.92

2

0.02

3.9

Pgbd5

8

13.40 12.12 2

0.02

3.3

Gene

A

Fmn
2-/-B

9.32

9.17

FoldC

PD

LODE

-6

DatasetE
BXD
Hippocampus
B6D2F2
striatum
BXD
Hippocampus
BXD
Hippocampus
BXD HBP
Striatum

6330569M2 3
6.42 10.63 18
0.03
2Rik
A
Physical location of gene; BAverage expression signal in Fmn2-null and wild-type lines;
C
Fold difference in expression between Fmn2-null and wild-type lines; DBonferroni
adjusted p-values; corrected for 46,620 tests; EHighest LOD in Qrr1 and data set in
which transcript has highest LOD in Qrr1.
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Figure 5-6
Expression of FMN2 protein in hippocampal neurons
(A) Neurons exhibited pronounced fine granular immunoreactivity for FMN2. The cell
body had the strongest signal. The fine granular staining extended into apical and distal
dendrites (arrows). Thin axon-like processes were also labeled (arrow head). (B) The fine
granular staining is not detected in controls of sister cultures processed in parallel without
the first antibody.
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Table 5-6
Gene

Seizure associated genes with trans-QTLs in Qrr1p
ChrA

Data setB

LODC

B/DD

Reference

Scn1b
Chr 7 Forebrain
3.5
D
Wallace et al., 1998
Akt1
Chr 12 Forebrain
3.0
D
Henshall et al., 2002
Cacna1g Chr 11 Forebrain
2.8
D
Song et al., 2004
Pnpo
Chr 11 Cerebellum
29
D
Mills et al., 2005
Dapk1
Chr 13 Cerebellum
6.3
D
Henshall et al., 2004
Kcnma1 Chr 14 Cerebellum
3.7
D
Du et al., 2005
Socs2
Chr 10 Cerebellum
3.7
D
Rosell et al., 2003
Nsf
Chr 11 Cerebellum
3.3
D
Yin et al., 2005
Grm2
Chr 9 Cerebellum
3.3
D
Thomsen et al., 1994
Adora1
Chr 1 Hippocampus 3.0
D
Fedele et al., 2006
A
Physical location of gene; Adora1 is located on Chr 1 at 136 Mb; BDataset in which
transcript has highest trans-QTL in Qrr1p; CHighest LOD scores in Qrr1p; DAllele that
increases expression.
2007). Both are strongly cis-regulated. The tight linkage between these genes (within 100
kb) limits further genetic dissection, but in situ expression data from the Allen Brain
Atlas (ABA, http://www.brain-map.org) provides us with a powerful complementary
approach to evaluate these candidates (Lau et al., 2008). Kcnj9 (Figure 5-7A) is
expressed most heavily in neurons within the dentate gyrus, whereas Kcnj10 (Figure
5-7B) is expressed diffusely in glial cells in all parts of the CNS. The seizure-related
transcripts with trans-QTLs near Szs1 are most highly expressed in neurons, and all have
comparatively high expression in the hippocampus. Furthermore, expression patterns of
six of the seizure transcripts that map to Qrr1p show spatial correlations with Kcnj9.
Dapk1 and Cacna1g (Figure 5-7C) have expression pattern that match Kcnj9 with strong
labeling in the dentate gyrus and CA1, and weaker labeling in CA2 and CA3. In contrast,
Socs2 (Figure 5-7D), Adora1, Pnpo, and Kcnma1 complement the expression of Kcnj9
with comparatively strong expression in CA2 and CA3, and weak expression in CA1 and
dentate gyrus.
5.5

Discussion

Qrr1 is a complex regulatory region that modulates expression of many genes and
classical phenotypes. By exploiting a variety of microarray data sets and by applying a
combination of high-resolution mapping, sequence analysis, and multiple cross analysis,
we have dissected Qrr1 into segments that are primarily responsible for variation in the
expression of functionally coherent sets of transcripts. The distal portion of Qrr1 (Qrr1d)
has a strong trans-effect on RNA metabolism, translation, tRNA aminoacylation, and
transcripts that are transported into neuronal dendrites. Fmn2, Rgs7, and a cluster of
tRNAs are strong candidates in Qrr1d. We analyzed gene expression changes in the CNS
of Fmn2-null mice and detected a profound effect on the expression of a small number of
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Figure 5-7
Expression pattern of seizure-related genes with QTLs in Qrr1
Candidate gene Kcnj9 (A) has heavy expression in neurons. Kcnj9 shows a regionally
restricted expression in the hippocampus with intense labeling in dentate gyrus, strong
labeling in CA1, and relatively weak labeling in CA2 and CA3. Candidate gene Kcnj10
(B) has a more diffused pattern and expressed primarily in glial cells. There is almost no
labeling for Kcnj10 in the hippocampus. Transcripts of seizure-related genes, Cacna1g
(C) and Socs2 (D), have trans-QTLs in Qrr1p. Both genes show high expression in
neurons. Cacna1g matches the expression of Kcnj9 with strong labeling in dentate gyrus
and CA1, and weak labeling in CA2 and CA3. Socs2 complements the expression of
Kcnj9 and Cacna1g with intense labeling in CA2 and CA3. In situ expression data are
from the Allen Brain Atlas.
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transcripts that map to Qrr1d, particularly on the expression of the transcription factor
Pou6f1. We have shown that the FMN2 protein is highly expressed in the cell body and
processes of neurons, and is a high priority candidate in Qrr1d.
5.5.1 Kcnj9 vs. Kncj10 and Seizure Susceptibility
The two inwardly rectifying potassium channel genes—Kcnj9 and Kcnj10—are
strong candidates for the seizure susceptibility QTL in Qrr1p that has been
unambiguously narrowed to the short interval from Atp1a2 to Kcnj10 (Ferraro et al.,
2004). In BXD CNS data sets, Qrr1 also modulates the expression of a set of genes
implicated in the etiology of seizure and epilepsy, including Pnpo, Scn1b, Kcnma1,
Socs2, and Cacna1g. Polymorphisms in the Kcnj9/Kcnj10 interval that influence
expression of these genes are excellent candidates for the Szs1 locus.
The in situ expression data in the ABA shows a striking spatial correlation
between expression of Kcnj9 and other seizure-related transcripts that have trans-QTLs
in Qrr1p. The complementary expression of Kcnj9 and the seizure-related transcripts
make Kcnj9 a stronger candidate than Kcnj10. Kcnj9 has over a 2-fold higher expression
in D2 (Hitzemann et al., 2003), a seizure prone strain, compared to B6, a relatively
seizure resistant strain, suggesting that the proximal cause of Szs1 may be high
expression of this gene, perhaps due to the promoter polymorphism discovered by
Hitzemann and colleagues (2003).
5.5.2 Multiple Loci in a Major QTL Interval
Fine mapping of complex traits have often yielded multiple constituent loci within
a QTL interval (Legare et al., 2000; Demarest et al., 2001). Our mapping analyses of
expression traits also show that multiple gene variants, rather than one master regulatory
gene, cause the aggregation of expression QTLs in Qrr1. Subgroups of genes with tight
coexpression can be dissected from the dense cluster of QTLs. Most notable is the strong
trans-regulatory effect of Qrr1d on genes involved in amino acid metabolism and
translation, including a host of ARS transcripts. However, there are limits to our ability to
dissect Qrr1, and genes associated with protein degradation and RNA metabolism map
throughout the region. In part this may be due to inadequate mapping resolution, but it
may also reflect clusters of functionally related loci and genes (Petkov et al., 2006). At
this stage we are also unable to discern whether there is a single or multiple QTLs within
Qrr1d. While it is likely that a single QTL modulates the expression of the ARS, there
may be additional gene variants in Qrr1d that modulate other transcripts involved in
translation and RNA metabolism. With increased resolving power it may be possible to
further subdivide transcripts that map to Qrr1p and Qrr1d into smaller functional
modules.
There may be multiple loci in Qrr1 that modulate different stages of protein
metabolism in the CNS. Maintenance of cellular protein homeostasis requires finely
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tuned cross talk between transcription and RNA processing, the translation machinery,
and protein degradation (Ding et al., 2007), gene functions highly overrepresented among
the transcripts that map to Qrr1. While these are generic cellular processes, there are
unique demands on protein metabolism in the nervous system. Neurons are highly
polarized cells and specialized mechanisms are in place to manage local protein synthesis
and degradation in dendrites and axons (Steward et al., 2003). The nervous system is also
particularly sensitive to imbalances in protein homeostasis (Malgaroli et al., 2006), a
possible reason why the trans-effects of Qrr1 are detected only in neural tissues.
5.5.3 Candidates in Qrr1d and Possible Link with Local Protein Synthesis
Transfer RNAs are direct biological partners of the ARS, and the cluster of
tRNAs in the highly polymorphic intergenic region of Qrr1d is an enticing candidate. In
addition to their role in shuttling amino acids, tRNAs also act as sensors of cellular amino
acid levels and regulate transcription of genes involved in amino acid metabolism and the
ARS (Ryckelynck et al., 2005). There is tissue specificity in the expression of different
tRNA isoforms (Dittmar et al., 2006) and we speculate that the tRNA cluster in Qrr1d is
specifically functional in neural tissues.
Rgs7, a member of the RGS (regulator of G-protein signaling) family, is another
high-ranking candidate in Qrr1d. RGS proteins are important regulators of G-protein
mediated signal transduction. Rgs7 is predominantly expressed in the brain and has been
implicated in regulation of neuronal excitability and synaptic transmission (Saitoh et al.,
1999; Hunt et al., 2003). Although RGS proteins are usually localized in the plasma
membrane, RGS7 has been found to shuttle between the membrane and the nucleus
(Drenan et al., 2005). This implies a role for RGS7 in gene expression regulation in
response to external stimuli.
Our final high-ranking candidate in Qrr1d is Fmn2. It codes for an actin binding
protein exclusively expressed in the CNS and oocytes, and is involved in the
establishment of cell polarity (Leader et al., 2000; Leader et al., 2002). In Drosophila, the
formin homolog, cappuccino, has a role in RNA transport and in localizing the staufen
protein to oocyte poles (Emmons et al., 1995; Johnstone et al., 2001). It is possible that
FMN2 has parallel functions in mammalian neurons. Interestingly, Staufen 2 (Stau2), a
gene involved in RNA transport to dendrites (Duchaîne et al., 2002), maps to Qrr1d in
BXD CNS data sets. Furthermore, deletion of formin homologs in yeast results in
inhibition of protein translation (Gross & Kinzy, 2007), compelling evidence for an
interaction between the protein translation system and formins. Evidence for a role for
Fmn2 in dendrites also comes from our immunocytochemical analysis that clearly
demonstrates the expression of FMN2 protein in dendrites. Taken together, Fmn2 is a
functionally relevant candidate gene in Qrr1d and may be related to RNA transport and
protein synthesis in the CNS.
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CHAPTER 6. SUMMARY AND CONCLUDING REMARKS
The work presented in this dissertation is an integrative, systems genetics
approach to explore the molecular factors and brain structures that underlie emotional
processing and behavior. The overarching question that was pursued in this study was—
how does information in the DNA sequence give rise to the rich variants of neural and
behavioral traits? A combination of analytical methods, including morphometric analysis,
classic QTL mapping, behavioral assays, gene expression analysis, and expression QTL
mapping was used to identify the genetic modulators of the corticolimbic brain structures,
particularly the basolateral amygdala (BLA), and associated emotion-related behavior.
The molecular origins of psychological conditions such as stress, anxiety and fear,
and the resultant behavioral traits are extraordinarily complex and arise from the
interaction of a host of genetic, epigenetic, and environmental factors. The integrative
approach taken by system genetics is to consider each phenotype within the context of a
vast network of causal factors and interrelated phenotypes. For example, multiple gene
variants and molecular traits define the cellular and physiological traits that make up
neural structures such as the BLA, which in turn give rise to higher-order cognitive and
behavioral traits. In this light, genetic variations can be viewed as perturbations that
resonate across multiple phenotypic levels.
Within the framework of systems genetics, each phenotype that was examined in
this study was considered in relation to other phenotypes. The analytical strategy can be
broken down into four basic steps: (1) exploit natural variations in neuroanatomy to
uncover genes that may have pleiotropic influence on brain structure and behavior, (2)
examine the association between variations in neuroanatomy and behavior, (3) examine
gene expression (both baseline and in response to stressful experience) in the
neuroanatomic substrates of behavior, and (4) examine genetic regulators of expression
traits to identify genes and gene-networks that underlie higher-order structural and
behavioral traits.
In the first step, variation in the size and cytoarchitecture of the BLA was
analyzed to identify the underlying DNA sequence variants. As a central modulator of
emotional processes, we reasoned that such variations associated with the BLA might be
coupled to variations in fear, anxiety and stress responses. This analysis was done in a
genetically segregating population of BXD RI mouse strains and harvests the power of
natural variations to uncover multiple genes and gene-networks. This stands in contrast to
the very reductive approach of examining a single or few genes at a time, as is the case
with most gene knockout and transgenic studies. Genetic mapping of the BLA traits
uncovered multiple QTLs linked to the BLA neuroanatomy (Vol8a in Chr 8, and loci on
Chrs 11 and 13). This study implicated genes with no prior known association with the
BLA (e.g., Large, Neurocan), and also genes already known to be involved in the
development of the BLA, e.g., NeuroD2 (Lin et al., 2005).
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Following the morphometric and QTL analyses, the second step was to examine
whether the variation in BLA neuroanatomy could indeed predict behavioral outcome. A
correlative analysis with a variety of behavioral traits collected from the BXD strains
showed significant correlations between the BLA and emotion- and addiction-related
behavior. A systematic analysis was also done to compare the behaviors of BXD strains
with small, medium, and large BLAs. The three groups of BXD strains showed
significant differences in fear learning and stress reactivity. Mice with smaller BLA
volumes showed significantly higher fear responses to conditioned auditory stimuli and
contextual stimuli. The smaller BLA group also showed a more pronounced
glucocorticoid response to stress. Given that the neuroanatomical data and behavioral
data were collected from two different sites (UTHSC and NIH, respectively), this
association between the traits demonstrates the robustness of the effect of BLA size on
emotion-related processes.
To introduce more genetic diversity, we then went on to survey a panel of seven
inbred strains (129/SvImJ, A/J, BALB/cJ, BALB/cByJ, FVBN/J, and B6 and D2) for
emotion-related behavior. We also asked how these strains differed in their relative
vulnerability to stressful experience by examining their behavior prior to, and following
stress. We found that B6 and D2 showed the most interesting divergence in behavior.
Consistent with previous studies, D2 showed a higher anxiety-like trait compared to B6.
In addition, while B6 remained relatively resilient to restraint-stress (i.e., this strain
showed no difference in anxiety-like behavior before and after restraint), D2 mice
showed heightened anxiety-like behavior after restraint-stress.
In the third step, to elucidate the molecular correlates of such behavioral contrasts,
we examined gene expression in the amygdala (primarily the BLA) of B6 and D2 mice.
The prefrontal cortex and hippocampus were also included in the expression analysis as
these two regions have also been implicated in stress-responsiveness and anxiety-related
behavior. By comparing both baseline expression between B6 and D2, and expression
changes following restraint-stress, we hoped to identify genes that contribute to the
striking trait divergence that characterizes these two strains. This study revealed
substantial quantitative differences in expression between B6 and D2. There was also
marked strain difference in the set of genes that showed stress-induced changes in
expression. Interestingly, several of the genes that were identified by this study have been
implicated in human neuropsychiatric disorders (e.g. Rgs2, Nr4a2, Comt, and clock genes
such as Dbp, Per1, Per2, and Per3).
In the fourth step, we sought to identify DNA sequence variants that influence
both molecular phenotypes as well as phenotypes at the structural and behavioral level. A
remarkable region located on the distal end of mouse Chr 1 (172–178 Mb) was the ideal
subject for such an integrative study. This region, which we have named as Qrr1 (QTL
rich region on distal Chr 1), is known for its unusually high density of QTLs for neural
and behavioral traits, e.g., traits like anxiety-related behavior, seizure, hippocampal
volume, and alcohol preference consistently map to this region. Additionally, Qrr1 is also
an expression QTL hotspot and controls the expression of hundreds of mRNA transcripts
in neural tissues. Our analysis of Qrr1 uncovered much complexity in this QTL region.
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Rather than one “master-regulator” gene controlling multiple phenotypes, Qrr1 appears
to be a complicated cluster of QTLs controlling modules of gene-networks. At the current
level of resolution, we were able to delineate a proximal region (Qrr1p) in which Kcnj9 is
a strong candidate, and a distal region (Qrr1d) in which Fmn2 is the strongest candidate.
Increasing the mapping resolution may be able to further subdivide the proximal and
distal regions into even finer regulatory loci. This influence on gene expression may be
the reason why so many classical QTLs have been mapped to Qrr1.
The complexity highlighted by Qrr1 may very well be the rule rather than the
exception for loci that modulate complex traits. Efforts to fine-map a single QTL have
often been confronted by clusters of multiple small effect QTLs within the original
interval (Legare et al., 2000; Demarest et al., 2001). This poses a serious challenge, and
to date, only a small handful of genes have been definitively identified for complex traits.
Our own efforts to identify a causal gene were stymied by the compound nature of QTLs
and the high gene density in Qrr1, and in Vol8a. Furthermore, it is now becoming clear
that in addition to the canonical candidate genes, there are multiple spliced variants,
microRNAs, and epigenetic factors to be considered.
With what appears to be an increasingly complex genomic landscape, it is now all
the more necessary to apply the multipronged approach taken by systems genetics. The
work expounded in this dissertation is an example of such an integrative approach and
could be considered as the groundwork for even deeper analyses of the information coded
in the DNA. Further advancement in genomic technology, higher resolution sequencing
of the DNA, and more sophisticated statistical and analytical techniques will ultimately
yield answers that, up to this point, may seem elusive.
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